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Abstract 
 
Injury of the recurrent laryngeal nerve (RLN), a branch of the vagus nerve, results 
in ipsilateral vocal fold (VF) paralysis that contributes to dysphagia, dysphonia, and 
dyspnea (i.e., swallow, vocal, and respiratory dysfunction, respectively). 
Unfortunately, there is no clinical intervention that will reliably restore physiologic 
movement to the VF after an RLN injury. Throughout this work, the effects of RLN 
injury on murine VF motion, swallowing behavior, vocalization production, and 
respiratory function are examined. Furthermore, methods for refining the functional 
assays used to assess these behaviors are developed, allowing for the production 
of more reliable and translatable results. Therefore, in Chapter 2, the effects of 
RLN injury are explored to confirm the fidelity of the laryngeal innervation pattern 
and functional outcomes (for vocal fold motion and swallowing) between mice and 
humans. In Chapter 3, an automated VF tracking and quantification software is 
developed to objectively measure dynamic VF motion, which is further refined in 
Chapter 4. Also in Chapter 4, we expand our translational mouse model to 
characterize swallow, vocal, and respiratory function in mice with unilateral VF 
paralysis following RLN injury. Lastly, VNS and its role as a therapeutic 
intervention for RLN injury is studied (Chapter 2), as well as the potential off-target 
effects this therapy may have on the many other organ systems provided 
innervation by the vagus nerve (Chapter 5). In conclusion, this work aims to 
provide a refined and reproducible animal model for researchers to use to 
investigate RLN pathophysiology and treatment options. 
1 
 
Chapter One 
 
INTRODUCTION 
 
 
1.1 Recurrent Laryngeal Nerve Injury  
Injury of the recurrent laryngeal nerve (RLN), a branch of the vagus nerve, 
results in ipsilateral vocal fold (VF) paralysis that contributes to dysphagia, 
dysphonia, and dyspnea (i.e., swallow, vocal, and respiratory dysfunction, 
respectively).1-5 RLN injury may occur as a result of idiopathic disease, infection, 
inflammation, neck trauma, or malignancy, but the nerve is particularly prone to 
iatrogenic injury during surgical procedures that target the anterior neck and upper 
thoracic cavity, such as thyroidectomies and anterior cervical discectomy and 
fusion.3,6-9 During surgery, the nerve may be injured through a variety of 
mechanisms, including traction, compression, thermal, electrical, and transection 
injuries.6,10 The increased incidence of RLN injury during these procedures is 
attributed to the RLN’s location, long length, and variable topographical 
patterns.11,12 As a result, dysphagia, dysphonia, and dyspnea are common upper 
airway complications following cervical and thoracic surgeries.13 These conditions, 
especially if chronically persistent, are associated with poor quality of life, major 
depression, increased financial burden, and decreased general health for the 
patient.1,5,7,14  
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Though the peripheral nervous system initiates a robust regenerative 
response after an RLN injury, functional recovery is often inadequate.2 The RLN 
innervates the majority of intrinsic laryngeal adductor muscles, as well as the only 
abductor muscle, the posterior cricoarytenoid.4 Poor specificity during 
reinnervation of these antagonist muscles after an injury can lead to weak, 
uncoordinated, and sometimes paradoxical muscle contraction of the VFs (i.e., 
synkinesis).6,10 In addition to reduced specificity of reinnervation, poor clinical 
recovery can be attributed to slow and staggered rates of axonal regeneration and 
death of neuronal cell bodies in the brainstem motor nucleus, the nucleus 
ambiguus, the extent of which depends on the severity and location of the 
injury.10,15,16 Therefore, while the RLN may attempt to regenerate after damage, 
return to absolute normal function is not guaranteed.  
Unfortunately, there is no clinical intervention that will reliably restore 
physiologic movement to the VF after an RLN injury.3,17-19 Many of the current 
therapeutic interventions for VF paralysis focus on behavioral exercises and 
modifications (e.g., altering respiration while speaking or adjusting swallow 
behavior to prevent aspiration of food material) to improve laryngeal function.20 
Alternative therapeutic strategies include medialization of the impaired VF, which 
provides structural support for more favorable glottic closure, but does little to 
address VF mobility or muscle denervation atrophy. Invasive secondary surgeries, 
such as RLN anastomosis or nerve graft procedures, may also be attempted to 
reinnervate RLN target organs in order to improve tone to VF musculature.10,14,21 
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However, these techniques, even if successful, also fail to restore true physiologic 
movement to the VFs.   
Thus, it is imperative to continue research for potential treatments for RLN 
injury that will overcome the deficiencies in the nerve regenerative process and will 
restore full functionality to inadvertently impaired VFs following surgical 
procedures. To do so, animal models are required, as RLN injury and its 
associated sequelae are often impossible and unethical to scientifically investigate 
in human patients.  Moreover, it is necessary that animal models consistently 
replicate the many symptoms and complications associated with RLN damage to 
increase translatability to human patients.  In addition to the animals themselves, 
reliable functional assays to quantify these symptoms are fundamental to 
systematically and consistently evaluate the pathophysiology, recovery, and 
potential treatments for this complicated injury.  
 
1.2 Functional Assays to Investigate RLN Injury in Animal Models 
1.2.1 Vocal Fold Motion Analysis 
 The most common method to confirm ipsilateral VF paralysis and evaluate 
functional recovery after RLN injury is through the use of endoscopy to visualize 
and record the movement of the VFs.9,16,22,23 This technique provides immediate 
and robust information concerning the movement of the VF, but does not directly 
evaluate the other functional aspects of RLN injury, such as swallow, vocal, and 
respiratory function. However, as endoscopy is the most widely used procedure 
for assessing RLN injury and recovery, there are various approaches used by 
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research groups to evaluate and quantify VF motion with this technique. A common 
method utilizes subjective rating scales to categorize VF motion.9,13,16,24-26 For 
example, the VF may be scored as zero if immobile, one if partially immobile, and 
two if fully mobile. Though subjective scoring of VF motion is relatively simple and 
time efficient, scores may vary between observers and small changes in VF 
movement over time are not measureable and are likely missed. Thus, objective 
measures are available to better quantify VF motion.  
Most approaches for objectively determining VF function rely on using still-
frame image analysis while the VFs are in a state of maximum abduction and 
maximum adduction. In each of these states, one can calculate angles9,16,23 and/or 
the glottal area18,22,27 between the VFs to determine the degree of movement of 
the injured VF between maximum opening and maximum closing. However, these 
objective methods also have their own inherent limitations, which are discussed in 
depth in Chapter 3. One significant weakness of these types of objective measures 
is that they rely on static images from only two time points during the respiratory 
cycle. Thus, no information is provided about the dynamics of VF motion as a 
whole.  
To overcome this problem, one group performed frame-by-frame analysis 
to measure the displacement of each VF from midline throughout a video clip.28 
Through this technique, they were able to detect residual VF motion during or after 
an RLN injury. However, this method required the manual analysis of over 100 
individual video frames, rendering this method extremely time consuming and 
labor intensive, limiting its usefulness. While manual frame-by-frame analysis may 
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not be a practical tool, especially in a clinical setting, an automated approach may 
produce similar results and would increase efficiency. Furthermore, automated 
analysis could provide valuable, novel, and reproducible outcome metrics of VF 
motion throughout an entire video clip of a clinically meaningful duration (i.e., 
several seconds to minutes). The development of this technology would likely allow 
high throughput, reliable analysis of dynamic VF motion, potentially benefitting 
researchers and clinicians alike.  
 
1.2.2 Swallow Function Analysis 
 Swallowing is a vital human function to move nutritional material from the 
oral cavity through the oropharynx and into the esophagus.29 For a normal swallow, 
proper laryngeal kinematics are critical to move the bolus in the appropriate 
direction and to protect the airways from foreign material. The VFs, specifically, 
play an essential role in protecting the airway during this complex process. This 
protective mechanism is mediated, in part, by the RLN. Similarly, the laryngeal 
adductor reflex (LAR), another protective mechanism to prevent aspiration of 
foreign material into the airways, also relies on the RLN. The entire reflex is 
initiated when mechanoreceptors and chemoreceptors in the laryngopharyngeal 
mucosa are stimulated. The superior laryngeal nerve (SLN) transmits sensory 
information from these receptors to the brainstem. Motor information is then 
projected along the RLN, which in an intact nerve will stimulate a brief bilateral 
contraction of the VF adductor muscles, causing medialization of the VFs and 
protection of the airway from penetration of foreign material.30,31 Therefore, RLN 
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injury may compromise VF closure during swallowing and/or the LAR, resulting in 
a less responsive and unprotected airway that can contribute to dysphagia with 
laryngeal penetration and/or aspiration.1 These conditions may in turn lead to 
aspiration pneumonia, asphyxiation, malnutrition, and dehydration, further 
decreasing the general health of the patient.29 
 The RLN also provides innervation to the esophagus, particularly the upper 
esophagus and the cricopharyngeus muscle, a major component of the upper 
esophageal sphincter.32,33 As such, patients with RLN injury may experience 
symptoms related to esophageal dysphagia, rather than or in addition to 
oropharyngeal dysfunction. In fact, studies using manometry in rat and rabbit 
models have shown that RLN transection significantly decreases the negative 
pressure of the upper esophageal sphincter during swallowing.29,34 Thus, swallow 
dysfunction after RLN injury is likely due to a combination of incomplete opening 
of the upper esophageal sphincter and incomplete closure of the glottis.34 In 
addition, RLN injury may initiate a cascade of events that impact interneural 
connections in the central nervous system, which in turn may influence the 
muscles and structures involved in swallowing beyond those solely innervated by 
the RLN.35,36  
In clinical settings, dysphagia is most commonly assessed using 
videofluoroscopic and videoendoscopic techniques.37-40 During a video-
fluoroscopic swallow study, the gold standard diagnostic test for dysphagia, a 
human patient is positioned in a fluoroscopy machine to assess the real time 
movement of food or liquid traveling from the mouth to the stomach. Video 
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recordings of multiple swallows can then be analyzed for various physiologic 
outcome metrics for each patient.41 This technique has been limited in animal 
models due to unique challenges, such as reliance on sedation and nonphysiologic 
feeding positions, motion artifact, and opposition to ingestion of oral contrast 
material.42,43  
Fortunately, these challenges have been largely overcome by recent 
research groups. In fact, videofluoroscopy has been adapted for use to assess 
normal and abnormal swallowing in freely-behaving (i.e., unanesthetized) non-
human primates44, cats45, dogs43, infant pigs35,36,46-50, rats51, and mice41,52,53. Yet, 
dysphagia, specifically after RLN injury, has only been extensively investigated in 
the infant pig model. Through this model, it has been shown that RLN injury results 
in dysphagia with compromised airway protection and esophageal dysfunction.49 
Furthermore, a unilateral RLN injury in this model likely affects central brainstem 
integration and the complex interneuron connections within the brain; thus, it 
influences the activity of other muscles involved with swallowing, such as muscles 
responsible for bolus aggregation and movement (e.g., geniohyoid and 
genioglossus muscles) that are not directly innervated by the RLN.35 Despite the 
many impressive and novel findings obtained from the infant pig model, the results 
are better translational to neonatal patients whose nervous system is in similar 
stages of development. However, as many anterior neck surgical procedures are 
performed in older patients (greater than 50 years of age),1,54 an aged RLN injury 
model with a fully developed nervous system is necessary to investigate the 
pathophysiology and treatment of this injury in this target population.  
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1.2.3 Vocal Function Analysis 
 Up to 80%-100% of patients with unilateral VF paralysis are affected by 
dysphonia (i.e., vocal dysfunction).1,5,22 Though dysphonia itself is not life 
threatening, it is perhaps the most life-altering complication of RLN injury. 
Dysphonia can greatly interfere with one’s social life and employment, potentially 
even necessitating a career change.1 Though animals obviously “speak” and 
articulate information differently than humans, vocalization in animals is extremely 
important for intraspecies communication and expressing emotion.55-59 Therefore, 
vocalizations in animal models are often recorded and analyzed for the frequency 
(pitch), duration, and amplitude of their vocalizations, as well as for various call 
types, which differ between species. Rodents are unique in that they express both 
audible and ultrasonic (i.e., tones above 20 kHz) vocalizations. Despite different 
frequencies and functions of these calls, the larynx is likely the source of each.60 
 Early laryngeal nerve transection studies have shown that unilateral RLN 
injury severely disrupts ultrasonic vocalizations in rodents, which begin to recover 
one week following the injury.60-63 These studies have noted that there is a 
decrease in the proportion of rodents that vocalize, as well as a reduction in the 
number of calls in this early timeframe after surgery. Thus, unilateral RLN 
transection has become a method to acutely “devocalize” rodents for other 
investigations examining the role of ultrasonic production in mating behavior or to 
ensure vocalizations are collected from a specific test subject when two mice are 
paired together.64,65 However, the analyses in these early studies is limited to 
audible calls and ultrasonic calls with a specific frequency, 70 kHz for mice.63 Also, 
9 
 
only the number of calls were quantified. Without a more extensive and thorough 
analysis, it is difficult to translate the vocal impairment in rodent models after RLN 
injury to the complex, vocal dysfunction seen in human patients.  
 Fortunately, with new technology, analysis software, and methods, 
ultrasonic calls can be detected in a wide frequency range and can be 
characterized by the type of call and the complexity of the call, along with various 
other parameters, such as frequency, bandwidth, duration, rate, and relative 
intensity of the calls.59,65 With the advent of better analysis techniques, more recent 
studies have used ultrasonic vocalizations to behaviorally phenotype certain 
neurologic disorders in rodent models, such as Down syndrome and Parkinson’s 
disease models.66-69 Thus, improved ultrasonic vocalization analysis is now 
possible in rodent models of RLN injury to better characterize the impairment and 
subsequent recovery of vocalization that has been noted in the past after RLN 
transection.  
 Though detailed analyses of rodent ultrasonic vocalizations following RLN 
injury have yet to be performed, one group has utilized audible vocalizations in rats 
to determine functional impairment and recovery after RLN transection injury.9,10 
These audible vocalizations are evoked by restraining the rat and firmly pressing 
on the hindlimb with forceps. Subjectively, it was noted the vocalizations of 
denervated rats sounded hoarse and deep compared to an uninjured control 
group. Spectral analysis revealed shorter vocalizations with low amplitudes in RLN 
transected rats at three weeks post injury that gradually increased over time, with 
the amplitude reaching control levels by a 16 week time period.9,10 As such, both 
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audible and ultrasonic vocalizations are potentially useful tools for examining vocal 
function after RLN injury, as they can be easily recorded and quantified using a 
variety of outcome metrics. However, as most audible vocalizations in rodents are 
a result of stressful or painful stimuli59, it may be more humane and translational 
to systematically assess ultrasonic vocalizations rather than audible calls in rodent 
species.  
 
1.2.4 Respiratory Function Analysis 
 Dyspnea, respiratory dysfunction, is a complex condition, occurring in a 
variety of cardiopulmonary and functional disorders.  One such mechanism of 
dyspnea is increased work of breathing due to increases of mechanical loading 
when the VFs are adducted during inspiration, when they should be fully 
abducted.70 In patients with VF paralysis, the affected VF is often maintained in a 
paramedian position, but can vary between individuals, and may be maintained in 
a lateral to fully adducted location.71 As such, any adduction of the VF during 
inspiration may cause obstruction of the airway and inhibit airflow, creating 
difficulty in breathing for patients with VF paralysis after RLN injury.72 Another likely 
source of dyspnea in patients with unilateral VF paralysis may be due to an air leak 
from incomplete closure of the glottis, as opposed to a true obstruction.73,74 This 
can lead to the use of compensatory mechanisms, contributing to vocal fatigue 
and the feeling of having shortness in breath.  
 Though respiratory distress is immediate and severe following bilateral VF 
paralysis1 due to airway obstruction, this severe distress is usually not detected in 
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patients with unilateral paralysis. However, despite the fact that patients with 
unilateral VF immobility may have normal or near normal working respiratory 
capacity, many of these patients (up to 76%) complain of respiratory impairment 
in clinical settings, particularly with problems pertaining to breathing during 
phonation and physical effort.1,5,71,75-77 Although breathing impairment is a 
common complaint from patients with unilateral VF paralysis, little work has been 
done in human populations or animal models to investigate this phenomenon. In 
fact, no nonpulmonary dyspnea scales have been published that allow for 
systematic assessment of the laryngeal portion of breathing in patients with 
unilateral VF paralysis.76 However, of the few publications available, most have 
noted impaired inspiratory flow rates in patients with unilateral VF paralysis, which 
may or may not be worsened with a VF medialization procedure.72,77-80 
 While no animal model has been utilized to directly investigate the effect of 
RLN injury on respiration, work has been done in the aforementioned infant pig 
model to examine the coordination between breathing and swallowing with this 
injury.48 This study noted a greater magnitude of coordination changes (e.g., a 
greater delay between swallow time and onset of inspiration) from neonatal to pre-
weanling pigs after an RLN injury, perhaps providing a protective effect during 
swallowing. However, as discussed above, these findings were discovered in pigs 
with developing nervous systems and cannot be extrapolated well to humans or 
animals with a well-developed and potentially aged nervous system. 
 As a large majority of the previous RLN injury work has been performed in 
rodent models, it would be logical for future studies to examine respiration in these 
12 
 
species either through invasive or noninvasive methods. Invasive techniques for 
assessing respiratory function in rodents include invasive plethysmography and 
forced oscillation.81 However, the invasive nature and often necessity of 
anesthesia in these methods can interfere with results and limit longitudinal 
analysis. For non-invasive, longitudinal assessment of respiration, unrestrained 
whole-body plethysmography (WBP) is often utilized.81 Not only is WBP useful for 
collecting respiratory parameters including tidal volume, respiration rate, 
inspiratory and expiratory times, and flow rates, it is valuable for detecting changes 
in breathing associated with sighs and apneic episodes. Thus, any future work with 
rodent models of RLN injury should include one or more of these tests to begin to 
better understand the dyspnea reported by human patients with unilateral VF 
paralysis.  
 
1.3 The RLN as a Branch of the Vagus Nerve 
 The RLN is a branch of the 10th and longest cranial nerve, the vagus nerve. 
The vagus is composed of thousands of axons, both afferent and efferent, and 
provides a vast majority of the autonomic innervation in the body.82 Consisting of 
three different fiber types, A, B, and C, the vagus carries sensory, sympathetic, 
parasympathetic, and somatic information to various parts of the body.82 The 
vagus nerve not only innervates the larynx, pharynx, and lungs, but also the heart 
and gastrointestinal tract, regulating homeostasis in a multitude of organs. Given 
the vagus nerve’s wide-ranging anatomic targets and functions within the body, it 
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is critical to consider this nerve as a whole when investigating pathologic outcomes 
and preventative and therapeutic interventions for RLN injury. 
 
1.3.1 Vagus Nerve Stimulation to Detect RLN Injury 
 Exogenous stimulation of the vagus nerve results in contraction of the VFs, 
and has proven to be a useful “tool” for detecting and preventing RLN injury during 
surgery. With the use of continuous intraoperative nerve monitoring (CIONM), the 
surgeon can be alerted to RLN damage in real time, and potentially reduce the 
extent of the damage.83,84 CIONM involves atraumatically placing a stimulating 
electrode on the vagus nerve during anterior neck surgical procedures. Vagal 
nerve stimulation (VNS) is then applied as an automatic repeated pulse throughout 
the surgical procedure to evoke serial contraction of the VFs.84 VF movement is 
subsequently detected by EMG electrodes positioned on a specialized 
endotracheal tube. If RLN injury occurs during the surgery, action potentials from 
the vagus nerve to the VFs are interrupted, resulting in lack of EMG activity and a 
loss of signal. An alert will sound, and the surgeon can consequently change his 
or her surgical technique or make necessary modifications.  
 Though CIONM has the potential to decrease the incidence of RLN injury 
and post-operative upper airway complications, it is not 100% preventative.85 If the 
loss of signal is due to a more gradual and milder RLN injury, such as a traction 
injury, it is easier for the surgeon to adjust and release disturbed nerves to prevent 
long-term injury and post-operative complications. However, if the loss of signal is 
due to a rapid or severe RLN injury, such as transection or thermal injury from 
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electrocautery, the damage cannot be easily reversed by the surgeon. 
Unfortunately, these situations often yield slower recovery rates of VF function,85 
resulting in poor quality of life for the patient following surgery. In the case of rapid 
onset RLN injury, an effective intraoperative therapeutic strategy to increase the 
efficiency of nerve healing post-operatively would be beneficial to shorten recovery 
time and improve quality of life in the patient, while avoiding medical litigation 
against the surgeon.  
 
1.3.2 Potential Therapeutic Role of Vagal Nerve Stimulation after RLN Injury 
 VNS has been shown as an effective therapeutic strategy for a multitude of 
disorders, and various forms of VNS are currently FDA-approved for treating 
refractory epilepsy, depression, migraines, cluster headaches, and obesity.82,86-89  
However, VNS, especially chronic implantable VNS for epileptic patients, has been 
known to have adverse effects on VF function and voice. This is likely due to the 
stimulation parameters, such as stimulus intensity, that are required to produce a 
positive effect in epileptic patients.90 Even at low stimulus intensities, VNS can 
produce a profound effect on the VFs, such as VF contraction and subsequent 
hoarseness in the patient.91 However, with the right stimulation settings, this 
relative ease of VF contraction elicited with VNS may prove beneficial for 
promoting nerve regeneration in the case of RLN injury. Though further work is 
necessary to determine the optimal stimulation parameters for this purpose.  
 In fact, electrical nerve stimulation is a continually evolving treatment 
modality for peripheral nerve damage. When applied proximal to a nerve injury 
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site, electrical stimulation has been beneficial in promoting functional recovery in 
rodent models of multiple different nerve injuries26,92-94, as well as in humans with 
carpal tunnel syndrome.92 The enhanced functional recovery observed after nerve 
stimulation is largely attributed to upregulation of neurotrophic factors and 
regeneration-associated genes in the nerve cell bodies that may function to 
accelerate axonal regeneration across the injury site and improve the specificity of 
target reinnervation94-96. Interestingly, electrical stimulation is most effective in 
early stages after injury, as its effects on gene expression occur acutely, despite 
long-term daily treatment.95,97 Thus, a treatment of one hour or less immediately 
after the injury may be therapeutic to promote RLN regeneration and functional 
recovery. 
 Therefore, intraoperative VNS may prove to be a useful tool in preventing 
or alleviating post-operative complications. If the optimal stimulation settings were 
discovered, VNS could be applied immediately after an RLN injury is detected 
during surgery to promote nerve regeneration. In this case, vagal nerve monitoring 
equipment could be modified to allow adjustments for therapeutic settings, 
removing the need for further RLN or vagal nerve manipulation to apply an 
electrical stimulus. However, before employing VNS as a treatment in clinical 
settings, work must be done to evaluate the optimal settings and safety of VNS for 
this purpose, including any “off-target” effects VNS may have on other organ 
systems such as the cardiorespiratory or gastrointestinal systems that are also 
innervated by the vagus nerve.  
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1.4 Conclusions 
 Despite nerve identification and intraoperative monitoring techniques, 
iatrogenic RLN injury remains a genuine concern for patients undergoing cervical 
or thoracic surgical procedures. A thorough understanding of RLN reinnervation 
and an effective treatment to restore physiologic function after injury is critical, as 
these procedures carry significant risk to reduce quality of life in patients and 
potential litigation against the medical professionals performing them. Therefore, 
work in animal models is essential to further our understanding of this injury. 
However, the translational potential in current studies is lacking, as many fail to 
investigate all functional aspects associated with VF paralysis.   
 The majority of animal work has utilized laryngoscopy and histological 
techniques to examine VF motion and RLN reinnervation, respectively. However, 
other translatable outcome measures such as voice, respiration, and swallow 
function have yet to be comprehensively investigated in a single model. It is critical 
to examine these behaviors to obtain a complete understanding of the dysfunction 
caused by an RLN injury. Therefore, one of the overarching goals of this research 
is to characterize and refine a mouse model of RLN injury for use in future 
therapeutic investigations. 
 Throughout this work, the effects of RLN injury on murine VF motion, 
swallowing behavior, ultrasonic vocalization production, and respiratory function 
are examined. Furthermore, methods for refining the functional assays used to 
assess these behaviors are developed, allowing for the production of more reliable 
and translatable results. Therefore, in Chapter 2, we explore the effects of SLN vs 
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RLN injury to confirm the fidelity of the laryngeal innervation pattern and functional 
outcomes (for vocal fold motion and swallowing) between mice and humans. In 
Chapter 3, we develop an automated VF tracking and quantification software to 
objectively measure dynamic VF motion, which is further refined in Chapter 4. Also 
in Chapter 4, we expand our translational mouse model to characterize swallow, 
vocal, and respiratory function in mice with unilateral VF paralysis following RLN 
injury. Lastly, VNS and its role as a therapeutic intervention for RLN injury is 
studied (Chapter 2), as well as the potential off-target effects this therapy may have 
on the many other organ systems provided innervation by the vagus nerve 
(Chapter 5). In conclusion, this work aims to provide a refined and reproducible 
animal model for researchers to use to investigate RLN pathophysiology, with the 
hope that one day there may be effective treatment options to fully restore 
physiologic function to patients with RLN injury and VF paralysis. 
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2.1 Abstract 
Objectives: Iatrogenic recurrent laryngeal nerve (RLN) injury is a morbid 
complication of anterior neck surgical procedures. Existing treatments are 
predominantly symptomatic, ranging from behavioral therapy to a variety of 
surgical approaches. Though laryngeal reinnervation strategies often provide 
muscle tone to the paralyzed vocal fold (VF), which may improve outcomes, there 
is no clinical intervention that reliably restores true physiologic VF movement. 
Moreover, existing interventions neglect the full cascade of molecular events that 
affect the entire neuromuscular pathway after RLN injury, including the intrinsic 
laryngeal muscles, synaptic connections within the central nervous system, and 
laryngeal nerve anastomoses. Systematic investigations of this pathway are 
essential to develop better RLN regenerative strategies. Our aim was to develop 
a translational mouse model for this purpose, which will permit longitudinal 
investigations of the pathophysiology of iatrogenic RLN injury and potential 
therapeutic interventions. 
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Methods: C57BL/6J mice were divided into 4 surgical transection groups 
(unilateral RLN, n=10; bilateral RLN, n=2; unilateral SLN, n=10; bilateral SLN, 
n=10) and a sham surgical group (n=10). Miniaturized transoral laryngoscopy was 
used to assess vocal fold (VF) mobility over time, and swallowing was assessed 
using serial videofluoroscopy. Histological assays were conducted 3 months post-
surgery for anatomical investigation of the larynx and laryngeal nerves. Eight 
additional mice underwent unilateral RLN crush injury, half of which received 
intraoperative vagal nerve stimulation (iVNS). These 8 mice underwent weekly 
transoral laryngoscopy to investigate VF recovery patterns. 
Results: Unilateral RLN injury resulted in chronic VF immobility but only acute 
dysphagia. Bilateral RLN injury caused intraoperative asphyxiation and death. VF 
mobility was unaffected by SLN transection (unilateral or bilateral), and dysphagia 
(transient) was evident only after bilateral SLN transection. The sham surgery 
group retained normal VF mobility and swallow function. Mice that underwent RLN 
crush injury and iVNS treatment demonstrated accelerated and improved VF 
recovery. 
Conclusions: We successfully developed a mouse model of iatrogenic RLN injury 
with impaired VF mobility and swallowing function that can serve as a clinically 
relevant platform to develop translational neuroregenerative strategies for RLN 
injury. 
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2.2 Introduction  
Iatrogenic recurrent laryngeal nerve (RLN) injury, a complication of anterior 
neck surgical procedures, results in ipsilateral vocal fold (VF) immobility and 
associated dysphagia, dysphonia, and dyspnea.1-3 Although the RLN may 
spontaneously regenerate after injury, recovery may take several months to years, 
and full return of normal function rarely occurs.2,4,5 Poor outcomes are largely 
attributed to pathological reinnervation of the intrinsic laryngeal muscles, either by 
preferential reinnervation of laryngeal adductors by regenerating RLN fibers or by 
collateral reinnervation by the superior laryngeal nerve (SLN).2,6,7 While 
pathological reinnervation may mitigate laryngeal muscle atrophy, VF movement 
typically remains ineffective and unsynchronized.6,8,9 Older individuals are 
particularly at risk for worse outcomes, as aged peripheral nerves have reduced 
regenerative capacity.10-12 This biological deficiency is especially concerning for 
the increasingly aging population undergoing anterior neck procedures.13,14  
Existing treatments for RLN injury are predominantly symptomatic, ranging 
from behavioral therapy to a variety of surgical approaches. Though laryngeal 
reinnervation strategies often provide muscle tone to the paralyzed VF, which may 
improve functional outcomes, there is no clinical intervention that reliably restores 
true physiologic VF movement.15-19 Moreover, existing interventions neglect the full 
cascade of molecular events that affect the entire neuromuscular pathway after 
RLN injury, including the intrinsic laryngeal muscles, synaptic connections within 
the central nervous system, and laryngeal nerve anastomoses. Systematic 
investigations of this pathway are essential to develop better RLN regenerative 
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strategies. Animal models such as pigs,20-25 dogs,26 cats,27 rats,28,29 and rabbits15 
provide suitable platforms for this purpose. Rats, in particular, are at the forefront 
of an emerging treatment for nerve regeneration -- electrical stimulation applied 
proximal to the nerve injury site. This approach has shown promising effects after 
facial nerve30,31 and RLN29 injury. However, these studies have predominantly 
focused on infant or young adult rats whose developing nervous systems bear little 
resemblance to mature humans. Moreover, no animal study of RLN injury has 
integrated basic science techniques with the clinical gold standard combination of 
endoscopy and videofluoroscopy for clinicopathological investigation of the 
aerodigestive tract. 
The goal of this study was to develop a mouse surgical model of iatrogenic 
RLN injury to accelerate scientific discovery. We chose the C57BL/6J mouse 
because it is an established translational model for investigations of swallowing32 
and laryngeal biology.33 The short life-span of the mouse permits high throughput, 
longitudinal investigations in aged populations more representative of anterior 
neck surgical patients. However, its small size (Figure 2.1) has been prohibitive to 
the development of directly translatable functional outcome measures for 
correlation with histological findings.34 Here, we have overcome this challenge by 
using our “miniaturized” endoscopic35 and fluoroscopic32,36 imaging methodology 
to develop a translational mouse model of iatrogenic RLN injury. 
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Figure 2.1. Size Comparison between a Human and Mouse Larynx. A photograph of side-by-side 
specimens of a human and mouse larynx next to a US penny (approximately 1.9 cm diameter), 
overlaid on a proportionately scaled schematic of a human head and neck. The cartilaginous/bony 
framework is drawn on both specimens for anatomical clarity. A 2 cm scale bar is shown for added 
size perspective. 
 
 
 Our first endeavor was to ensure the fidelity of the laryngeal innervation 
pattern and functional outcomes between humans and mice. We focused on 
transection (neurotmesis) injuries because they are most experimentally 
replicable,5 and included the RLN and SLN because of the growing evidence of 
dual innervation of the intrinsic laryngeal muscles.37,38 We hypothesized that like 
humans, RLN transection in mice would cause chronic impairment of VF mobility 
and dysphagia, whereas SLN transection would result in subtle, transient changes 
in VF mobility and swallowing function. Furthermore, we expected more severe 
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symptoms after bilateral injury. Finally, we adapted our model to include a more 
prevalent crush (axonotmesis) injury,5 and conducted a feasibility study of 
intraoperative vagal nerve stimulation (iVNS) as a novel RLN regenerative 
strategy. In doing so, we expanded upon a recent study in young adult rats in which 
RLN stimulation accelerated the recovery of VF mobility after RLN crush injury.29 
However, rather than stimulating the RLN, we chose the cervical vagus nerve as 
a more clinically relevant treatment site to simultaneously target all potentially 
injured RLN branches and promote widespread regeneration. Moreover, we tested 
this strategy in aged mice to better correspond to the average age of anterior neck 
surgical patients, thus highlighting our translational intent. 
 
2.3 Materials and Methods 
2.3.1 Animals 
Fifty adult C57BL/6 (also known as B6) mice of either sex were included in 
this study, which was approved by our Institutional Animal Care and Use 
Committee. The majority of these mice (n=42) were used to develop our surgical 
model of iatrogenic laryngeal nerve injury (i.e., transection), and the remaining 
(n=8) were allowed to age for further model refinement (i.e., RLN crush injury and 
exploratory regenerative treatment). All mice were offspring from our C57BL/6J 
colony established by mating sibling pairs purchased at 6 weeks of age from The 
Jackson Laboratory (Bar Harbor, ME). Over a 2-year period, offspring between 3 
and 12 months of age were randomly assigned to several surgical cohorts, with 
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transection injury groups completed before beginning the crush injury component 
of this investigation. 
Mice were group housed (2-4 animals per cage, based on sex and litter) in 
a standard 12:12 light/dark cycle facility with controlled temperature and humidity 
conditions. Free access to water and standard rodent food pellets was provided, 
except during the experimental procedures described below. An enhanced 
enrichment protocol (e.g., running wheel and chewable treats) was used for all 
cages to minimize aggression and the need for single housing in our aging B6 
colony. Daily monitoring by veterinary and research staff ensured that all mice 
remained healthy throughout the study. 
 
2.3.2 Surgical Procedures 
General Surgical Approach: All 50 mice underwent microsurgery using a midline 
ventral neck approach, closely following our previously established methods.39 
After a 4-6 hour food restriction, mice were anesthetized with a single 
subcutaneous injection of ketamine-xylazine (90/11.25 mg/kg), followed by 
scheduled maintenance doses of ketamine (half the original dose) every 10-20 
minutes as needed to maintain a surgical plane of anesthesia (i.e., absence of 
pedal withdrawal and eye blink reflexes). Eyes were lubricated (Lacrilube®, 
Allergan, Inc.; Irvine, CA) to prevent drying. The ventral neck was shaved and 
prepared aseptically for surgery. Next, the head was stabilized in ear bars, with the 
mouse positioned in dorsal recumbency on a custom surgical platform beneath a 
surgical microscope (M125; Leica Microsystems, Inc., Buffalo Grove, IL). Core 
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body temperature was maintained at 37 ± 0.2 ºC using a homeothermic heating 
system (DC Temperature Controller; FHC, Bowdoin, ME). Mice spontaneously 
breathed room air during the entire surgical procedure, except during iVNS 
treatment, when supplemental oxygen was provided (described below).  
Immediately prior to the surgical neck incision, laryngoscopy (described 
below) was performed according to our published protocol35 to establish baseline 
VF function. Next, an approximate 2 cm midline skin incision was made from the 
suprasternal notch to the intersection of the anterior digastric muscles near the 
mandibular symphysis, using a micro scalpel and micro scissors. The large 
salivary glands were gently retracted from midline with micro forceps and secured 
with a pediatric ophthalmic retractor for unobstructed visualization of the surgical 
field (Figure 2.2a). The target laryngeal nerve was visualized within the fascia 
along the lateral aspect of the larynx (SLN) or trachea (RLN). After careful isolation 
using micro forceps, laryngeal nerve injury was performed according to 
experimental group assignment (transection versus crush injury, described below).  
Immediately following surgical manipulation, laryngoscopy was repeated to assess 
the effect on VF mobility (described below). Next, soft tissue structures were 
approximated medially, and the neck incision was closed with 6-0 monocryl suture 
material (Ethicon™, Johnson & Johnson Company; New Brunswick, NJ) and 
surgical glue (Tissumend II, Veterinary Products Laboratories; Phoenix, AZ). 
Postsurgical analgesics (buprenorphine, 0.05 mg/kg; banamine, 2.2 mg/kg) and 
saline (0.2 mL) were administered subcutaneously prior to transferring mice to a 
recovery cage warmed to 37 °C on a water-circulating heating pad (Model #TP700, 
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Stryker Medical, Portage, MI). Mice were returned to their home cage when fully 
ambulatory, typically within 1 hour after surgery. For 72 hours post-surgery, pain 
management (buprenorphine, 0.05 mg/kg) was provided every 8-12 hours, and the 
home cage was kept warm by placing it half way on a 37 °C water-circulating 
heating pad (Stryker) to prevent anesthesia-related hypothermia. Post-operative 
monitoring was conducted daily by research staff for 1 week, and then daily health 
monitoring by animal care staff continued throughout the remainder of the study.  
 
 
Figure 2.2. Microsurgical Approach. (A) Our microsurgical approach in mice to access the laryngeal 
nerves via a midline ventral neck incision is typically a bloodless procedure. Micro retractors (white 
asterisks) are used to maintain the large salivary glands out of the surgical field. The strap muscles 
obscure the RLN (B) and SLN (C), which are shown at higher magnification in Images B and C, 
respectively. (B) To access the RLN, the strap muscles are carefully divided along the midline 
fascia and gently retracted with micro forceps to expose the tracheal rings (numbered) and RLN 
(yellow arrows).The inset image shows a close-up of the target tracheal ring region, with the RLN 
(yellow arrows) isolated from the inferior thyroid artery (black asterisks) with a micro hook in 
preparation for surgical transection. (C) To access the SLN, the strap muscles covering the lateral 
aspect of the larynx are gently elevated with micro forceps to expose the SLN (yellow arrows) 
traveling alongside the superior laryngeal artery (black arrows) near the bifurcation of the common 
carotid artery (black asterisk). The inset image shows a close-up of the SLN (yellow arrow) isolated 
from the fascia with micro forceps.   
 
Laryngeal Nerve Transection Injury: Mice (n=42) were randomly allocated to one 
of five surgical groups: unilateral RLN transection (n=10), bilateral RLN transection 
(n=2, due to anticipated mortality from mechanical asphyxiation), unilateral SLN 
transection (n=10), bilateral SLN transection (n=10), and sham surgery (n=10). For 
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RLN transection, the strap muscles overlying the trachea were retracted from 
midline between the 4th and 6th tracheal rings to visualize the RLN running 
alongside the inferior thyroid artery (Figure 2.2b). For SLN transection, the SLN 
was readily identified within the superficial fascia on the lateral aspect of the larynx, 
traveling alongside the superior laryngeal artery (Figure 2.2c). For the unilateral 
nerve injury groups, only the right side was included because it was the most 
ergonomic for our custom surgical set-up and workflow. The target laryngeal nerve 
(either SLN or RLN, unilateral or bilateral) was gently isolated from the surrounding 
fascia and blood vessels with micro forceps. The nerve was then transected with 
micro scissors and a 1-2 mm section was removed to prevent spontaneous re-
attachment of the proximal and distal nerve stumps during recovery. The 
transection location was always proximal (i.e., closer to the central nervous 
system) to any visible branches from the main nerve trunk. Sham surgery mice 
underwent all aspects of the surgical procedure, except the laryngeal nerves were 
visualized within the fascia and isolated, but not transected. For all surgical groups, 
laryngoscopy was repeated at the end of the procedure to assess the effect of 
surgical manipulation on VF mobility.  
Immediately prior to transection of the SLN, a confirmatory step of brief 
electrical stimulation (described below) was added to assure that we had indeed 
identified the correct nerve. Previous work in our lab39 and others40 has shown that 
40 Hz stimulation of the SLN (main trunk) in mice reliably evokes swallowing. In 
contrast, RLN stimulation parameters to evoke swallowing in mice have not yet 
been established, and our preliminary work (unpublished) has shown that 40 Hz 
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stimulation of the RLN in mice does not reliably evoke swallowing. Therefore, 
correct targeting of the RLN was confirmed by endoscopic visualization of 
ipsilateral VF immobility immediately after surgical transection.  
For SLN stimulation, we used custom, bipolar hook electrodes (FHC, 
Bowdoin, ME) made of platinum iridium, with a 300-μm tip diameter, spaced 800 
μm apart. The electrodes were positioned near the SLN using a manual 
micromanipulator (model U-30CF; Narishige, Co, LPD, Setagaya-Ku, Tokyo, 
Japan), and the SLN was gently draped over the electrodes using micro hooks. 
Electrical stimulation was delivered continuously for a single 20-second train using 
our previously published parameters for evoking SLN-stimulated swallowing in 
mice: 40 Hz, biphasic 0.5 ms square wave pulses, with a 0.1 ms interphase delay, 
delivered at 800 µA.39 Stimulation was delivered using a constant current stimulus 
isolator (model 1101; ADInstruments, Colorado Springs, CO) coupled to an A/D 
converter (PowerLab 8/30, ADInstruments), with both devices controlled by 
LabChart software (ADInstruments). Current flow was directed toward the brain by 
positioning the anode electrode distal to the cathode electrode on each nerve, with 
directionality verified using a current probe (model P6042; Tektronic, Beaverton, 
OR) and voltage meter (True RMS MultiMeter; Extech Intruments, Waltham, MA). 
The stimulus shape and intensity were continually verified using a digital 
oscilloscope (model TDS 2024B; Tektronix) connected to the stimulus isolator. 
Swallowing events were identified by endoscopic visualization of tongue base 
retraction in conjunction with observable laryngeal elevation within the surgical 
site; both events were simultaneously video recorded at 30 frames per second 
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(fps) via the endoscope camera and surgical microscope camera. If no swallowing 
events were observed, visible exudate around the SLN was absorbed using paper 
points (#501; Henry Schein, Inc., Melville, NY), the nerve was repositioned on the 
bipolar electrode to prevent any contact with the surrounding tissues, and then a 
2nd 20-second stimulus train was delivered. For the bilateral SLN transection 
group, this stimulation approach was performed separately for each side.  
 
RLN Crush Injury and iVNS Treatment: For this feasibility study, we included 8 
aged mice (over 12 months old) from our B6 colony to expand the utility and 
translatability of our surgical model. Rather than a transection (neurotmesis) injury, 
all 8 mice underwent a right-sided RLN crush (axonotmesis) injury. To do this, the 
RLN was carefully isolated from the fascia and inferior thyroid artery between the 
4th and 6th tracheal rings using micro forceps. Next, a micro hook was used to 
place the RLN perpendicularly across smooth jaw hemostatic forceps (1 mm tip 
diameter, 13007-12; FST, Foster City, CA), which were then closed to the second 
locking position for 30 seconds.41  
Laryngoscopy was repeated after RLN crush injury to assess the immediate 
effect on VF mobility. Mice were then randomly allocated to iVNS treatment (n=4) 
or control (n=4) groups. For the iVNS treatment group, the right cervical vagus 
nerve was isolated from the carotid sheath and placed on our previously described 
hook electrodes for continuous electrical stimulation at 20 Hz, as has been used 
for previous cranial nerve regeneration studies in rats. 29,31,30,42 For the control 
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group, the vagus nerve was neither isolated nor placed on electrodes after the RLN 
crush injury.  
During iVNS treatment, current flow was directed toward the brain by 
positioning the anode electrode distal to the cathode electrode on the vagus nerve, 
with directionality verified as described above. This approach ensured that iVNS-
evoked action potentials traveled toward the central nervous system to stimulate 
the cell bodies of the injured axons, which is essential for triggering upregulation 
of neurotrophic factors, their receptors, and growth associated proteins that 
accelerate regeneration at the distal nerve injury site.43,44 We used our standard 
stimulus waveform parameters (biphasic 0.5 ms square wave pulses, with a 0.1 
ms interphase delay) to deliver 20-second stimulus trains continuously for up to 60 
minutes, depending on respiratory tolerance (described below). Stimulus intensity 
was increased from 0.2 to 0.8 mA in 0.1 mA steps to quickly (within 1-2 minutes) 
identify the highest subthreshold intensity level that did not evoke swallowing or 
cause agonal/labored breathing. This subthreshold stimulus level was then used 
for iVNS treatment, with the waveform morphology (shape and intensity) 
continually verified via oscilloscope, as described above.  
During the additional surgical time required for the iVNS-treated mice, 
supplemental oxygen was provided via a nose cone at 1 L/min, and respiratory 
rate was monitored every 10 minutes throughout the treatment duration. If 
agonal/labored breathing developed during iVNS treatment, the stimulus intensity 
level was lowered in 0.1 mA steps to quickly (within 1-2 minutes) identify the level 
at which breathing stabilized; this new subthreshold level was used for the 
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remainder of the iVNS treatment. If respiratory status was not stabilized by 
lowering the stimulus intensity, iVNS treatment was immediately stopped to 
prevent ensuing morbidity or mortality. 
 
2.3.3 Functional Measures 
Laryngoscopy and VFSS were conducted at baseline (pre-surgery) and 
several post-surgical time points to assess VF mobility and swallowing function, 
respectively, during a three month recovery period, as described below. Post-
surgical VFSS was always conducted 3-5 days before laryngoscopy to avoid 
confounding effects of anesthesia (required for laryngoscopy) on VFSS outcomes.   
 
VF Mobility: To assess VF mobility, laryngoscopy was performed according to our 
established protocol,35 with mice under surgical plane of anesthesia while 
spontaneously breathing room air (Figure 2.3). Laryngoscopy was performed 
twice during the surgical procedure -- immediately before surgical incision (to 
record baseline bilateral VF movement during spontaneous breathing) and again 
following surgical manipulation (to determine the immediate effect on VF mobility). 
Additionally, laryngoscopy was performed at multiple post-surgical time points with 
mice under brief (<15 minutes), surgical-level sedation. Mice allocated to the 
transection protocol underwent post-operative laryngoscopy at 1 week and 3 
months post-surgery to assess acute versus chronic effects, respectively, on VF 
mobility. Mice allocated to the RLN crush/iVNS protocol underwent laryngoscopy 
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more frequently (i.e., weekly) to better characterize the pattern of spontaneous 
functional recovery versus treatment efficacy.  
Our laryngoscopy protocol entailed securing anesthetized mice in ear bars 
in dorsal recumbency on our custom surgical platform. Next, a sialendoscope 
(R11573A; Karl Storz) with a custom laryngoscope was inserted transorally and 
advanced via a custom micromanipulator to visualize the larynx on a Storz Tele 
Pack X monitor (Karl Storz Endoskope, Tuttlingen, Germany). The endoscope was 
slowly advanced until the bilateral VFs filled the entire field of view, and VF 
movement was video recorded at 30 fps for approximately 1 minute during 
spontaneous breathing. Videos (MP4 files) were viewed frame-by-frame by two 
independent reviewers (authors TEL and BZ or MMH) using video editing software 
(Pinnacle Studio 14, Pinnacle Systems, Inc., Mountain View, CA), and VF mobility 
was scored using a subjective rating scale: 2 = normal movement, 1 = reduced 
movement, and 0 = no movement.28,45 Reviewer discrepancies were resolved by 
group consensus with the principal investigator (TEL). 
43 
 
 
Figure 2.3. Laryngoscopy Assay. (A) Lateral view of our custom endoscopy suite for mice, with 
labeled components. (B) An anesthetized mouse in dorsal recumbency undergoing laryngoscopy, 
with the head gently secured in ear bars. The micromanipulator in Image A is used to precisely 
guide oral insertion, gentle advancement, and precise positioning of the sialendoscope (fitted with 
a custom laryngoscope) to visualize the larynx. (C) Representative endoscopic image of the murine 
larynx at maximum VF abduction during spontaneous breathing, taken from a 30 fps video at 
baseline (i.e., before surgery). Visible laryngeal structures of interest include the bilateral VFs (black 
asterisks), epiglottis, aryepiglottic folds (AEF), and pyriform sinuses (PS). In contrast to the human 
larynx, the VFs of mice retain midline proximity at the dorsal commissure (yellow asterisk), and the 
ventral commissure is consistently obscured by the epiglottis. 
 
Swallow Function: Mice allocated to the transection protocol underwent VFSS 
testing according to our standard, freely behaving (unanesthetized) protocol32,36 
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(Figure 2.4) at 3 time points: baseline (i.e., approximately 1 week prior to surgery) 
as well as 1 week and 3 months post-surgery to assess acute versus chronic 
effects, respectively. Mice allocated to the RLN crush/iVNS treatment protocol 
were not subjected to VFSS testing in order to minimize resources used for this 
feasibility study.  
Beginning two weeks prior to baseline VFSS testing, mice underwent a 
behavioral conditioning program to assure familiarity and acceptance of the 
contrast solution and test environment. At each VFSS time point, mice were fluid 
restricted overnight for 14-16 hours and provided additional chewable enrichment 
(e.g., nut and seed mix) to motivate voluntary drinking during VFSS testing the 
following morning. During testing, mice were individually enclosed in a custom 
VFSS test chamber secured to a custom, remote-controlled lift table within our 
miniaturized fluoroscope (Glenbrook Technologies, Randolph, NJ). Each mouse 
was then exposed to approximately 2-3 minutes of low-dose radiation (~30 kV and 
0.2 mA) for fluoroscopic examination of swallowing in the lateral plane while freely 
drinking a species-specific oral contrast agent recipe: Omnipaque (350 mg iodine 
per mL; GE Healthcare, Inc., Princeton, NJ) diluted to a 25% solution with 
deionized water and 3% chocolate syrup. The contrast solution was administered 
through a custom delivery system into a custom bowl positioned immediately 
above the test chamber floor. To minimize radiation exposure, the fluoroscope was 
activated only when mice were drinking from the bowl, which was identified by real-
time viewing via a webcam (C920 HD Pro Webcam; Logitech International S.A., 
Lausanne, Switzerland) positioned above the VFSS test chamber. The 
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oropharyngeal stage of swallowing was visualized first (Figure 2.4c), followed by 
remote-controlled repositioning of the chamber to visualize the entire esophageal 
stage of swallowing in a single field of view (Figure 2.4d). Fluoroscopic videos 
were captured at 30 fps during real-time viewing via computer monitor. 
Videos (AVI files) were subsequently analyzed frame-by-frame by two 
independent reviewers (authors AM, VC, BB, DO, or ID) using video editing 
software (Pinnacle Studio 14) to quantify 6 swallow metrics established by our prior 
work,32,36 as described in Table 2.1. We also quantified airway protection using the 
standardized 8-point Penetration-Aspiration Scale (PAS) that ranges from 1 (no 
penetration or aspiration) to 8 (silent aspiration).46 Reviewer discrepancies were 
resolved by group consensus with the principal investigator (TEL). 
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Figure 2.4. Videofluoroscopic Swallow Study (VFSS) Assay. (A) A custom VFSS test chamber 
(black asterisk) is positioned in lateral view between the X-ray source (white asterisk) and image 
intensifier (yellow arrow) of our custom, miniaturized c-arm fluoroscope. The X-ray beam is turned 
on only when mice are actively drinking, identified via a webcam positioned above the test chamber. 
A remote-controlled positioning lift is used to readily maintain the mouse’s aerodigestive tract within 
the fluoroscopy field of view. (B) Close-up of the VFSS test chamber in Image A, designed to 
promote voluntary drinking of liquid contrast agent by mice with minimal behavioral distractions. 
Note the bowl within the test chamber is filled using a syringe delivery system that is manually 
controlled a few feet away from the fluoroscope. (C and D) Representative X-ray images from a 30 
fps video of a mouse drinking in lateral view. Image C shows the oropharyngeal stage of 
swallowing, immediately prior to triggering of the swallow reflex. Note the liquid contrast agent 
accumulating in the vallecula within the pharynx, which is the stereotypical swallow trigger point in 
mice. Image D shows the esophageal stage of swallowing. Note the swallowed bolus traversing 
the distal esophagus into the stomach while liquid contrast continues to accumulate in the vallecula 
prior to triggering a subsequent swallow.    
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Table 2.1. VFSS Metrics to Detect and Quantify Dysphagia in Mice 
 
VFSS Metrics Operational Definition 
Lick Rate The number of licks per second (30 frames) during uninterrupted drinking. 
Each lick cycle begins with the jaw maximally opened and tongue 
protruding. Each subsequent maximal jaw excursion/tongue protrusion is 
counted as an individual lick cycle. 
Swallow Rate The number of swallows occurring during each 2-second (60 frames) 
episode of uninterrupted drinking. Each 2-second episode begins at the 
“rest frame” that immediately precedes triggering of the pharyngeal swallow 
(i.e., bolus flow from the valleculae to the esophagus). 
Inter-Swallow 
Interval 
The time (ms) between two successive, uninterrupted swallows during 
uninterrupted drinking. The start frame is the ‘‘rest frame’’ that immediately 
precedes triggering of the pharyngeal swallow. The end frame is the ‘‘rest 
frame’’ of the subsequent swallow. The number of frames between the two 
successive swallows is then divided by 30 frames per second (fps) to 
convert to time (ms). 
Lick-Swallow 
Ratio 
The number of licks during the inter-swallow interval (i.e., between two 
successive, uninterrupted swallows). 
Pharyngeal 
Transit Time 
The time (ms) it takes the bolus to be swallowed through the pharynx. The 
start frame is the ‘‘rest frame’’ that immediately precedes visible transfer of 
the bolus from the swallow trigger point (i.e., valleculae). The end frame is 
when the bolus tail enters the esophagus. The number of frames between 
the start and end frames is divided by 30 fps and converted to ms. 
Esophageal 
Transit Time 
The time (ms) it takes the bolus to be swallowed through the esophagus. 
The start frame is when the bolus tail enters the esophagus (i.e., the PTT 
end frame). The end frame is when the bolus tail enters the stomach. The 
number of frames between the start and end frames is divided by 30 fps and 
converted to milliseconds (ms). 
Note: Three to five measures of each VFSS metric are obtained for each mouse.  
 
2.3.4 Histological Investigation 
At the study end point (3 months post-surgery), mice were euthanized by 
transcardial perfusion with saline followed by 4% paraformaldehyde, and relevant 
tissues were collected for a variety of postmortem assays. For gross anatomical 
mapping of the laryngeal nerves, a subset of samples (n=10) were collected as 
whole head and thorax specimens for laryngeal nerve mapping using a modified 
Sihler staining protocol.47-50 This lengthy (~6 months) 8-step technique, 
summarized in Table 2.2, rendered the entire specimen transparent while staining 
myelinated nerves a dark purple color. Stained specimens were examined under 
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a dissection microscope (LM80; Leica) and carefully trimmed to remove soft tissue 
overlying the laryngeal nerves for improved visualization. Specimens were then 
placed on an X-ray light box beneath our surgical microscope (M125; Leica) for 
trans-illumination and digital imaging (Pixelink E421CU camera, Ottawa, Canada).  
Another subset of samples (n=10) was subjected to post-mortem dissection 
of the laryngeal nerves using our surgical (M125; Leica) and dissection (LM80; 
Leica) microscopes. A separate subset of samples (n=4) underwent paraffin 
processing and embedding, sectioning by microtome (10 µm serial transverse 
sections), hematoxylin and eosin (H&E) staining, and light microscopy (DM4000, 
Leica), according to our standard protocols.39,51 Color processing of digital images 
via Photoshop CS5 (Adobe Systems, San Jose, CA) was used to enhance 
visualization of the anatomical regions of interest. For the remaining samples, the 
larynx and brain were collected to establish histological methods for subsequent 
use in a larger RLN crush injury/iVNS study. 
 
 
 
Table 2.2. Sihler Staining Protocol for Nerve Mapping 
 
Processing Step Duration Target Reaction 
4% paraformaldehyde; change 
solution once a week 
50-55 days Tissue fixation 
3% potassium hydroxide (KOH) with 
3 drops of 3% v/v hydrogen peroxide 
per 100 mL; change solution twice a 
week 
50-60 days Maceration and depigmentation. Endpoint: 
specimen becomes translucent and 
nerves can be clearly seen as white fibers 
under a transilluminated microscope. 
Sihler I solution;  change solution 
twice a week 
30 days Decalcification 
Sihler II solution; change solution 
every other week or more often if 
solution changes from dark blue to 
purple. 
30-40 days Staining. Endpoint: nerves become dark 
blue. 
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Sihler I solution (with agitation); 
change solution 1-2 times as needed 
when it becomes blue or purple. 
24 hours Destaining. Endpoint: nerves become dark 
purple but all other tissues become a 
transparent lavender color under a 
transilluminated microscope; check every 
2-3 hours. 
0.05% lithium carbonate (with 
agitation) 
2 hours Neutralizing. Endpoint: Nerves turn from 
purple to deep blue; check every 30 
minutes under a transilluminated 
microscope. 
50% glycerine 4 days Clearing. Endpoint: when the finest nerve 
twigs can be seen clearly under a 
transilluminated microscope; check daily. 
100% glycerine with thymol crystals n/a Long-term preservation 
Note: Perform water washes between steps: rinse 5 times, incubate with agitation for 1 hour, then 
rinse again 5 times.  
 
2.3.5 Statistics 
Basic summary statistics were calculated for each outcome measure of 
interest for each component of this investigation: laryngeal nerve transection injury 
(i.e., model development) and RLN crush/iVNS treatment (i.e., model refinement 
and therapeutic investigation). For the transection component, analysis was 
focused on three clinically-relevant time points: 1) baseline (1 week prior to 
surgery), 2) 1 week post-surgery to capture acute functional changes in VF mobility 
and swallowing, and 3) at the end of the surgical recovery period (i.e., 3 months 
post-surgery; chronic recovery stage) to capture any functional improvement or 
progression of the surgical injury. One-way repeated measures ANOVAs and one-
way ANOVAs were used to demonstrate differences in outcome measures across 
time and between surgical groups. Two-sample t-tests were used to assess mean 
differences between a treated group and control. Some analyses used change 
scores rather than the original data values; change scores were calculated using 
the difference from each measure at each time point (acute or chronic recovery 
surgery), compared to baseline. If warranted, post-hoc testing was performed 
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using Tukey HSD. For the RLN crush/iVNS component, the small sample size (n=3 
per group) precluded rigorous statistical analyses. All statistics were calculated 
using SPSS v24 with a two-sided alpha of 0.05 to determine statistical significance. 
 
2.4 Results 
Six of the 50 mice (12%) included in this study died during the surgical 
procedure. Four of the 6 mice died unexpectedly from intra-operative respiratory 
distress: unilateral SLN transection (n=1), unilateral RLN transection (n=1), and 
RLN crush/iVNS (n=1 in the 60-minute treatment group, and n=1 in the no 
treatment group). As expected, the 2 mice in the bilateral RLN transection group 
died from mechanical asphyxiation (i.e., VFs fixed in the median position) 
immediately after the 2nd RLN was transected. These 6 mice were excluded from 
statistical analysis, as no post-operative data were collected. Below, the results for 
the surviving 44 mice are summarized separately for the model development (i.e., 
transection injury, n=38) and model refinement (i.e., RLN crush injury and iVNS 
treatment, n=6) aims of this study.   
 
2.4.1 Model Development: Laryngeal Nerve Transection Injury 
Descriptive statistics for the 4 surgical groups are shown in Table 2.3. All 
38 mice underwent functional testing of VF mobility (i.e., laryngoscopy) and 
swallowing (i.e., VFSS) as planned at each time point, with results described 
below. 
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Table 2.3. Sample Size, Age, and Body Weight for Surgical Groups at the 
Study Start and End Points.  
 
SURGICAL 
GROUPS 
Group 
Sample 
Size 
START OF STUDY END OF STUDY 
MALES FEMALES MALES FEMALES 
Age 
Body 
Weight 
Age 
Body 
Weight 
Age 
Body 
Weight 
Age 
Body 
Weight 
RLN 
Transection 
(Unilateral) 
9 
(4M, 5F) 
6.85 
(0.45) 
31.35 
(2.09) 
7.30 
(0.00) 
24.02 
(0.53) 
11.55 
(0.45) 
31.85 
(2.68) 
11.20 
(0.12) 
25.47 
(0.69) 
SLN 
Transection 
(Unilateral) 
9 
(4M, 5F) 
4.25 
(0.03) 
24.93 
(1.03) 
5.24 
(.27) 
20.80 
(0.77) 
7.75 
(.03) 
28.64 
(0.89) 
8.8 
(0.29) 
22.29 
(0.64) 
SLN 
Transection 
(Bilateral) 
10 
(3M, 7F) 
3.20 
(0.16) 
27.67 
(2.07) 
3.27 
(0.09) 
20.92 
(0.39) 
7.05 
(.42) 
30.92 
(0.97) 
6.67 
(0.08) 
23.80 
(0.70) 
Sham 
Surgery 
10 
(6M, 4F) 
3.87 
(0.08) 
26.33 
(0.99) 
4.00 
(2.00) 
22.92 
(1.17) 
7.62 
(0.19) 
31.58 
(0.91) 
7.60 
(0.21) 
25.11 
(1.76) 
Note: Age = months (standard error of the mean); body weight = grams (standard error of 
the mean); M = males; F = females. 
 
VF Mobility: A total of 152 laryngoscopy videos (38 mice X 4 time points) were 
manually analyzed using a 3-point rating scale. Only RLN transection injury had 
an effect on VF mobility. Specifically, unilateral RLN transection resulted in 
immediate, ipsilateral VF immobility (i.e., fixation in the paramedian position; score 
= 0, Figure 2.5) that persisted at the acute (1 week) and chronic (3 month) post-
surgical time points. In contrast, SLN transection (unilateral or bilateral) had no 
effect on VF mobility, as the score remained unchanged (i.e., 2 = normal) across 
time points. Similarly, the sham surgery itself did not impair VF mobility. Change 
scores in VF mobility at the acute (1 week) versus chronic (3 month) post-surgical 
time points (compared to baseline function) are shown in Table 2.4. However, 
statistical analysis could not be performed because there was no variability in the 
data within treatment groups (i.e., standard deviation = 0).   
52 
 
 
Figure 2.5. VF Immobility after RLN Transection. Endoscopic images showing the bilateral VFs of 
an anesthetized mouse during spontaneous breathing of room air after transection of the right RLN. 
Top: Maximal VF abduction during inspiration. Bottom: Maximal VF adduction during expiration. 
Note the paralyzed (immobile) right VF during the inspiratory and expiratory phases of the 
respiratory cycle. 
 
Table 2.4. Change in VF Mobility after Surgical Injury 
 
Change Score 
Mean Change Score (Standard Deviation) 
RLN 
Transection 
(Unilateral) 
SLN  
Transection 
Sham 
Surgery 
Unilateral Bilateral 
1 week post-surgery 
minus baseline 
-2 (0) 0 (0) 0 (0) 0 (0) 
3 months post-surgery  
minus baseline 
-2 (0) 0 (0) 0 (0) 0 (0) 
 
53 
 
Swallow Function: A total of 114 VFSS videos (38 mice X 3 time points) were 
manually analyzed to calculate 6 VFSS metrics as well as to assign a penetration-
aspiration score for each mouse at each time point. Descriptive statistics are 
provided in Table 2.5. We first assessed the effect of the surgical injury itself (i.e., 
without laryngeal nerve transection) using a one-way repeated measures ANOVA. 
Results revealed that the mean value for each variable was not statistically 
different between time points, thus validating that the surgical procedure does not 
cause dysphagia.  
Three VFSS metrics (swallow rate, lick-swallow ratio, and inter-swallow 
interval) were problematic for hypothesis testing because mean values for both 
SLN transection groups were statistically different from the RLN transection and 
sham surgical groups at baseline, but not at post-surgical time points. Therefore, 
we conducted separate one-way ANOVAs at each time point (rather than using 
change scores which utilizes baseline values) at the 1 week and 3 month post-
surgery time points to facilitate model development. No statistically significant 
differences were identified between surgical groups for each of these 3 VFSS 
metrics, which suggests these metrics may not be useful for detecting post-surgical 
dysphagia in this model.  
In contrast, the group means for lick rate (i.e., tongue motility), pharyngeal 
transit time, and esophageal transit time were similar at baseline but different at 
the post-surgical time points, as shown in Figure 2.6. ANOVAs based on change 
scores revealed statistically significant (p<0.05) differences in lick rate and 
pharyngeal transit time, but not esophageal transit time, (F3,34 = 4.470, p=0.009; 
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F3,34 = 3.956, p=0.016 respectively) at the acute recovery time point (Table 2.6). 
No significant differences in swallow function were evident at the chronic recovery 
time point (Table 2.7), indicating that acute changes in swallow function had 
returned to normal by 3 months post-surgery. Post-hoc t-tests were conducted only 
for the two significant acute recovery ANOVA change scores (i.e., lick rate and 
pharyngeal transit time). Results revealed that lick rate was significantly slower 
after unilateral RLN transection compared to unilateral SLN transection (diffΔuRLN-
ΔuSLN=-0.522; p=0.035), bilateral SLN transection (diffΔuRLN-ΔbSLN=-0.992; p=0.011), 
and sham surgery (diffΔuRLN-Δsham=-0.835; p=0.047), whereas pharyngeal transit 
time was significantly longer after bilateral SLN transection compared to unilateral 
SLN transection (diffΔbSLN-ΔuSLN=0.003; p=0.009). All other group comparisons for 
these two VFSS metrics were not statistically different (p>0.05). Although not 
statistically different, esophageal transit time was noticeably longer for the 
unilateral RLN and bilateral SLN transection groups at the 1 week post-surgery 
time point.  
The final VFSS metric under investigation was PAS. At each time point, all 
mice in each of the four surgical groups had a score of 1 (i.e., no evidence of 
penetration or aspiration). Therefore, statistical analysis was not performed for this 
metric because there was no variability in the data (i.e., standard deviation = 0).   
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Figure 2.6. Effect of Laryngeal 
Nerve Transection Injury on 
Swallow Function. Of the four 
surgical groups investigated, 
only unilateral RLN 
transection and bilateral SLN 
transection had a statistically 
significant effect on swallow 
function. At the acute (1 week 
post-surgery) time point, lick 
rate (i.e., tongue motility) was 
significantly slower after 
unilateral RLN transection 
(red line, Oral Stage – top 
panel), and pharyngeal transit 
time was significantly longer 
after bilateral SLN transection 
(purple line, Pharyngeal Stage 
– middle panel). In addition, 
esophageal transit time was 
longer for the unilateral RLN 
and bilateral SLN transection 
groups (red and purple lines, 
respectively, Esophageal 
Stage – bottom panel); 
however, results did not reach 
statistical significance. At the 
chronic (3 month post-
surgery) time point, swallow 
function was not significantly 
different from baseline 
function. Asterisk denotes 
statistical significance 
(p<0.05) based on change 
scores; error bars = ±1 SEM. 
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Table 2.5. Descriptive Statistics for VFSS Metrics 
 
 
 
 
 
 
RLN TRANSECTION - UNILATERAL 
VFSS 
METRICS 
(units) 
Baseline 1 Week Post-Surgery 
3 Months Post-
Surgery 
min max 𝒙 SD min max 𝒙 SD min max 𝒙 SD 
Lick Rate               
(# per second) 
7.00 8.00 7.67 0.47 6.00 8.00 7.14 0.59 7.00 8.00 7.50 0.51 
Swallow rate         
(# per 2 sec) 
2.00 6.00 3.70 0.86 2.00 6.00 3.66 0.75 2.00 6.00 3.74 0.96 
Inter-swallow 
Interval (sec) 
0.23 1.30 0.65 0.21 0.27 1.03 0.64 0.17 0.37 1.30 0.62 0.24 
Lick-swallow 
Ratio 
(licks/swallow) 
1.00 10.00 4.47 1.84 1.00 9.00 4.09 1.55 2.00 10.00 4.12 2.18 
PTT (seconds) 0.07 0.13 0.09 0.02 0.07 0.10 0.09 0.01 0.07 0.10 0.09 0.02 
ETT (seconds) 0.57 1.43 0.79 0.22 0.60 2.23 1.01 0.40 0.57 1.50 0.89 0.25 
SLN TRANSECTION - UNILATERAL 
VFSS 
METRICS 
(units) 
Baseline 1 Week Post-Surgery 
3 Months Post-
Surgery 
min max 𝒙 SD min max 𝒙 SD min max 𝒙 SD 
Lick Rate               
(# per second) 
7.00 8.00 7.46 0.51 7.00 8.00 7.64 0.48 7.00 9.00 7.68 0.52 
Swallow rate         
(# per 2 sec) 
2.00 5.00 3.18 0.89 2.00 6.00 4.04 0.95 2.00 6.00 3.91 0.83 
Inter-swallow 
Interval (sec) 
0.33 1.47 0.77 0.29 0.37 1.20 0.59 0.19 0.27 1.03 0.62 0.18 
Lick-swallow 
Ratio 
(licks/swallow) 
2.00 10.00 5.51 2.37 2.00 9.00 3.96 1.60 1.00 7.00 4.16 1.51 
PTT (seconds) 0.07 0.17 0.10 0.03 0.07 0.13 0.08 0.02 0.03 0.10 0.08 0.02 
ETT (seconds) 0.53 1.50 0.84 0.30 0.53 2.23 0.81 0.35 0.60 2.07 0.82 0.29 
SLN TRANSECTION - BILATERAL 
VFSS 
METRICS 
(units) 
Baseline 1 Week Post-Surgery 
3 Months Post-
Surgery 
min max 𝒙 SD min max 𝒙 SD min max 𝒙 SD 
Lick Rate               
(# per second) 
7.00 9.00 7.72 0.54 7.00 9.00 8.00 0.47 7.00 9.00 8.04 0.54 
Swallow rate         
(# per 2 sec) 
3.00 8.00 4.92 1.05 3.00 7.00 4.26 0.92 2.00 6.00 4.06 1.04 
Inter-swallow 
Interval (sec) 
0.23 0.87 0.47 0.14 0.23 0.87 .55 0.13 0.33 1.20 0.59 0.17 
Lick-swallow 
Ratio 
(licks/swallow) 
1.00 6.00 3.18 1.16 1.00 7.00 3.91 1.25 2.00 9.00 4.16 1.56 
PTT (seconds) 0.07 0.13 0.11 0.02 0.03 0.20 0.12 0.03 0.07 0.13 0.09 0.02 
ETT (seconds) 0.50 1.77 0.81 0.29 0.63 2.27 1.00 0.40 0.57 1.43 0.80 0.22 
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Note: PTT = pharyngeal transit time; ETT = esophageal transit time; VFSS metric values represent 
min (minimum), max (maximum), 𝑥 (mean), and SD (standard deviation).   
 
 
Table 2.6. Acute Changes in Swallow Function 
 
 
 
VFSS 
Metrics 
(units) 
Mean Change Score: 
1 week post-surgery minus baseline (standard deviation) 
 
p-
value 
ANOV
A 
RLN 
Transection 
(Unilateral) 
SLN Transection 
Sham 
Surgery Unilateral Bilateral 
Tongue 
motility 
(licks per 
second) 
-0.5 (0.6) 0.18 (0.5) 0.3 (0.5) 0.1 (0.5) 0.009 
Pharyngeal 
transit time 
(ms) 
-2.0 (11.7) -1.7 (17.6) 8.9 (21.1) -5.1 (1.4) 0.016 
Esophageal 
transit time 
(ms) 
210.6 (273.2) 
-27.9 
(318.3) 
189.6 
(248.7) 
17.0 (106.9) 0.103 
Note: bold p-values indicate statistical significance; ms = milliseconds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SHAM SURGERY 
VFSS 
METRICS 
(units) 
Baseline 1 Week Post-Surgery 
3 Months Post-
Surgery 
min max 𝒙 SD min max 𝒙 SD min max 𝒙 SD 
Lick Rate                
(# per second) 
7.00 8.00 7.67 0.48 7.00 9.00 7.79 0.46 7.00 9.00 7.63 0.53 
Swallow rate          
(# per 2 sec) 
2.00 6.00 3.87 0.94 0.00 7.00 3.89 1.67 2.00 7.00 4.18 1.11 
Inter-swallow 
Interval (sec) 
0.27 1.07 0.57 0.19 0.23 1.07 0.56 0.20 0.23 1.00 0.56 0.19 
Lick-swallow 
Ratio 
(licks/swallow) 
1.00 8.00 3.93 1.63 0.00 8.00 3.35 1.95 1.00 7.00 3.55 1.61 
PTT (sec) 0.07 0.17 0.10 0.03 0.07 0.13 0.09 0.02 0.07 0.13 0.09 0.02 
ETT (sec) 0.53 1.40 0.74 0.16 0.53 1.40 0.75 0.19 0.43 1.70 0.91 0.33 
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Table 2.7. Chronic Changes in Swallow Function 
 
 
 
VFSS 
Metrics 
(units) 
Mean Change Score: 
3 months post-surgery minus baseline (standard 
deviation) 
 
p-value 
ANOVA 
RLN 
Transection 
(Unilateral) 
SLN Transection Sham 
Surgery Unilateral Bilateral 
Tongue 
motility 
(licks per 
second) 
-0.2 (0.5) 0.2 (0.4) 0.3 (0.5) -0.00 (0.6) 0.169 
Pharyngeal 
transit time 
(ms) 
-7.5 (12.9) -23.8 (14.3) -11.0 (16.5) -7.7 (13.5) 0.066 
Esophageal 
transit time 
(ms) 
96.7 (128.5) -23.6 (248.2) 
-20.1 
(177.2) 
175.6 (224.8) 0.098 
Note: ms = milliseconds. 
 
2.4.2 Model Refinement and Therapeutic Investigation: RLN Crush Injury and 
iVNS Treatment 
Descriptive statistics for the two experimental groups (RLN crush without 
iVNS, and RLN crush with iVNS) are shown in Table 2.8. Initially, the four iVNS-
treated mice were evenly split into 60-minute (n=2) versus 30-minute (n=2) 
treatment groups. However, the first mouse in the 60-minute treatment group died 
intraoperatively due to respiratory distress, and the second mouse developed 
irregular breathing that was not resolved by lowering the stimulus intensity; 
therefore treatment was prematurely ended at 50 minutes for this mouse. In 
contrast, the 30-minute iVNS treatment duration was well-tolerated by the other 2 
mice, without adverse events. The 3 surviving iVNS-treated mice (one 50-minute 
treatment and two 30-minute treatment) were combined into a single iVNS 
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treatment group for comparison with the control group (n=3, RLN crush without 
iVNS treatment).  
Post-surgery, all 6 mice underwent functional testing of VF mobility (i.e., 
laryngoscopy) once a week as planned until the study end point (3 months post-
surgery). VFSS was not performed on these mice because results from the more 
severe RLN injury group (i.e., transection) revealed only a transient tongue motility 
deficit; no other significant swallow-related impairments were identified after RLN 
injury. Thus, we elected to defer this extremely labor-intensive assay for a 
subsequent larger RLN crush/iVNS treatment study that will benefit from our VFSS 
analysis software that is currently under development. 
 
Table 2.8. Sample Size and Age Range for Experimental Groups  
 
 
 
 
 
 
 
 
 
Note: Age is expressed as mean ± standard deviation at the time of surgery;  
M = male; F = female. iVNS = intraoperative vagal nerve stimulation. 
 
 
VF Mobility: A total of 84 laryngoscopy videos (6 mice X 14 time points) were 
manually analyzed using a 3-point rating scale. As shown in Figure 2.7, RLN crush 
injury caused immediate, ipsilateral VF immobility (i.e., VF mobility score = 0) in all 
6 mice. Beginning at 2 weeks post-injury, iVNS-treated mice demonstrated 
markedly improved recovery of VF mobility compared to untreated mice. Although 
the small sample size precluded rigorous statistical analyses, an independent 
Experimental Group 
Sample Size 
Age 
(months) Group 
Sex 
M F 
RLN Crush without iVNS 
(control; no treatment) 
3 1 2 14.7 ± 2.3 
RLN Crush with iVNS 
(treatment) 
3 1 2 13.3 ± 2.3 
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samples t-test performed at only the final time point (12 weeks post-crush) 
revealed that treatment recovery after iVNS (mean=1.67 ±0.58, median=2.00, n=3) 
was significantly different compared to controls (mean=0.34±0.58, median=0.00, 
n=3), suggesting a beneficial treatment effect (p=0.047). 
 
 
Figure 2.7. Effect of iVNS on VF Mobility after RLN Crush Injury in Aged Mice. VF mobility improved 
in a stair step pattern after RLN crush injury in iVNS-treated mice >1 year of age. Untreated age-
matched mice fluctuated in VF mobility, with minimal improvement after a 12 week post-surgical 
recovery period. VF mobility was scored using a 3-point Likert scale. Error bars = ±1 SEM; n=3 
mice per group. Time points with collapsed error bars indicate no within group variation of VF 
mobility scores. Asterisk = p=0.047, based on a single t-test at the final time point. 
 
2.4.3 Histological Results 
Using our Sihler whole mount staining protocol, we were able to grossly 
map the laryngeal nerves (RLN and SLN) in this small mammal and show that the 
anatomic pattern is remarkably similar to humans (Figure 2.8). This staining 
method also provided confirmatory evidence that the target laryngeal nerve was 
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completely transected, without reattachment throughout the post-surgical recovery 
period. Trans-illumination of Sihler stained specimens under our surgical 
microscope permitted identification of tiny RLN branches that were not visible 
during the surgical procedure. RLN branching was also apparent during post-
mortem dissections, but only with extreme lateral retraction (Figure 2.9). As lateral 
retraction of the RLN was avoided in our surgical approach, we expect that any 
existing RLN branches were likely included with the RLN trunk when it was isolated 
and transected. However, this hypothesis requires histological confirmation in our 
future studies.  
Of the 20 combined specimens subjected to either Sihler staining or post-
mortem dissection, most (80%) had 1-2 visible branches emanating from the main 
RLN trunk bilaterally (but not in a symmetrical pattern), in the vicinity of the 4th to 
8th tracheal rings. A few specimens had RLN branching only on the right (n=2) or 
left (n=1) side, and one specimen did not have any visible RLN branches on either 
side. All branches disappeared as they approached the larynx, where they became 
too tiny to visualize using standard light microscopy methods.  
A representative H&E stained transverse section of the murine larynx is 
shown in Figure 2.10, which highlights important differences in VF structure and 
function between the mouse and human. However, striking cross-species similarity 
of the cartilaginous and muscular framework of the larynx is indeed apparent. For 
example, like humans, the murine thyroarytenoid muscle consists of medial and 
lateral bellies, as well as a more ventrally located oblique belly that has only 
recently been identified in humans.52 
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Figure 2.8. Sihler Staining for Laryngeal Nerve Mapping. A representative Sihler stained sample 
from a mouse in the bilateral SLN transection group demonstrates that the murine laryngeal 
framework and laryngeal nerve branching pattern are remarkably similar to humans. Red X 
indicates the location of SLN transection. Black arrows show the origin of nerve branches from the 
RLN trunk bilaterally. CN X = Cranial Nerve 10 (i.e., vagus nerve); RLN = recurrent laryngeal nerve; 
SLN = superior laryngeal nerve. 
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Figure 2.9. Post-mortem Dissection Demonstrating RLN Branching. The left side shows that with 
minimal retraction of the soft tissues, as is used in our surgical approach, RLN branching is not 
visible. Instead, only the RLN trunk (gray arrow) can be seen running between the inferior thyroid 
artery (gray asterisk) and trachea. As shown on the right side, RLN branching is visible only during 
extreme lateral retraction of the midline strap muscles and fascia. In this specimen, the right RLN 
trunk (black arrow) has been pulled away from the inferior thyroid artery (black asterisk) to expose 
a single RLN branch (between the green arrows) near the 6th tracheal ring.   
 
64 
 
 
Figure 2.10. Murine Laryngeal Framework. (A) Hematoxylin and eosin (H&E) stained transverse 
section (10 µm) of a mouse larynx at the level of the VFs, with labeled structures. (B) Endoscopic 
image of the murine VFs, with corresponding labeled structures from Image A. In contrast to the 
human larynx, mice have proportionately larger arytenoid cartilages (black asterisks) and a 
proportionately smaller mucosal region extending beyond the vocal processes (VP) to the ventral 
commissure (red asterisk). In the mouse, the ventral commissure (which is obscured during 
laryngoscopy) is framed by a U-shaped alar cartilage (AC) that does not exist in humans. During 
spontaneous breathing in the mouse, the most dorsal portion of the arytenoids (yellow asterisk; 
dorsal commissure) remains relatively fixed near midline, serving as a pivot point for VF abduction 
and adduction. As a result, VF movement in the mouse is more readily apparent at the ventral 
(yellow bidirectional arrow in Image B) rather than the dorsal (posterior) region as in humans. TC: 
thyroid cartilage; AC: alar cartilage; VP: vocal process; TA: thyroarytenoid muscle (M: medial belly; 
L: lateral belly; O: oblique belly); S: strap muscles; blue asterisk: glottis; black asterisk: arytenoid 
cartilage; yellow asterisk: dorsal commissure; red asterisk: ventral commissure. Scale bar = 500 
µm. 
 
2.5 Discussion 
We successfully developed a mouse model of iatrogenic RLN injury with 
impaired VF mobility and swallowing function to serve as a translational platform 
for investigations of the pathological mechanisms contributing to poor functional 
outcomes and the development of novel regenerative treatment strategies. We 
used our “miniaturized” endoscopic35 and fluoroscopic32,36 imaging assays to 
characterize VF mobility and swallow function, respectively, after transection 
injury. We included the SLN in our model development because of its hypothesized 
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collateral innervation of intrinsic laryngeal muscles after RLN injury, which 
presumably contributes to VF synkinesis and resultant poor functional 
outcomes.6,2,7 Thus, we investigated the effect of four distinct laryngeal nerve injury 
patterns: RLN transection (unilateral versus bilateral) and SLN transection 
(unilateral versus bilateral). We examined four clinically relevant time points for 
longitudinal assessment of functional outcomes: baseline (1 week prior to surgery), 
during surgery (immediately post-transection), an acute recovery stage (1 week 
post-surgery), and a chronic recovery stage (3 months post-surgery). A sham 
surgical group was included as a negative control. Additionally, we studied a 
potential therapeutic intervention (iVNS) in aged mice to better correspond to the 
average age of anterior neck surgical patients. Moreover, the recovery period in 
our study roughly corresponds to over a decade in human years,53 thus providing 
additional translational perspective for human surgical patients with chronic 
adverse outcomes after iatrogenic RLN injury. 
As hypothesized, unilateral RLN transection resulted in immediate, 
ipsilateral VF paralysis (i.e., immobilization in the paramedian position), suggesting 
the RLN motor innervation pattern of intrinsic laryngeal muscles in mice is similar 
to humans. As expected, bilateral RLN transection caused complete airway 
obstruction from the medialized, immobile vocal folds, resulting in intraoperative 
mortality. In contrast, SLN transection (unilateral or bilateral) had no visible effects 
on VF mobility. Importantly, our sham surgery group did not develop impaired VF 
mobility, thus validating the surgical technique itself had no confounding effects on 
functional outcomes. 
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Whereas unilateral RLN transection in mice resulted in chronic impairment 
of VF mobility, dysphagia was transient and limited to the oral stage of swallowing, 
specifically affecting lick rate (i.e., tongue motility). This finding is in alignment with 
a recent report of significant oral stage alterations (e.g., tongue shape and bolus 
formation) in infant pigs after unilateral RLN transection;54 however, a related study 
showed no alteration in piglet suckling rate.20 We suspect this difference may be 
because licking (drinking) behavior in adult mice requires marked tongue 
protrusion that visibly elevates the hyoid bone (and hence larynx), whereas 
suckling in piglets requires comparatively little movement of the tongue and hyoid. 
As the tongue is anatomically coupled to the larynx via the hyoid,55 the resultant 
VF immobility after unilateral RLN transection in mice may be causing an 
anchoring effect that hinders normal tongue protrusion during drinking. 
Alternatively, RLN injury in infant pigs was shown to affect EMG swallowing activity 
in muscles that are not directly innervated by the RLN, particularly the tongue.56 In 
this case, muscle activity was decreased in lesioned animals prior to swallow 
initiation and during bolus transit, resulting in marked differences in tongue shape, 
movement, and timing, as well as corresponding differences in the size and shape 
of the bolus. These findings provide rationale for inclusion of EMG and other 
kinematic assessments of tongue function to further explore the link between RLN 
injury and altered lick rate in our model.  
Moreover, these findings suggest that an RLN lesion may impact upstream 
neural connections between the numerous brainstem nuclei and/or cortical regions 
involved in swallowing.56 In our study, we suspect the 4 day post-surgical VFSS 
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time point provided an ample window for Wallerian degeneration, a stereotypical 
process that initiates degeneration of the myelin sheath and axons within 24-36 
after nerve injury, paving the way for nerve regeneration.57 Moreover, the act of 
surgically creating the nerve injury generates an immediate burst of action 
potentials that travel centrally along the injured axons to reach the neuronal cell 
bodies and their synaptic connections. This nerve injury signal triggers the 
necessary metabolic processes within the cell bodies to promote nerve 
regeneration and promote neural plasticity.58 In the case of the RLN, the “injury 
signal” travels along the vagus nerve to stimulate the vagal ganglia (i.e., 
afferent/sensory neurons of the RLN) and the nucleus ambiguus in the brainstem 
medulla (i.e., efferent/motor neurons of the RLN), and their synaptic connections 
with the numerous brainstem and cortical regions involved in swallowing. Thus, 
our mouse model of RLN injury with resultant tongue motility deficit at the 4 day 
post-surgical time point provides a suitable platform for systematic investigations 
of the peripheral and central effects of RLN injury and for exploring novel 
mechanisms to enhance neural plasticity and optimize functional outcomes.  
Interestingly, esophageal transit time was noticeably (but not significantly) 
longer after RLN transection, resembling findings with infant pigs.20 Given that 
esophageal dysphagia is a common report in humans after anterior neck surgical 
procedures,59,60 we are currently strategizing alternative esophageal outcome 
measures via VFSS that may be more robust indicators of RLN injury for use in 
future experiments with this model. We also are exploring the possibility of 
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performing EMG and manometry in this small animal for better detection and 
objective quantification of esophageal impairment.  
In contrast to humans and other larger animal models of RLN injury, VF 
paralysis in mice does not result in aspiration during swallowing. As the sensory 
receptors of the RLN are located below the VFs and there is no aspirated fluid 
stimulating this region (based on our VFSS findings), the sensory component of 
the RLN is unlikely to contribute to the overall swallow pathology and recovery in 
our model. Instead, we suspect the dichotomy in recovery between VF mobility 
and swallowing function after RLN injury may be due to the mice adopting 
compensatory behavioral strategies during feeding to maintain adequate nutrition 
and hydration, as previously described for people.61-63 
This recovery dichotomy may also be due to technological limitations of our 
fluoroscope as well as species-related differences in the swallowing mechanism. 
For example, we have previously shown the pharyngeal stage of swallowing in 
mice is approximately 10 times faster than humans.36,32 Therefore, the 30 fps 
limitation of our fluoroscopy camera prevents sufficient temporal resolution to 
reliably quantify the numerous rapid events occurring during swallowing. Further, 
our low energy X-ray system prevents visualization of soft tissue and cartilaginous 
structures of the larynx and pharynx; therefore, quantification of swallowing 
function was largely limited to bolus flow dynamics. At no time was there evidence 
of laryngeal penetration or aspiration of the oral contrast agent, likely because mice 
are preferential nasal breathers whose larynx resides in the nasopharynx, 
inherently protected from the path of the bolus during swallowing.32,36 However, 
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impaired VF mobility is a significant risk factor for penetration/aspiration in humans, 
thus highlighting the translational applicability of our mouse model. 
Results for the SLN transection groups further support model development. 
We expected SLN transection would result in subtle, transient changes in VF 
mobility and swallowing function, which would be more pronounced after bilateral 
transection. However, VF mobility was unaffected by SLN transection, and 
dysphagia was evident only after bilateral SLN transection, which resolved by the 
3 month post-surgery time point. Only the pharyngeal stage of swallowing was 
significantly affected by bilateral SLN transection, as evidenced by longer 
pharyngeal transit times. This finding is congruent with studies of infant pigs, in 
which SLN transection resulted in increased pharyngeal transit time, as well as 
increased bolus area and aspiration incidence21,22 with more severe outcomes for 
bilateral injuries.23 
Importantly, we refined our RLN transection (neurotmesis) model to include 
a more prevalent axonotmesis surgical injury type. We chose a crush injury 
because it is easier to standardize than experimental traction or thermal 
approaches. Additionally, because crush injury shows spontaneous recovery over 
time, treatments targeting accelerated recovery can be assessed. We tested this 
hypothesis by conducting a feasibility study of intraoperative vagal nerve 
stimulation (iVNS) as a novel regenerative strategy. In doing so, we expanded 
upon a recent study in young adult rats, whereby intraoperative RLN stimulation 
accelerated the recovery of VF mobility after RLN crush injury.29 However, rather 
than stimulating the RLN, we chose the cervical vagus nerve as a more clinically 
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relevant treatment site. Our rationale was based on the highly variable and 
extensive branching pattern of the RLN which renders it quite challenging, if not 
impossible, for surgeons to pinpoint the exact site(s) of injury.2,64,65 Thus, iVNS 
may circumvent this problem by simultaneously targeting all RLN branches to 
promote widespread regeneration. 
Although our study provides encouraging preliminary data that iVNS may 
improve recovery after RLN axonotmesis, larger studies must be conducted to 
establish optimal iVNS treatment parameters (e.g., stimulus frequency and 
intensity, treatment duration, etc.) and to characterize voice, respiratory, and 
swallowing outcomes in parallel with VF mobility. Furthermore, effects on RLN fiber 
types (motor, sensory, and autonomic/parasympathetic) must be considered, as 
each may require different stimulation parameters for optimal regeneration.43,44,66 
Nevertheless, the high clinical-translational potential of our proposed iVNS 
treatment strategy is supported by existing FDA-approved vagal nerve stimulation 
technology, for example continuous intraoperative nerve monitoring (CIONM).67-69 
CIONM enables EMG monitoring of the VFs to detect RLN injury by providing 
periodic, low-level neuro-stimulation throughout the surgery via an electrode 
secured around the vagus nerve. Thus, if iVNS proves to be effective in promoting 
RLN regeneration, we propose the CIONM software could be modified to include 
settings appropriate for iVNS treatment, thereby expanding this technology from 
purely an RLN monitoring device into a robust therapeutic nerve regeneration 
strategy. 
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Additionally, we successfully performed laryngeal nerve mapping using 
post-mortem dissections and a Sihler whole mount staining technique. Results 
revealed multiple RLN branches terminating along the esophagus and larynx, 
similar to the variable innervation pattern described for the human RLN.70-73 For 
this reason, our future studies will include histological confirmation in each mouse 
that all RLN branches at the injury site are effectively targeted, thus providing a 
methodological control to improve scientific rigor. We also performed basic 
histologic evaluation of the larynx using H&E staining of transverse sections, which 
confirmed the previously published, detailed description of the mouse larynx.33 
However, our ability to perform in vivo endoscopic assessment of the larynx for 
comparison with post-mortem histological assays provides a novel perspective of 
the similarities and differences between the mouse and human larynx. Given the 
extremely small size of mice, more in depth microscopic investigations (e.g., 
immunohistochemistry and transmission electron microscopy) will be essential for 
detailed laryngeal nerve mapping, as well as objective quantification of normal and 
pathological neuromuscular innervation and remodeling after laryngeal nerve 
injury and subsequent treatment interventions such as iVNS. 
Other limitations of our study were that we did not investigate simultaneous 
injury of the RLN and SLN, we included a small sample size in our RLN crush/iVNS 
feasibility study, we did not include EMG recordings of the laryngeal muscles, nor 
did we include vocalization and respiratory assays for added translational impact. 
In addition, sex differences have not yet been explored in this model. Larger 
studies are underway to address each of these limitations. 
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A final notable limitation of our study involves interpretation of our 
endoscopic and fluoroscopic videos. For endoscopy, we used a qualitative Likert 
scoring system that introduces subjectivity; whereas, for fluoroscopy, we used a 
frame-by-frame manual analysis approach that is highly objective, but extremely 
labor intensive and therefore significantly slows the scientific discovery process. 
To overcome these limitations, we have developed custom software for semi-
automated analysis of endoscopic74 and fluoroscopic videos; validation studies are 
currently underway. We expect automation will permit high throughput, objective 
quantification of the fast-paced breathing35 and drinking32,36 behaviors observed in 
mice. Further, subtle changes in VF motion and swallowing function in mice that 
are difficult to detect with the human eye may be clinically relevant, as small 
changes in this small animal may in fact be large changes in humans. In addition, 
in human medicine, subjectivity is a known limitation of the “gold standard” 
endoscopic and fluoroscopic swallow tests, which results in poor inter- and intra-
rater reliability.75-80 Thus, we are in the process of adapting our software for 
validation with endoscopic and fluoroscopic videos obtained from humans, to 
further facilitate our translational research agenda.  
In summary, we successfully developed a translational mouse model of 
iatrogenic RLN injury that demonstrates laryngeal (chronic) and swallowing (acute) 
dysfunction. We developed this model using our established endoscopic and 
fluoroscopic assays that permit longitudinal assessment in mice. We anticipate this 
new model will serve as a clinically relevant platform to: 1) develop intraoperative 
strategies for RLN injury prevention, 2) elucidate the functional roles of the RLN 
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versus SLN under normal versus lesioned conditions, 3) hasten our understanding 
of the molecular mechanisms contributing to poor functional outcomes after RLN 
injury, and 4) develop innovative regenerative treatment strategies to significantly 
accelerate and improve functional recovery of swallowing, voice, and breathing, 
which are all negatively impacted by RLN injury. 
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3.1 Abstract 
Objectives: The goal of this study was to objectively examine vocal fold (VF) 
motion dynamics after iatrogenic recurrent laryngeal nerve (RLN) injury in a mouse 
surgical model. Furthermore, we sought to identify a method of inducing injury with 
a consistent recovery pattern from which we can begin to evaluate spontaneous 
recovery and test therapeutic interventions.  
Methods: The right RLN in C57BL/6J mice was crushed for 30 seconds using an 
aneurysm clip with 1.3 Newtons closing force. Transoral laryngoscopy enabled 
visualization of VF movement prior to surgery, immediately post-crush, and at two 
endpoints: 3 days (n=5) and 2 weeks (n=5). VF motion was quantified with our 
custom motion analysis software. At each endpoint, RLN samples were collected 
for transmission electron microscopy (TEM) for correlation with VF motion 
dynamics.  
Results: Our VF tracking software permitted automated quantification of several 
measures of VF dynamics, such as range and frequency of motion. By 2 weeks 
post-injury, the frequency of VF movement on the right (injured) side equaled the 
left, yet range of motion only partially recovered. These objective outcome 
measures enabled detection of VF dysfunction that persisted at 2 weeks post-
crush. TEM images revealed RLN degeneration 3 days post-crush, and partial 
regeneration at 2 weeks, consistent with functional results obtained with 
automated VF tracking. 
Conclusions: Our motion analysis software provides novel objective, quantitative, 
and repeatable metrics to detect and describe subtle VF dysfunction in mice that 
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corresponds with underlying RLN degeneration and recovery. Adaptation of our 
tracking software for use with human patients is underway. 
 
3.2 Introduction 
Iatrogenic recurrent laryngeal nerve (RLN) injury is a common complication 
of anterior neck surgical procedures, such as cervical spinal surgery or 
thyroidectomy.1-3 Injury to the RLN results in ipsilateral vocal fold (VF) paralysis 
that may contribute to dysphagia, dysphonia, and/or dyspnea (i.e., swallow, voice, 
and respiratory dysfunction, respectively).4-7 These conditions are devastating for 
patients, especially if chronically persistent, as they are associated with poor 
quality of life, major depression, increased financial burden, and decreased 
general health.3,7-9 Furthermore, effective treatment options to promote RLN 
regeneration and restore full functionality of the injured VF are lacking.4,7,10-12 
Unfortunately, RLN injury and associated sequelae are impossible to 
systematically investigate in human patients. Therefore, a consistent animal model 
that mimics iatrogenic RLN injury is required in order to investigate the responsible 
mechanisms and explore potential therapeutics.13 Indeed, work in animal models 
has shown that unilateral RLN injury causes ipsilateral VF paralysis, as it does in 
humans.11,14-18 Though other translatable outcome measures such as voice, 
respiratory, and swallow function remain to be comprehensively examined, VF 
motion dynamics have provided robust and direct information in regard to RLN 
injury and subsequent recovery in these animal models. However, current methods 
often rely on subjective rating scales15,16,19-21 that do not permit thorough and 
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meticulous evaluation of VF motion dynamics. As a result, VF mobility scores may 
vary between observers, and minute improvements (or deteriorations) in VF 
motion are likely overlooked or misidentified.  
Due to the inherent concerns with subjective VF analysis, efforts have been 
attempted to objectively quantify VF movement. One strategy involves measuring 
the angle between VFs during maximum abduction and maximum adduction using 
still-frame images.14-16 However, angles may vary slightly within an individual 
animal, as total range of spontaneous VF movement during breathing depends on 
factors such as depth of anesthesia and ventilatory drive. Unlike human patients, 
anesthesia is necessary to immobilize rodent species to record VF movement. 
Thus, even “normal” VF movement in a single animal can vary between each 
laryngoscopic procedure, making longitudinal comparisons difficult with this 
analysis technique.  
Another method for objective quantification utilizes examination of glottal 
area, where the area of the glottic space between midline and the VF mucosa is 
calculated for the injured and uninjured sides.11,17 In this case, determining midline 
remains quite subjective unless there is clear visualization of both the anterior and 
posterior commissures, which is a challenging view to obtain in rodents. Even if 
midline is identified accurately, the measurements are again affected by the total 
range of movement of the VFs under anesthesia, which is variable between 
anesthetic episodes. In addition, the fluctuating distance of the camera from the 
glottic space between procedures also contributes to variation in the area 
measured. To overcome this concern, measurements of the right VF have been 
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compared to the left VF as a ratio to normalize VF function for each video 
recording.11,17 However, this technique, as well as other manual analysis methods 
are time-consuming and therefore prohibitive to high-throughput data analysis in 
research or clinical practice. 
Another major limitation of these analysis techniques is that they rely on 
still-frame images representing only two time points of VF movement (maximum 
abduction and maximum adduction), revealing little about VF motion dynamics as 
a whole. Therefore, with static images, it is impossible to demonstrate how the VFs 
are moving in relation to each other. Are the VFs moving symmetrically and in 
synchrony with one another? Is the motion fluid or uneven? Is there intermittent or 
paradoxical movement of the VFs? At what rate are the VFs moving? Is there 
compensation of the uninjured VF? These questions cannot be answered with still-
frame images alone.  
To alleviate the limitations of still-frame image analysis, we have developed 
custom computational video analysis software that includes two components: 
VFTrack and VFQuantify. VFTrack is a VF motion tracker software, whereas 
VFQuantify is an analytics module that computes a set of objective, quantitative 
outcome measures describing VF motion dynamics, enabling objective 
comparisons across time and populations. These measures quantify aspects of 
motion behavior pertaining to healthy and paralyzed VFs, such as amplitude, 
frequency, range, symmetry, etc. In this study, two measures, Mean Motion Range 
Ratio (MMRR) and Open Close Cycle Ratio (OCCR), were developed to begin to 
objectively assess VF motion dynamics. VFQuantify was also used to calculate the 
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maximum angle of abduction and the minimum angle during adduction to correlate 
our findings with previous techniques described in the literature.   
To accomplish our primary objective (i.e., demonstration of the utility of our 
VFTrack and VFQuantify software), we produced a unilateral RLN compression 
(crush) injury in a mouse model using an aneurysm clip to induce ipsilateral VF 
dysfunction.19-23 To visualize VF motion, transoral laryngoscopy was performed 
prior to and immediately following crush injury, as well as 3 days and 2 weeks post-
crush. Our secondary objective was to confirm that this nerve crush methodology 
and severity of force produces unilateral VF immobility in mice, and to characterize 
how VF function recovers over time without treatment. In addition to functional 
analysis, we performed transmission electron microscopy (TEM) to document 
nerve pathology at each respective endpoint.  
 
3.3 Materials and Methods 
3.3.1 Animals 
 Ten C57BL/6J (B6) mice (n=4 males; 6 females), approximately 4 months of 
age, were used for this study, which was approved by our Institutional Animal Care 
and Use Committee. Mice were group housed by sex on a 12:12 light/dark cycle 
using individually ventilated cages, and had free access to food and water.  
 
3.3.2 RLN Crush Injury Procedure 
 Mice were anesthetized using a ketamine-xylazine cocktail (90;11.25 mg/kg), 
prepared aseptically for surgery, and placed in dorsal recumbency on a 
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customized platform under a surgical microscope. A midline incision (~1-2 cm) was 
made on the ventral neck, and the salivary glands were retracted laterally to 
expose the strap muscles overlying the trachea. The right RLN was gently isolated 
at the level of the 5th tracheal ring and crushed with a Sugita Titanium aneurysm 
clip (Mizuho, Tokyo, Japan)19,20,22,23 with a 1.3 N manufacturer-calibrated closing 
force. The aneurysm clip was closed for 30 seconds to induce a 1 mm injury24 in 
all mice (Figure 3.1). The left RLN served as an internal control for this study.  
 
Figure 3.1. A Sugita titanium aneurysm clip with a 1.3-N closing force was used to crush the right 
RLN in all mice at the level of the fifth tracheal ring. (A) The aneurysm clip (1 mm wide) was closed 
for 30 seconds to induce injury. Arrow indicates the RLN. (B) Ultraviolet sterilized carbon powder 
was placed on the crush tool to mark the site of injury on the RLN for postmortem identification, 
indicated by arrowhead. The right strap muscle is retracted laterally to allow visualization of the 
RLN. RLN = recurrent laryngeal nerve. 
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3.3.3 Transoral Laryngoscopy 
 Transoral laryngoscopy25 was performed immediately prior to surgical incision, 
while the mice were anesthetized, positioned in dorsal recumbency, and 
immobilized in ear bars. To do so, the tongue was retracted with a cotton swab 
and gentle finger-grip, and a micromanipulator-controlled sialendoscope with a 
customized laryngoscope sheath was gently inserted into the oral cavity to 
visualize baseline VF movement. In mice, VF movement is spontaneous with 
breathing, rather than an evoked response. Immediately post-crush, laryngoscopy 
was performed again to confirm ipsilateral VF paralysis. After repeat laryngoscopy, 
the incision was sutured closed, and the mouse was recovered. Laryngoscopy was 
performed once more at 3 days post-crush (n=5) or 2 weeks post-crush (n=5), prior 
to euthanasia and tissue collection. Laryngoscopy video recordings (30 frames per 
second; approximately 1-3 minutes long) were subjectively analyzed by two 
trained, blinded reviewers using a Likert scoring system (0 = no VF movement, 1 
= partial VF movement, 2 = normal VF movement).15,19-21 Additionally, VF 
movement was tracked bilaterally with our automated motion tracking software, 
VFTrack. Then VFQuantify was used to measure amplitude- and frequency- based 
outcome metrics, MMRR and OCCR, respectively, along with VF angle during 
maximum abduction and adduction, described below. 
 
3.3.4 Automated Analysis with VFTrack and VFQuantify 
 Our custom, VF motion analytics software package was used to analyze VF 
motion dynamics. A 10 second clip was selected from each video recording, based 
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on adequate visualization of the VFs and no aberrant camera movement. On the 
first video frame in each clip, a pair of points was manually placed on each VF (VF-
glottal region boundary) for automated tracking over time using our VFTrack 
software. Point selection was based on the anatomical structure of the VFs, which 
were selected on the upper (i.e., ventral) half of each VF to ensure higher 
sensitivity to small VF motions. Because of the V-shaped nature of the VFs, VF 
points with higher y coordinates result in larger displacements for the same angular 
motion. Left (LL) and right (LR) lines were automatically passed through each pair 
of tracked points to approximate the medial side of the VF and the ipsilateral 
arytenoid cartilage in each video frame (Figure 3.2a). Three points of interest (po, 
pL, pR) were automatically located on the two VF lines (LL and LR) in each frame. 
Po was the intersection point of the two VF lines, typically located midline, dorsal 
to the arytenoid cartilages, and pL and pR were two points on LL and LR, each at 
the same fixed distance from po (determined as the largest distance between the 
tracked points and po) (Figure 3.2a). Left and right VF motion ranges and 
corresponding motion midlines were automatically computed based on 
displacement (in pixels) of points pL and pR (Figure 3.2b). VF motion was 
automatically calculated through displacement of points pL and pR with respect to 
their motion midlines and graphically displayed as a cyclic waveform due to the 
oscillatory motion of the VFs during breathing (Figure 3.3).  
Using VFQuantify, motion behavior differences between left and right VFs 
were measured using two complementary ratios, OCCR (Open Close Cycle Ratio) 
and MMRR (Mean Motion Range Ratio), to characterize the frequency and 
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amplitude of VF motion, respectively. The number of motion cycles for each VF 
was computed as the number of motion midline crossings. OCCR was then 
computed as the ratio of number of motion cycles for right and left VFs. Motion 
range of each VF was defined as the distance between the left-most and right-
most positions of the VF (i.e., local minima and maxima in Figure 3.3) for each 
cycle. Mean Motion Range (MMR) was computed by averaging motion ranges over 
all time periods (i.e., each VF cycle within the 10 s video clip). MMRR was defined 
as MMRright/MMRleft, which compares right and left VF motion amplitudes. The 
described point selection protocol [pL(t), pR(t) equidistant from p0(t)] and unitless 
MMRR ensure robustness against variations in VF size across different subjects 
and camera distance from the VFs. In addition, the two VF lines, LL and LR, were 
used for automated measurement of VF angle during maximum abduction 
(maximum angle) and maximum adduction (minimum angle) for each video, 
without needing to manually acquire still images. The angular range of VF 
movement for each mouse was calculated by subtracting the minimum angle from 
the maximum angle measurements. 
 
Figure 3.2. (A) Automatically tracked VF lines (LL and LR) and points of interest (po, pL, pR) shown 
on a sample video frame. (B) Illustration of left/right VF motion ranges and associated motion 
midlines. VF = vocal fold. 
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Figure 3.3. (A, B) Displacement of the left (blue) and right (red) VFs individually over time. The x-
axis is the video frame number and the y-axis is VF displacement measured in pixels. The graphs 
display the cyclic movement as the VFs oscillate back and forth across their respective motion 
midlines (dashed lines) during inspiration and expiration in a normal mouse at baseline under a 
surgical level of anesthesia. Solid arrows indicate the VF is adducting (closing), whereas dashed 
arrows indicate the VF is in a state of abduction (opening). (C) The left and right VF displacement 
graphs from baseline are overlaid with respect to their motion midlines. Right VF range and 
frequency of motion are similar to the left. (D) Combined right and left VF movement immediately 
after a right RLN crush injury. There is no right VF movement, compared with normal left VF 
movement. RLN = recurrent laryngeal nerve; VF = vocal fold. 
 
3.3.5 VFTrack Validation and Performance Evaluation 
 We validated tracking accuracy of our VFTrack software by comparing the 
automatically generated tracks from VFTrack to manually generated tracks by two 
independent reviewers (MH and TL) on a subset of videos (2 out of 5 videos per 
time point). For each selected video, manual tracks were generated by selecting a 
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point (x-y coordinate) on each VF boundary and sequentially marking the same 
boundary coordinate on every frame of each video. Given that different points can 
be manually selected and tracked on the VF boundary to produce the same line 
used to compute our outcome measures (MMRR and OCCR), reviewers were 
asked to track only the x-coordinate on the VF boundary in each frame. The y-
coordinate was automatically displayed on each frame, indicated by a blue 
horizontal line spanning the image. MMRR and OCCR measures were calculated 
for each video based on the manual points (n=600 per video) placed by each 
reviewer. VFTrack performance was evaluated by computing (1) the pixel distance 
between manually and automatically tracked points along the VF boundary; (2) 
differences in MMRR and OCCR measures produced by these points; and (3) the 
time needed to generate these points. In addition, VFTrack was ran twice more by 
two independent reviewers to verify its reliability between reviewers.     
 
3.3.6 Transmission Electron Microscopy 
 Mice were perfused with saline followed by 4% paraformaldehyde (PFA). 
RLNs were dissected en bloc and post-fixed in 4% PFA / 2% glutaraldehyde in 100 
mM sodium cacodylate buffer. Samples were sent to our Electron Microscopy Core 
for standard tissue processing, embedding, and sectioning (85 nm). High 
resolution TEM cross-sectional images from the left and right RLNs distal to the 
crush-site were obtained using a JEOL JEM 1400 TEM microscope at 80 kV with 
a Gatan Ultrascan 1000 CCD camera.  
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3.3.7 Statistics 
 Mice were divided into two groups based on endpoint. Change scores between 
baseline and endpoint were calculated, and independent samples T-tests were 
used to separately analyze both outcome metrics (MMRR and OCCR). 
Spearman’s correlations were utilized to compare subjective (Likert scale) and all 
objective outcome measures (MMRR, OCCR, and VF angle). Pearson’s 
correlations were computed between the calculated angular range of motion and 
MMRR, to compare traditional objective analysis techniques with our novel 
objective metrics. Statistics were computed using IBM SPSS Statistics 24 and p 
values of less than 0.05 were considered significant.  
 
3.4 Results 
3.4.1 Subjective VF Motion Results  
 All mice survived the RLN crush surgical procedure and subsequent 
laryngoscopy recordings. Our subjective analysis of laryngoscopy video 
recordings revealed that all mice (n=10) had normal, bilaterally-symmetrical VF 
motion (score = 2) prior to injury. Immediately post-crush, all mice developed 
complete right-sided (ipsilateral) VF paralysis (score = 0). At the 3 days post-crush 
endpoint, the right VF remained immobile in all 5 mice. In contrast, mice had partial 
to full recovery of right VF movement at 2 weeks post crush (n=5; average score 
= 1.4; std = 0.55) (Figure 3.4a).  
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3.4.2 Objective VF Motion Results  
 Due to variable total range of VF motion in individual mice between anesthetic 
episodes, right VF movement was compared to left VF movement and quantified 
as a ratio (right:left) for our objective outcome measures. Our amplitude-based 
measure, Mean Motion Range Ratio (MMRR), allows quantification of right 
(injured) versus left (control) VF range of motion. Our frequency-based measure, 
Open Close Cycle Ratio (OCCR), quantifies the number of right VF movements 
compared to the left. At baseline, ratios for both MMRR and OCCR were near 1, 
signifying that right VF motion dynamics were similar to the left. Immediately post-
crush, ratios were virtually 0, indicating complete paralysis of the right VF. At 3 
days post-crush, MMRR and OCCR remained near 0, suggesting minimal to no 
recovery. By 2 weeks, our findings revealed partial recovery of VF range of motion 
and full recovery of VF frequency (Figure 3.4b and 3.4c). Mice at 3 days and 2 
weeks post-crush had significantly different change scores for both outcome 
metrics. In addition, our automated VF angle measurements (Figure 3.4d) 
correlated with MMRR outcomes, signifying our novel, automated MMRR metric 
corresponds with previously reported angle measurement methods that are based 
on time-consuming analysis of still-frame images.14-16 Correlations between 
outcome measures are displayed in Tables 3.1 and 3.2.  
 In summary, our automated outcome measures, MMRR and OCCR, had 
statistically significant correlation with our subjective analysis, as well as with 
angular range of motion, indicating our novel outcome measure detect similar 
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changes as with historic analysis methods, while providing more objective and 
informative outcome metrics that can be expanded upon in future studies. 
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d 
Figure 3.4. VF motion was quantified 
using (A) subjective and (B–D) objective 
outcome metrics. In all cases, VF motion 
was impaired by the RLN crush injury, 
which partially recovered by 2 weeks post-
crush. One video file (immediately post-
crush) had poor image quality for 
automated tracking and was excluded 
from graphical analysis in (B) and (C). PC 
= post-crush; RLN = recurrent laryngeal 
nerve; VF = vocal fold. 
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Table 3.1. Associations between subjective and objective VF measures 
using Spearman’s correlation. 
   MMRR OCCR 
Angular Range of 
Motion 
Subjective Score 
(n=30) 
Correlation 
Coefficient 
 
0.874
** 0.824** 0.886** 
**. Correlation is significant at the 0.0001 level (2-tailed). 
MMRR = Mean Motion Range Ratio; OCCR = Open Close Cycle Ratio 
 
Table 3.2. Associations between objective measures of VF motion using 
Pearson correlations. 
  MMRR OCCR 
Angular Range of 
Motion 
MMRR (n=30) 
Pearson 
Correlation    1 0.799
** 0.817** 
OCCR (n=30) 
Pearson 
Correlation 0.799
**     1 0.686** 
Angular Range of 
Motion (n=30) 
Pearson 
Correlation 0.817
** 0.686** 1 
**. Correlation is significant at the 0.0001 level (2-tailed). 
MMRR = Mean Motion Range Ratio; OCCR = Open Close Cycle Ratio 
 
3.4.3 VFTrack Validation and Performance Evaluation 
 To validate our automated tracking software, two reviewers performed manual, 
frame-by-frame analysis on a subset of videos. The average pixel distance 
between the automated software and each independent reviewer was 1.94 pixels 
(sd = 1.16; MH) and 1.88 pixels (sd = 1.10; TL). The average pixel distance 
between reviewers was 1.59 pixels (sd = 0.40). Figure 3.5 displays a 
representative image of pixel error in a single video frame between each reviewer 
and VFTrack. On average, it took approximately 18 minutes longer to manually 
track the two VF boundary points compared to our automated process. Thus, 
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VFTrack drastically decreases the time to collect the MMRR and OCCR measures 
reported in this study. Calculations of these measures were performed the same 
for both manual and automated tracks using our VFQuantify software. The average 
difference in MMRR and OCCR was less than 0.09 and 0.20, respectively, for all 
three cases. The larger error in OCCR was likely due to inconsistent point selection 
with manual analysis. Additionally, MMRR and OCCR results did not significantly 
change when VFTrack was reran by two different reviewers. 
 
 
Figure 3.5. Representative image of VFTrack validation process. VF boundaries were tracked with 
our automated software (red points). Manual points were placed on each frame by 2 independent 
reviewers (green and blue points). The expanded view of the left and right VF boundaries shows 
individual pixels and the pixel location of each point along the given blue horizontal line. In this 
image, both reviewers are no more than 2 pixels away from the automatically tracked point, 
demonstrating high reliability of our automated tracking software. For perspective, the total 
endoscopy field of view contains approximately 60,000 pixels. VF = vocal fold. 
 
 
3.4.4 TEM 
 Cross-sections of the left (control) RLN in all mice revealed thick axonal 
myelination with minimal interstitial space between axons. In contrast, there was 
evidence of extensive axonal degeneration in the right RLN at 3 days post-crush. 
This degeneration was indicated by collapsed nerve fibers and dense, compressed 
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myelin debris. At 2 weeks post-crush, the presence of thinly myelinated axons 
provided evidence of nerve regeneration (Figure 3.6). 
 
Figure 3.6. Representative TEM images of control and experimental RLN (above; 1,200×). Left 
(control) nerves showed thick myelination (white arrows) and tightly packed axons. At 3 days post-
crush, the right (experimental) RLN showed extensive signs of degeneration, indicated by collapsed 
fibers and dense, compressed myelin debris (asterisks). At 2 weeks post-crush, regeneration of 
thinly myelinated axons was evident (arrows) within an expanded perineurial space. PC = post-
crush; RLN = recurrent laryngeal nerve; TEM = transmission electron microscopy. 
 
 
3.5 Discussion  
The results from this study show that an aneurysm clip induced method of 
unilateral RLN compression injury resulted in ipsilateral VF impairment that 
allowed partial recovery by 2 weeks post-crush. This recovery was objectively 
evaluated with our custom VF motion analytics software, VFTrack and VFQuantify, 
to provide novel outcome metrics to detect and quantify subtle changes in VF 
motion in mice after RLN injury. Our primary objective was to demonstrate the 
feasibility of our novel software by comparing outcome metrics with previously 
described methods (i.e., objective angle measurements and subjective scoring). 
Thus, we have shown that our software can achieve similar results as currently 
used methods; however, it does so via automated objective quantification 
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methods, enabling efficient analysis of a high volume of dynamic VF motion 
recordings, rather than single frame analysis. 
The subjective VF recovery results found in this study correlated with the 
objective measures obtained by our software, which were further validated by 
semi-automated manual analysis methods. However, our objective measures 
provide more precise and accurate metrics to quantify longitudinal VF recovery. 
Not only can our motion analysis software detect the difference between paralyzed 
and fully functional VFs, but it can detect small, but perhaps clinically important, 
changes in VF motion. Without VFTrack and VFQuantify, it would be extremely 
challenging and time consuming to calculate the novel functional outcome 
measures identified in this study, mean motion range ratio (MMRR) and open close 
cycle ratio (OCCR). Additionally, with our objective VF tracking there is less 
variation between mice in each group when compared to subjective scoring 
methods, which increases the likelihood of detecting significant findings when 
evaluating different treatments and time points.  
Objective tracking allows full visualization of VF motion dynamics 
throughout the entire video clip, thus overcoming the limitation of quantifying static 
images at only two positions in the respiratory cycle. The data supplied by our 
motion analysis software includes both raw measures along with the ratios of right 
VF dynamics compared to the left. In addition to the metrics quantified in this study, 
we are searching for additional robust outcome measures that may provide new or 
complementary information for improved diagnostics and treatment evaluation. 
These measures can be used to acquire more meaningful information beyond 
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basic range of motion and quantification of VF angles at maximum adduction and 
abduction. Possible automated metrics of VF motion dynamics include: rate of VF 
movement, fluidity of VF motion, VF length/size/area, the amount of VF jitter, and 
uninjured VF compensation, among many others.  
Our VF motion software is a crucial asset for objective and reproducible 
analysis of VF movement for experimental purposes, but it may have much 
broader applications beyond a laboratory setting. In fact, we are currently working 
on using this technology to quantify VF motion dynamics in healthy human 
patients, along with patients with known laryngeal dysfunction. Besides tracking 
VF movement with respiration, we have begun tracking more complex laryngeal 
functions, including the laryngeal adductor reflex and other behavioral tasks, such 
as sniffing through the nose, taking a deep breath, holding the breath, and vocal 
diadochokinetic tasks. Once perfected and validated, healthcare professionals can 
begin to use VFTrack and VFQuantify in a clinical setting in real time to advance 
diagnostic capabilities. We hope this will allow healthcare professionals to better 
monitor disease progression and treatment effects over time, enabling them to 
tailor therapeutic approaches to distinct symptoms and objectively quantify 
treatment efficacy in individual patients. 
 
3.6 Conclusions 
 In conclusion, subjective analysis remains crucial for investigators to estimate 
VF motion dynamics. However, because subjective analysis is inadequate for 
detecting small changes in VF motion over time, objective, quantitative measures 
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are needed to fully and accurately assess VF motion dynamics. Furthermore, 
automation of VF motion quantification allows for high through-put analysis of 
dynamic VF motion recordings, enabling increased, highly-efficient research with 
our animal models. Most important, we have been expanding our software 
capabilities to identify additional outcome metrics that are amenable to automation, 
and are also clinically relevant (i.e., translatable to humans). As such, our software 
is currently being tested with human patients to improve diagnosis of VF disorders 
and enhance monitoring of treatment efficacy. 
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4.1 Abstract 
Objectives: The recurrent laryngeal nerve (RLN) is responsible for normal vocal 
fold (VF) movement, and is at risk for iatrogenic injury during anterior neck surgical 
procedures in human patients. Injury, resulting in VF paralysis, may contribute to 
subsequent swallowing, voice, and respiratory dysfunction. Unfortunately, 
treatment for RLN injury does little to restore physiologic function of the VFs. Thus, 
we sought to create a mouse model with translational functional outcomes to 
further investigate RLN regeneration and potential therapeutic interventions.  
Methods: To do so, we performed ventral neck surgery in 21 C57BL/6J male mice, 
divided into two groups: Unilateral RLN Transection (n=11) and Sham Injury 
(n=10). Mice underwent behavioral assays to determine upper airway function at 
multiple time points prior to and following surgery. Transoral endoscopy, 
videofluoroscopy, ultrasonic vocalizations, and whole-body plethysmography were 
used to assess VF motion, swallow function, vocal function, and respiratory 
function, respectively. Outcome metrics were identified to increase the 
translational potential of this model. Additionally, immunohistochemistry was used 
to investigate neuronal cell death in the nucleus ambiguus.  
Results: Results revealed that RLN transection created ipsilateral VF paralysis 
that did not recover by 13 weeks post-surgery. Furthermore, there was evidence 
of significant vocal and respiratory dysfunction in the RLN transection group, but 
not the sham injury group. No significant differences in swallow function or 
neuronal cell death were found between the two groups.  
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Conclusions: In conclusion, our mouse model of RLN injury provides several 
novel functional outcome measures to increase the translational potential of 
findings in preclinical animal studies. We will use this model and behavioral assays 
to assess various treatment options in future studies. 
 
4.2 Introduction 
Unilateral vocal fold (VF) paralysis is a common complication of iatrogenic 
recurrent laryngeal nerve (RLN) injury during cervical and thoracic surgeries. In 
patients with unilateral VF paralysis, 56% experience dysphagia, up to 80% are 
affected by dysphonia, and 75% encounter dyspnea.1-3 Moreover, dysphagia may 
result in life-threatening complications such as aspiration pneumonia, dehydration, 
and malnutrition,4 whereas dysphonia can greatly interfere with one’s social life 
and employment, potentially necessitating a career change.1 In fact, complications 
due to RLN palsy are among the leading reasons for litigation of healthcare 
professionals who perform these procedures.1,3,5,6  
Unfortunately, treatments that restore normal physiologic function after RLN 
injury are lacking.1,3,7 Current strategies include voice therapy4,8-10 and 
medialization of the impaired VF.4 Alternative secondary surgeries, such as RLN 
anastomosis, may increase background muscle activity, but do not guarantee 
return of normal VF mobility.3 Thus, more effective neuro-regenerative treatment 
options are needed. However, to investigate new therapeutic interventions, a 
translational animal model that consistently replicates the functional outcomes of 
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RLN injury in humans is essential. In addition, reliable functional assays to quantify 
these symptoms are critical. 
Current models principally use transoral endoscopy to assess VF mobility 
and evaluate functional impairment and recovery after RLN injury.11-14 While this 
methodology provides information on VF movement, it does not concurrently 
evaluate deficits associated with swallowing, vocalization, or respiration 
experienced by human patients. As these functions are fundamental to quality of 
life, it is essential to investigate them in animal models. However, no published 
study has comprehensively examined each potential complication in a single 
model.  
An infant pig model of RLN injury has provided novel insights concerning 
the role of the RLN and its neural connections in swallowing behavior. By using 
videofluoroscopic techniques, RLN injury has been shown to result in 
compromised airway protection and esophageal dysphagia,15 alterations in tongue 
shape,16 and modified tongue and epiglottis kinematics during swallowing.17 
However, these experiments were performed in neonatal and pre-weanling 
animals, better representing infants with immature nervous systems. In contrast, 
many patients undergoing common anterior neck procedures, such as 
thyroidectomy, belong to an aged population.1,18 Thus, a more appropriately aged 
animal with a fully developed nervous system is necessary to evaluate RLN injury 
and its sequela in this target population.    
Of the post-operative complications associated with RLN injury, dysphonia 
is often the most problematic for the patient. One group assessed audible 
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vocalizations in a rat model after RLN transection and showed hoarse, deep-
pitched, and shorter vocalizations with low amplitudes.7,13 However, audible 
vocalizations are not the primary means of rodent communication and are elicited 
in response to stressful or painful stimuli, whereas ultrasonic vocalizations 
represent communicative intent.19 Furthermore, rodent ultrasonic vocalization 
assays have been well established.20-22 Social ultrasonic vocalizations are 
analogous to human vocal communication in many important ways. For example, 
ultrasonic vocalizations are generated within the larynx23 and are capable of 
eliciting change in the behavior of the signal recipient.24-26 As such, ultrasonic, 
rather than audible, vocalizations are a more appropriate method to study vocal 
function in rodents.  
Similarly, comparative respiratory function has not been thoroughly 
assessed in animal models of RLN injury, except in coordination with swallowing 
in infant pigs.27 Dyspnea after RLN injury is also under-researched in the human 
literature, likely because many human patients with unilateral VF paralysis have 
normal or near normal working respiratory capacity. However, up to ~75% 
complain of breathing impairment, especially during phonation or physical effort.2 
Of the few studies investigating respiratory parameters following RLN injury, most 
have noted decreased inspiratory flow rates in patients with unilateral VF paralysis, 
which may or may not be improved with VF medialization procedures.28-31 
In this study, we hypothesized that RLN transection would significantly 
affect VF mobility, swallowing, vocalization, and respiration in an adult mouse 
model. We chose a transection injury as this is the most experimentally 
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reproducible injury, and removes severity of injury as a confounding variable. In 
addition, we performed immunohistochemistry to investigate if neuronal cell death 
was present in the brainstem motor nucleus, the nucleus ambiguus, after RLN 
transection, as peripheral nerve injury often results in various percentages of 
retrograde cell death.32 We also continued to refine our VF tracking and 
quantification software33 to better evaluate and characterize dynamic VF motion. 
Furthermore, behavioral tests were optimized to identify the most translational 
outcome measures for application towards human studies. Through this 
comprehensive behavioral regimen, this study offers the first look at the interplay 
between unilateral VF paralysis with the consequent somatic manifestations of 
dysphagia, dysphonia, and dyspnea in a single animal model.  
 
4.3 Materials and Methods 
4.3.1 Animals 
Animal care was conducted in accordance with the Guide for the Care and 
Use of Laboratory Animals and all experimental procedures performed in this study 
were reviewed and approved by the Institutional Animal Care and Use Committee 
at the University of Missouri, which is USDA-licensed and AAALAC-accredited. 
Twenty-one male C57BL/6J (B6) mice (age at beginning of study = 7.5 ± 0.6 
months; weight = 30.4 ± 2.4 g) were used for this study. Mice were housed in 
individually ventilated caging (Tecniplast, West Chester, PA) with aspen chip 
bedding. Mice were group-housed (2-4 mice per cage) whenever possible 
throughout the study, and had free access to food (Laboratory Rodent Diet 5001, 
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Purina, St. Louis, MO) and water, except for overnight water restriction for swallow 
assays, described below. Room temperature was maintained between 20.0 °C and 
26.0 °C, relative humidity was between 30% to 70%, and the photoperiod was a 
12:12-h standard light:dark cycle (lights on at 7:00 am). Standard enrichment 
(nestlet), running wheels, and mouse huts were provided to all cages.   
All mice were of the same health status and were housed in the same room 
throughout the study; however, surgical manipulations and behavioral assays were 
performed in separate rooms of the laboratory, located outside of the vivarium. At 
the time of the study, serology samples from colony sentinels were tested quarterly 
and were considered free of the following agents: mouse hepatitis virus, minute 
virus of mice, mouse parvovirus, Sendai virus, Theiler’s murine encephalomyelitis 
virus, mouse rotavirus, Mycoplasma pulmonis, Pasteurella pneumotropica, 
Salmonella spp., mouse pneumonia virus, reovirus 3, lymphocytic choriomeningitis 
virus, Ectromelia, mouse adenovirus 1 and 2, K virus, and polyoma virus. Fecal 
PCR was used to detect pinworms in sentinel mice, whereas cage PCR (pooled 
swabs by room) was used to detect fur mites, neither of which were detected. 
 
4.3.2 Experimental Design 
 Mice were randomized to undergo survival surgery to create an RLN 
transection injury (n=11), or a sham surgery to visualize, but not injure, the RLN 
(n=10). Transoral laryngoscopy was performed during surgery immediately prior 
to incision and immediately after surgery to assess the effect on VF motion. In 
addition, mice underwent baseline behavioral testing prior to surgery to quantify 
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normal swallow, vocal, and respiratory function. Testing consisted of 
videofluoroscopic swallow study, whole-body plethysmography, and ultrasonic 
vocalization assays. Mice received subsequent behavioral testing at various time 
points following surgical manipulations (Figure 4.1). At 13 weeks post-surgery 
(WPS), mice were anesthetized to repeat transoral laryngoscopy prior to 
euthanasia for tissue collection. 
 
 
Figure 4.1. Experimental Timeline. Baseline functional testing was performed 2-4 weeks prior to 
surgery. Additional functional analysis was performed following surgery. Whole body 
plethysmography was performed at 1,5, and 11 WPS. Videofluoroscopic swallow studies were 
performed 1, 6, and 12 WPS, and ultrasonic vocalizations were collected at 1, 2, and 5 WPS. 
Laryngoscopy was performed prior to surgical incision, immediately following surgical manipulation 
of the RLN, and at 13 WPS prior to perfusion for tissue collection. WPS = weeks post-surgery, 
WBP = whole body plethysmography, VFSS = videofluoroscopic swallow study, USV = ultrasonic 
vocalizations. 
 
4.3.3 Surgical Procedures 
 Mice were anesthetized with ketamine (90 mg/kg; Henry Schein, Melville, 
NY) and xylazine (11.25 mg/kg; Akorn, Lake Forest, IL), administered 
subcutaneously (SQ). Half doses of SQ ketamine were given to maintain the 
surgical plane of anesthesia every 10-20 min, as needed, throughout the 
procedure. The eyes were lubricated to prevent drying and the ventral neck was 
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shaved and prepared aseptically for surgery. Mice were positioned in dorsal 
recumbency on a heated, custom platform beneath a surgical microscope (M125; 
Leica Microsystems, Inc., Buffalo Grove, IL), and reflexes (toe-pinch) were 
checked at least every 10-15 minutes.  
A midline neck incision was made from the suprasternal notch to the 
mandible. The salivary glands were gently retracted laterally to expose the strap 
muscles overlying the trachea. In mice undergoing an RLN transection injury, the 
right RLN was isolated at the level of the 5th tracheal ring and a small section of 
nerve (~1-2 mm) was removed to prevent RLN regeneration. The left RLN served 
as an internal control for this study. Mice in the sham injury group underwent an 
identical surgical procedure; however, the RLN was only visualized, not isolated or 
transected.  
For both groups, the neck incision was closed with absorbable sutures (6-0 
Monocryl, Ethicon, Somerville, NJ) and surgical glue (Tissumend II, Veterinary 
Products Laboratories; Phoenix, AZ). After suturing was complete, 0.2 ml of warm, 
sterile saline was administered SQ, along with buprenorphine-SR (1 mg/kg, SQ; 
Zoopharm, Windsor, CO), flunixin meglumine (2.2 mg/kg, SQ; Merck, Kenilworth, 
NJ), and atipamezole (0.22 mg/kg, SQ; Zoetis, Parsippany-Troy Hills, NJ) as 
separate injections for pain control and to reverse anesthesia. Mice were 
transferred to a clean, heated cage for recovery, and were monitored at least every 
10-15 minutes until they were returned to their home cage once fully ambulatory. 
The home cages were placed half-on/half-off a heated water blanket (Model: 
TP700, Stryker, Kalamazoo, MI) overnight and returned to the vivarium the 
114 
 
following morning. All mice were monitored daily for 1 week after surgery for any 
signs of pain, distress, or surgical complications. 
 
4.3.4 Transoral Laryngoscopy 
 While mice were anesthetized for surgery, transoral laryngoscopy33,34 was 
performed immediately prior to surgical incision to establish baseline VF 
movement and immediately after surgical manipulation to determine the direct 
effect on VF mobility. To do so, a micromanipulator-controlled sialendoscope 
(R11573A; Karl Storz, Tuttlingen, Germany) with a customized laryngoscope was 
inserted into the oral cavity to visualize VF movement on a Storz Tele Pack X 
monitor (Karl Storz, Tuttlingen, Germany). In mice, VF movement is spontaneous 
with breathing, rather than an evoked response; therefore, no exogenous stimulus 
was required to elicit VF movement. Laryngoscopy was performed once more at 
13 WPS with mice under anesthesia prior to euthanasia and tissue collection. 
Laryngoscopy videos were recorded at 30 frames per second (fps) for 
approximately 1-3 minutes per mouse for analysis.  
 
4.3.5 Automated Vocal Fold Motion Analysis 
 Ten second clips from each laryngoscopy video were analyzed to detect left 
and right VF movement using our automated motion tracking software, VFTrack,33 
and outcome metrics were calculated using our custom VFQuantify software.33 
Briefly, points (pL and pR) were manually placed on the medial aspect of each VF 
or arytenoid cartilage on the first frame of each video clip. A third point (po), was 
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placed midline, dorsal to the arytenoid cartilages. Separate lines (LL and LR) were 
automatically drawn from pL and pR to po to approximate the medial edge of each 
VF and its associated cartilage (Figure 4.2a). The VFs were automatically tracked 
using points on LL and LR at the same fixed distance from po. Left and right VF 
motion ranges and corresponding motion midlines (dL=0 and dR=0) were 
automatically computed based on displacement (in pixels) of the VFs. VF motion 
was graphically displayed as a cyclic waveform due to the oscillatory motion of the 
VFs during spontaneous breathing.  
In addition to our previously published dynamic VF outcome metrics, Mean 
Motion Range Ratio and Open Close Cycle Ratio,33 we developed two additional 
metrics to characterize paradoxical movement of the right VF and compensation 
of the left VF, which we have observed in numerous mice after RLN injury. 
Abnormal, paradoxical movement of the VFs is characterized by the motion of the 
left and right VFs in the same direction, in contrast to the motion of the left and 
right VFs in the opposite direction during normal VF opening and closing behavior 
(Figure 4.2b). To differentiate between normal versus paradoxical movement, we 
have computed the motion correlation coefficient (Mcorr)35 between the time series 
of the left and right VF displacements. Mcorr is defined as,  
𝑀𝑐𝑜𝑟𝑟(𝑑𝐿 , 𝑑𝑅) =
1
𝑁 − 1
 ∑ (
𝑑𝐿 − µ𝐿̅̅ ̅̅ ̅̅ ̅̅ ̅̅
𝜎𝐿
) (
𝑑𝑅 − µ𝑅
𝜎𝑅
)
𝑁
𝑖=1
 
where dL and dR are displacements of the left and right VFs, and ,  denote mean 
and standard deviation of the displacement time series. The values of the 
correlation coefficients can range from -1 to 1, where values close to -1 represent 
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a negative correlation (i.e., motion in opposite directions; normal function), values 
close to 1 represent a positive Mcorr (i.e., motion in the same direction; paradoxical 
VF motion), and values close to 0 represent minimal correlation. Based on the 
Mcorr values between the left and right VF displacement series, we have defined 
a VF motion activity index (VFActivity) as follows: 
𝑉𝐹𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 = {
−1 ≤ 𝑀𝑐𝑜𝑟𝑟(𝑑𝐿 , 𝑑𝑅) ≤ −0.5 Normal VF motion behavior
−0.5 < 𝑀𝑐𝑜𝑟𝑟(𝑑𝐿 , 𝑑𝑅) < 0.5 Minimal motion correlation
0.5 ≤ 𝑀𝑐𝑜𝑟𝑟(𝑑𝐿 , 𝑑𝑅) ≤ 1 Paradoxical VF motion behavior (Pull or Push)
 
For the cases of paradoxical motion (VFActivity=Push/Pull), where the left 
and right VFs were moving in the same direction, further signal analysis was 
performed to differentiate pushing versus pulling behaviors. Pushing is 
characterized as the intact left VF pushing the injured right VF during glottal closing 
(adduction); while pulling is characterized as the intact VF pulling the injured VF 
during glottal opening (abduction) (Figure 4.3). Paradoxical motion is 
automatically classified as pushing versus pulling using the following processing 
steps:  
1. In this model, the intact left VF moves symmetrically; therefore, its 
motion midline, dL=0, is set as the steady state position for the left VF. 
2. Left VF steady state crossing times (ti) are detected as dL(ti)=0 (black 
dashed lines in Figure 4.4a). 
3. Next, the steady state positions of the right, injured VF are determined 
as positions of the right VF when the left VF is positioned at its steady 
state (no pulling or pushing behavior by the left VF; dashed yellow lines 
in Figure 4.4a). 
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4. Pulling versus pushing behaviors are identified by separately computing 
total displacements of the right VF during positive and negative 
displacements of the left VF. Positive displacement of the left VF occurs 
when the left VF moves to the right of its motion midline (dL=0) during 
adduction, indicated by positive movement on the displacement plots. 
Negative displacement of the left VF occurs when the left VF moves to 
the left of its motion midline (dL=0), indicated by negative movement on 
the displacement plots.  Larger total absolute displacement by the right 
VF during positive displacements of the left VF indicates pushing 
behavior (i.e., the area between the right VF and its steady state during 
positive displacements is greater than during negative displacements; 
Figure 4.4b). Larger total absolute displacement by the right VF during 
negative displacements of the left VF indicates pulling behavior (i.e., the 
area between the right VF and its steady state during negative 
displacements is greater than during positive displacements; Figure 
4.4c).  
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Figure 4.2. Representative still frame images (left) and displacement plots (right) of normal versus 
abnormal (paradoxical) vocal fold motion. On the first frame of each endoscopic video clip, two 
points, pL (blue circle) and pR (red circle), were manually placed on the medial aspect of each VF 
and associated arytenoid cartilage, and a third point, po (green circle), was placed midline, dorsal 
to the arytenoid cartilages. Using these manual reference points, separate lines (LL and LR) were 
automatically drawn to approximate the medial edge of each VF/arytenoid for motion tracking 
analysis, after automatic adjustment to make points pL and pR at the same fixed distance from po. 
These still frame images represent the positioning of the VFs in a state of maximum adduction. 
Note the left and right VF are symmetrical and do not cross the glottal midline in normal VF motion 
(a). However, in abnormal cases (b), the left VF may cross the glottal midline and contact the right 
VF, pushing it laterally, such that both VFs are paradoxically moving in the same direction. 
Alternatively, the left VF may pull the right VF medially during abduction, resulting in a similarly 
positive correlated displacement plot. VF = vocal fold. Asterisk (*) = arytenoid cartilage. Orange 
dashed line = glottal midline. Plots show displacement of the intact left (blue) VF and denervated 
right (red) VF with respect to their motion midline (0 on y-axis) over time. Normal VF motion (a) is 
represented by oscillatory motion of both VFs in opposite directions (negatively correlated). 
Abnormal (paradoxical) VF motion (b) is represented by movement of the VFs in the same direction 
(positively correlated). 
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Figure 4.3. Analysis of vocal fold motion behavior. (a) Left and right VF motion ranges; center 
dashed blue and red lines represents motion midline for each VF (i.e., dL= displacement of left VF 
= 0; dR= displacement of right VF = 0). (b) VF motion during pushing: The intact VF contacts the 
injured VF to push it laterally in the same direction during VF adduction. (c) VF motion during 
pulling: The intact VF pulls the injured VF medially in the same direction during abduction. Left VF 
(blue line) represents the healthy, intact VF; right VF (red line) represents the injured VF. Orange 
dashed line = glottal midline. VF = vocal fold. 
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Figure 4.4. Identification of pulling versus pushing behaviors from left and right VF displacement 
time series. (a) Synthetic plot illustrating analysis of pushing vs. pulling behaviors. Displacement of 
the left VF with respect to its motion midline is shown in blue. Displacement of the right VF with 
respect to its motion midline is shown in red. The solid black (horizontal) line illustrates the motion 
midline and steady state for the left VF. The dashed black (vertical) lines indicate where the left VF 
crosses its steady state position. The steady state position of the right VF is determined by the 
positions of the right VF when the left VF is positioned at its baseline (no pulling or pushing by the 
left VF). The dashed yellow lines denote the steady state positions for the right VF. Pulling versus 
pushing behaviors are identified by separately computing total displacements of the right VF during 
positive and negative displacements of the left VF. (b) Representative plot for pushing behavior. 
Larger total absolute displacement by the right VF during positive displacements (arrowheads) of 
the left VF indicates pushing behavior. (c) Representative plot for pulling behavior. Larger total 
absolute displacement by the right VF during negative displacements (arrows) of the left VF 
indicates pulling behavior. 
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4.3.6 Videofluoroscopic Swallow Study (VFSS) 
 To assess swallowing function in awake, freely behaving mice, 
videofluoroscopic swallow testing was performed using our standard protocol36,37 
at 4 time points: baseline (3 weeks prior to surgery), as well as 4 days post-surgery, 
6 WPS, and 12 WPS. Videofluoroscopy was performed the week after whole-body 
plethysmography and ultrasonic vocalization assays to reduce the amount of 
testing for a single mouse in a given week. Four days post-surgery was chosen as 
it was the earliest time point that mice could undergo fluoroscopy without risking 
confounding effects of post-surgical analgesics.  
Prior to baseline swallow testing, mice underwent a behavioral conditioning 
program to assure familiarity and acceptance of the contrast solution and test 
chamber. For each time point, mice were fluid restricted overnight for 14-16 hours 
and provided additional chewable enrichment (e.g., nut and seed mix) to motivate 
voluntary drinking during testing. During testing, mice were individually enclosed 
in a custom test chamber positioned on a custom, remote-controlled lift table within 
a miniaturized fluoroscope (Glenbrook Technologies, Randolph, NJ). Each mouse 
was then exposed to approximately 2-3 minutes of low-dose radiation (~30 kV and 
0.2 mA) for fluoroscopic examination of swallowing in the lateral plane while freely 
drinking a species-specific oral contrast agent recipe: Omnipaque (350 mg iodine 
per mL; GE Healthcare, Inc., Princeton, NJ) diluted to a 25% solution with 
deionized water and 3% chocolate syrup. The contrast solution was administered 
through a custom delivery system into a custom bowl positioned immediately 
above the test chamber floor.  
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To minimize radiation exposure, the fluoroscope was activated and video 
(30 fps) was recorded only when mice were drinking from the bowl, which was 
identified by real-time viewing via a webcam (C920 HD Pro Webcam; Logitech 
International S.A., Lausanne, Switzerland) positioned above the test chamber. 
Each video (AVI file) was subsequently analyzed frame-by-frame by two 
independent reviewers using video editing software (Pinnacle Studio 14; Corel 
Corporation, Ottawa, Ontario, Canada) to quantify several swallow metrics 
established by our prior work.36,37 Metrics included lick rate (licks/second), swallow 
rate (swallows/2 seconds), inter-swallow interval (seconds), lick-swallow ratio 
(licks/swallow), pharyngeal transit time (seconds), esophageal transit time 
(seconds), and percentage of esophageal swallow inhibition (%). Three to five 
measures of each videofluoroscopic swallow metric were obtained for each 
mouse. Reviewer discrepancies were resolved by group consensus. 
 
4.3.7 Ultrasonic Vocalizations (USV) 
 As vocal function has been noted to recover shortly after RLN denervation,38 
two acute time points and one chronic time point were selected to assess this 
functional outcome. Ultrasonic vocalization testing was performed to assess vocal 
function in mice 1 week prior to surgery and at 1, 2, and 5 WPS. Two to three 
nights prior to vocalization testing, mice were co-housed with a sexually mature 
female mouse overnight to sexually experience the male mice, as sexually 
experienced male mice are likely to produce greater numbers of ultrasonic calls.39 
For study feasibility, estrus cycle of the female mouse was not taken into account. 
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The night prior to testing, male mice were individually housed in a clean cage to 
establish a home cage environment for data collection the following day. For 
testing, the entire home cage was placed in a custom sound insulated chamber. 
To elicit calls, a random female “intruder” mouse was anesthetized using ketamine 
and xylazine (90:11.25 mg/kg; SQ) and placed inside the home cage with the test 
subject.40 This ensured that male-only vocalizations were obtained. The same 
intruder mouse was used approximately 4-6 times in succession until anesthetic 
depth began to lighten. Vocalization recording of the male mouse commenced 
immediately after placing the anesthetized female mouse in the test cage.  
Individual vocalizations from the mice were recorded for 3 minutes using an 
ultrasonic microphone (CM16, Avisoft, Germany) with 16-bit resolution and a 
sampling rate of 250-kHz, placed directly over the test cage fitted with a modified 
wire bar lid.40-42 Offline acoustic analysis of vocal recordings for each mouse were 
analyzed using SASLab Pro (Avisoft, Germany). The WAV files were analyzed 
with Avisoft-generated spectrograms using a Fast Fourier Transform (FFT) of 512 
points, frame size of 100%, flat top window, and temporal resolution set to display 
75% overlap. A high pass filter was used to eliminate noise below 25 kHz.42,43 The 
number of calls was automatically calculated by the Avisoft software and classified 
as low or high frequency modulated calls for all 4 time points. High frequency 
modulated calls were defined in the software as any call with a standard deviation 
of >0.1 for peak frequency of the entire call, whereas low frequency modulated 
calls had a standard deviation of <0.1 for peak frequency. These data were used 
to select the time points for additional in-depth ultrasonic vocalization analysis 
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consisting of call labeling and acoustic parameters, from which we could identify 
potential outcome metrics that could be used for future studies in this model.  
Using the high frequency modulated call results, baseline and 1 WPS were 
chosen for additional in depth analysis as follows: a trained reviewer independently 
classified and quantified all calls in a blinded fashion within the first 90 seconds 
after the first detected call. Ten call types (i.e., constant, downsweep, upsweep, 
harmonic, multiple jumps, jump up, jump down, half cycle, full cycle, and two cycle) 
were identified and grouped accordingly into four call categories based on 
complexity: simple, complex, jump, and cycle (Figure 4.5).42,43 The following 
acoustic properties that are common in communication signals among various 
species, including mice and humans, were measured for each call type and 
category:44 percentage of call type (%), bandwidth (kHz), peak frequency (kHz), 
duration (millisecond, ms), and duration of peak frequency (ms).  
Furthermore, mice preferentially produce ultrasonic calls in a repetitive 
series, which display a regular temporal structure.45-47 Thus, additional ultrasonic 
vocalization metrics were used to further characterize potential dysfunction in 
repetitive calling in this model. To do so, series of calls within the first 90 seconds 
after the first call were manually identified using spectrogram files with labeled 
calls. Series of calls were defined as a group of at least four calls spaced no more 
than 150 ms apart from one another (i.e., an intervocalization interval < 150 ms; 
Figure 4.6).47 The time in between series of calls was labeled as a pause. The 
number of call series and the average number of calls within a series, as well as 
the average length of call series and longest length of call series were calculated. 
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In addition, the average intervocalization interval within a series was determined. 
Groups of less than four calls or individual calls were counted as isolated calls 
within a pause. The average pause length and the average number of isolated 
calls within a pause were also calculated and compared between groups.  
 
 
Figure 4.5. Mouse USV Call Classifications. USV call types are classified into 4 call categories: 
simple, complex, jump, and cycle. Spectrograms are representative of baseline vocalization prior 
to any surgical manipulation. A high pass filter was used to eliminate noise below 25 kHz. Relative 
intensity (“vocal loudness”) is measured in decibels (dB) and encoded by the color spectrum at the 
bottom of the image. The y-axis represents frequency of the call in kilohertz (kHz). USV = ultrasonic 
vocalization. 
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Figure 4.6. Representative image of USV call runs and a pause. USV call series consisted of any 
group of calls with at least 4 calls spaced no more than 150 ms apart. Time between call series 
were considered pauses and may or may not have had isolated calls (groups of three or less calls) 
within the pause. The spectrogram X-axis represents time in seconds; the Y-axis is frequency in 
kilohertz (kHz). Relative intensity (“vocal loudness”) is measured in decibels (dB) and encoded by 
darkness of the signal; louder is darker. Some calls were not automatically detected by the 
software. These calls were labeled as “skipped” but were included in call series if they were visually 
and audibly confirmed by the reviewer. IVI = Intervocalization Interval. USV = ultrasonic 
vocalizations. 
 
4.3.8 Whole Body Plethysmography (WBP) 
 Mice underwent baseline whole-body plethysmography within 3 weeks prior 
to surgery and at 1, 5 and 11 WPS to assess respiratory function. Unrestrained 
and unanesthetized mice were placed in individual plethysmography chambers 
(Data Sciences International, St. Paul, Minnesota) and exposed to normoxia (21% 
O2) for 30 minutes to allow for unchallenged respiratory assessment. Mice were 
placed in the same chambers from week to week. Following normoxia, mice 
underwent a five minute hypercapnia (7% CO2) and hypoxia (10.5% O2) 
challenge.48-50 As human patients complain of dyspnea with phonation or exercise, 
this hypercapnic/hypoxic challenge was utilized to obtain respiratory metrics in 
mice with increased respiratory effort to better correlate with human experiences. 
A pressure calibration signal, ambient pressures, and chamber pressures 
were utilized for automated calculation of breath-by-breath respiratory parameters 
using Buxco FinePointe Software (Data Sciences International, St. Paul, 
Minnesota) to determine respiratory frequency (breaths/min), tidal volume (ml), 
inspiratory and expiratory time (seconds), peak inspiratory flow (ml/second), and 
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minute ventilation (ml/min) for each mouse during normoxia and during the 
hypercapnic/hypoxic challenge. In addition, the apnea detection function within 
FinePointe software was used to identify sighs (2x the average amplitude of the 
respiratory waveform)51,52 and apneas. An apnea was defined as the absence of 
at least two inspirations (i.e., a pause in breathing 2x the average frequency).53-57 
The automatically detected sighs and apneas were manually reviewed for each 
mouse to verify accuracy and were excluded if not identified correctly, for example, 
if two shallow breaths were detected as an apnea rather than two individual 
breaths. The software was also used to calculate the percentage of erratic 
breathing, which is defined by the software as any breathing that was not classified 
as a normal breath, sigh, apnea, or sniff (Data Sciences International).  
 
4.3.9 Neuronal Brainstem Histology 
 Mice were euthanized with an intraperitoneal overdose injection of 
pentobarbital solution following the final laryngoscopy procedure at 13 WPS, and 
were perfused with saline followed by 4% paraformaldehyde (PFA). Brainstems 
were collected from each mouse and post-fixed overnight in 4% PFA at 4 °C. They 
were then placed in 20% sucrose solution for 3 days, followed by 30% sucrose 
and stored at 4 °C. Samples were replaced with fresh 30% sucrose solution with 
1% sodium azide every 4 weeks until sectioning. Brainstems were sectioned at 40 
µm on a freezing-sliding microtome (Leica SM 2010R, Wetzlar, Germany). All 
sections were stored free-floating at -20 °C in tissue antifreeze solution (30% 
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ethylene glycol, 30% glycerol, and 40% 1xPBS) in well plates with every 6th 
section/well.   
To investigate if neuronal cell death occurred, one to two wells (randomly 
selected; containing every 6th section of serial 40 µm brainstem sections) from 
sham (n=6) and RLN transected (n=7) mice underwent fluorescent 
immunohistochemistry to identify and count neurons in the left and right nucleus 
ambiguus, the motor nucleus for the RLN.58 After washing with 1X PBS and placing 
in a blocking solution with 5% normal donkey serum (NDS) for 1 hour, sections 
were incubated overnight in primary antibody, rabbit anti-NeuN (1:500, Abcam, 
ab177487), to stain neuronal cell bodies. The following day, sections were washed 
with 1X PBS and then incubated in secondary antibody, anti-rabbit Alexa Fluor 
488-conjugated antibody (1:1000; Molecular Probes, #A21206), for 2 hours. 
Sections were washed a final time in 1X PBS and immediately mounted on 
positively-charged glass slides. Slides were mounted with Prolong Gold Antifade 
Mountant with DAPI (ThermoFisher Scientific, # P36931) and allowed to air dry for 
1 day in the dark. Slides were stored at -20 °C until quantification of staining was 
performed using an epifluorescence microscope (Model #:DM4000 B LED; Leica 
Biosystems, Wetzlar, Germany). Two to four sections containing an easily 
identifiable left and right nucleus ambiguus were randomly selected for each 
mouse for quantification (Figure 4.7). Sections incubated without primary and 
secondary antibodies served as negative controls. Stereo Investigator software 
(MBF Bioscience, Williston, VT) was used to count all neurons with a visible 
nucleolus within the entire nucleus ambiguus of each randomly selected section.  
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Figure 4.7. Fluorescent immunohistochemistry of the nucleus ambiguus (NA). (a) 40 µm brainstem 
sections were stained with primary antibody (anti-NeuN; 1:500) followed by an Alexa Fluor 488-
conjugated antibody (1:1000). Stereo Investigator software was used to outline the left (arrow 
heads) and right (arrows) NA with a 2.5x objective that permitted visualization of the entire 
brainstem section in a single field of view. (b) Neurons with a visible nucleolus (arrows) were 
counted for each NA (outlined in red) using a 40x objective throughout the entire 40 µm section. 
 
4.3.10 Statistics 
For normally distributed data, two-way repeated measures ANOVAs with 
surgical group (sham vs. transection) and time point as factors were performed 
using SigmaPlot 14.0 (Systat Software, San Jose, CA). If significant differences 
were indicated, multiple comparisons were made using a Tukey post hoc test. To 
take into account for any inherent baseline variability among the mice, a mixed 
effects model with a random intercept and group as fixed effects term was fitted 
using SAS 9.4 (SAS Institute, Cary, NC). To assess if the mean difference between 
the two groups also differed by time, the group*time interaction term was included 
in each of the fitted models. Post hoc Mann-Whitney U Tests were used to 
determine significant differences between the two experimental groups at each 
time point.  
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Baseline values often differed between groups for ultrasonic vocalization 
acoustic parameters and call series data, likely due to the inherently high acoustic 
variability in ultrasonic vocalizations.59 Thus, we fitted a regression model 
(Regression Model: Post_Surgery = Bo + B1*Group + B2*BaselineMeasure) using 
the baseline measurements as a covariate and the post-surgery measures as 
outcomes using SAS 9.4 (SAS Institute, Cary, NC). In addition, a two-way ANOVA 
was used to detect significant differences in mean neuron counts between 
experimental groups and the left and right nucleus ambiguus in each brainstem 
section. Analysis was performed using SigmaPlot 14.0 (Systat Software, San Jose, 
CA). P values less than or equal to 0.05 were considered significant for all tests.   
 
4.4 Results 
4.4.1 Effects of Denervation on Vocal Fold Motion 
As hypothesized, RLN transection significantly impaired VF motion 
compared to sham mice. All transected mice developed immediate right 
(ipsilateral) VF paralysis, which persisted at 13 WPS. As expected, a two-way 
repeated measures ANOVA revealed significant differences for the mean motion 
range ratio and open close cycle ratio (Figure 4.8a and b) between groups at both 
post-surgical time points (F2,38 = 181.40, P = < 0.001 and F2,38 = 2124.14, P = < 
0.001, respectively; Tukey post hoc = P = < 0.001 at both time points), signifying 
a decreased range and frequency of motion of the injured VF after RLN 
transection. Upon subjective review of each video, paradoxical movement of the 
right VF was noted in a subset of videos at both time points. In these cases, the 
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right VF was moving in the same direction as the left VF, rather than its 
physiological normal direction (i.e., opposite direction of the left VF). However, the 
nature of this paradoxical movement was different between the two time points. If 
this movement was noted during the time immediately post-injury, the left VF 
appeared to be pulling the right VF, likely due to loss of tension on the injured side. 
Interestingly, if paradoxical movement was noted at the 13 WPS time point, the left 
VF seemed to be pushing the right VF, rather than pulling, indicating potential 
compensation by the left VF.  
This paradoxical movement of the right VF contributed to increased range 
and frequency ratio measures for these mice, making it appear as if the right VF 
had physiologic movement, despite lack of normal function. Thus, in cases with 
positively correlated Mcorr values, a “0” was assigned to the mean motion range 
ratio and the threshold for the open close cycle ratio was manually adjusted within 
our VFQuantify software to more accurately represent the range and frequency of 
true physiologic motion of the impaired VF. In addition, we developed two novel 
outcome metrics to better characterize and document this abnormal movement of 
the VFs. Our first metric, Mcorr, calculates the correlation of the movement of the 
left VF compared to the right VF. In normal cases, the VFs are moving in opposite 
directions and are negatively correlated. In contrast, in instances of visible pushing 
or pulling motion, the VFs are moving in the same direction and are positively 
correlated. The sham mice retained a highly negative Mcorr value throughout the 
study, indicating normal directionality of VF movement. However, the transection 
mice developed minimally correlative or highly positive correlations at the two post-
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surgical time points (Figure 4.8c), signifying unilateral paralysis with or without 
abnormal movement of the injured VF. Mann-Whitney Rank Sum Tests revealed 
significant differences in Mcorr between the sham and RLN transection groups 
immediately post-surgery (T19 = 55.00, P = < 0.001) and at 13 WPS (T19 = 55.00, 
P = < 0.001). Mice with high positive Mcorr values were then automatically 
assigned a pushing or pulling activity classification based on the left VF steady 
state motion, quantified in Figure 4.8d. 
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Figure 4.8. Vocal Fold Motion Outcomes. (a) Mean Motion Range Ratio (MMRR) and (b) Open 
Close Cycle Ratio (OCCR) were significantly impaired in the RLN transected mice immediate post-
surgery and at 13 weeks post-surgery (WPS). If mice were detected to have a positive correlation 
value (paradoxical movement), a 0 was assigned for MMRR. Additionally, the frequency threshold 
for OCCR was manually adjusted in our VFQuantify software to more accurately represent the true 
physiologic movement of the injured VF. (c) Vocal fold (VF) activity was assigned using a motion 
correlation coefficient (Mcorr) value. RLN transection resulted in mice with positive Mcorr values 
post-surgery and at 13 WPS. Median = solid horizontal line; Mean = dashed horizontal line. (d) VF 
motion activity was assigned as determined by the Mcorr value in combination with the left VF 
steady state motion. All mice at baseline had normal VF activity. However, mice undergoing RLN 
transection displayed abnormal pulling or pushing of the right VF by the left VF at the two post-
surgical time points. At 13 WPS, 2 mice in the transection group had evidence of both pushing and 
pulling motion, and were manually assigned this dual classification. Mice with minimally correlative 
Mcorr values between -0.5 and 0.5 did not display normal VF motion nor the paradoxical pushing 
or pulling motion and received an activity classification of “N/A”. An asterisk (*) denotes statistical 
significance (p <0.001). Error bars = standard error. S = Sham, T = Transection, WPS = Weeks 
Post Surgery, VF = Vocal Fold 
 
4.4.2 Effects of Denervation on Swallowing 
 Though we hypothesized that swallow function would be impaired by RLN 
transection, no significant differences were found between groups for any swallow 
outcomes (P > 0.05). Reviewer discrepancies resolved by group consensus 
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consisted of less than 15% of all metrics analyzed. Outcomes for each 
videofluoroscopic swallow study metric are displayed in Table 4.1. Interestingly, 
esophageal transit time was noticeably longer for RLN transected mice, whereas 
esophageal transit for sham mice was appreciably shorter at 4 days post-surgery 
(Figure 4.9). Although a mixed effects model revealed a Group*Time interaction 
for esophageal transit time (F3,390 = 3.75, P = 0.011), there were no significant 
differences between groups at 4 days post-surgery (T19 = 84.00, P = 0.072) nor 
the other time points. In addition, laryngeal penetration or aspiration (i.e., contrast 
entering the airways), which are the most common manifestations of dysphagia in 
human patients with RLN injury, were not identified in any mice in this study.  
 
Table 4.1. Videofluoroscopic Swallow Study Outcomes 
 
VFSS Metrics  
units 
Baseline 4 DPS 6 WPS 12 WPS 
S T S T S T S T 
Lick Rate 
# per second 
7.94 
(0.60) 
8.09 
(0.30) 
7.54 
(0.57) 
7.58 
(0.42) 
7.98 
(0.55) 
7.91 
(0.50) 
7.74 
(0.43) 
7.62 
(0.56) 
Swallow Rate 
# per 2 seconds 
4.72 
(0.70) 
5.02 
(0.60) 
4.30 
(0.76) 
4.35 
(0.59) 
4.49 
(0.86) 
4.60 
(0.61) 
4.91 
(0.56) 
4.62 
(0.40) 
Inter-Swallow Interval 
seconds 
0.48 
(0.09) 
0.42 
(0.07) 
0.53 
(0.12) 
0.53 
(0.08) 
0.54 
(0.13) 
0.49 
(0.08) 
0.45 
(0.06) 
0.46 
(0.05) 
Lick-Swallow Ratio 
Licks/swallow 
3.08 
(0.09) 
2.75 
(0.70) 
3.42 
(1.21) 
3.40 
(0.58) 
3.76 
(1.28) 
3.22 
(0.73) 
2.80 
(0.39) 
2.80 
(0.51) 
Pharyngeal Transit 
Time seconds 
0.10 
(0.00) 
0.10 
(0.01) 
0.11 
(0.01) 
0.11 
(0.01) 
0.11 
(0.01) 
0.11 
(0.01) 
0.11 
(0.01) 
0.11 
(0.01) 
Esophageal Transit 
Time seconds 
0.90 
(0.31) 
0.75 
(0.12) 
0.71 
(0.11) 
0.86 
(0.23) 
0.85 
(0.17) 
0.81 
(0.13) 
0.89 
(0.27) 
0.83 
(0.19) 
Esophageal Swallow 
Inhibition percentage 
36.0 
(27.0) 
22.0 
(23.0) 
8.0 
(14.0) 
15.0 
(18.0) 
32.0 
(25.0) 
27.0 
(21.0) 
32.0 
(30.0) 
25.0 
(27.0) 
Note: VFSS = Videofluoroscopic Swallow Study; S = Sham; T = Transection; DPS = Days Post-
Surgery; WPS = Weeks Post-Surgery; VFSS metric values represent the mean (standard 
deviation).  
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Figure 4.9. Esophageal Transit Time (ETT). Though not statistically significant, mice in the RLN 
transection group had a trend for increased durations of ETT following surgery that appeared to 
recover by 6 WPS. On the other hand, sham mice had shortened ETT durations that also returned 
to baseline values by 6 WPS. WPS = Weeks Post-Surgery, Error bars = standard error. 
 
 
4.4.3 Effects of Denervation on Vocalization 
The total number of calls as well as the percentage of high frequency 
modulated calls were automatically detected by Avisoft Software and quantified for 
each group at all 4 time points (baseline, 1, 2, and 5 WPS). A two-way repeated 
measures ANOVA revealed no significant differences in the total number of calls 
between groups (F3,57 = 1.038, P = 0.38; Figure 4.10a); however, a significant 
group*time interaction existed for the percentage of high frequency modulated 
calls (F3,35 = 3.64, P = 0.022), indicating the mean change over time between the 
two groups was different. Tukey post-hoc analysis revealed a significant decrease 
in high frequency modulated calls in the transection group at 1 WPS (P = 0.031; 
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Figure 4.10b), which corresponded with an increase in the percentage of low 
frequency modulated calls in this group.  
 
 
Figure 4.10. Ultrasonic Vocalization (USV) Outcomes for all four time points. a) The total number 
of USV calls varied widely per group at each time point and were not significantly different between 
groups. Solid horizontal line = median; dashed horizontal line = mean; S = Sham, T = Transection. 
b) The percentage of high frequency modulated calls was significantly decreased in the RLN 
Transection group at 1 WPS, but recovered by 5 WPS. Only mice with greater than 20 calls were 
included in the analysis of high frequency modulated calls. WPS = Weeks Post-Surgery; S = Sham, 
T = Transection, Asterisk (*) = p = 0.031.    
 
When comparing the percentage of high frequency modulated calls across 
all time points, 1 WPS showed significant differences between groups. Therefore, 
this time point, in addition to baseline, was chosen for additional in depth acoustic 
analysis. The goal of this analysis was to identify potential outcome metrics that 
could be used for future studies using this model. As such, all calls within 90 
seconds after the 1st detected call were manually classified by a trained reviewer. 
Baseline measures were taken into account as a covariate to determine statistical 
significance between the sham and transection groups at 1 WPS for the following 
acoustic parameters: percentage of call type (%), bandwidth (kHz), duration (ms), 
peak frequency (kHz), and duration of peak frequency (ms). Results are 
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summarized in Table 4.2. In particular, bandwidth appeared to be the most 
affected acoustic parameter at 1 WPS, with 3 call types (upsweep, jump down, 
and half cycle), and 2 subsequent call categories (simple and cycle) significantly 
affected by RLN transection (Figure 4.11). Lastly, we compared a number of 
outcome metrics related to the repetitive calling nature observed in mice. Though 
most outcomes were not significantly different between groups, the mean 
intervocalization interval was significantly longer in the RLN transection group at 1 
WPS (F1,12 = 7.20, P = 0.02), and denervated mice showed a trend towards an 
increased number of isolated calls within a pause (F1,12 = 3.37, P = 0.091). These 
results are summarized in Table 4.3.  
 
Table 4.2. Ultrasonic Vocalization Acoustic Parameter Outcomes  
Percentage of Calls (%) 
Call Type 
Sham (n=10) Transection (n=9) 
F 
Value 
P Value 
Baseline 1 WPS Baseline 1 WPS 
𝒙 SD 𝒙 SD 𝒙 SD 𝒙 SD 
Simple 38.3 9.8 41.3 13.3 27.7 21.8 27.6 20.2 1.16 0.30 
Constant 2.4 3.5 5.1 4.3 4.3 3.4 8.2 11.0 0.46 0.51 
Downsweep 3.9 8.0 4.3 9.4 0.7 1.0 0.9  1.2 0.00 0.96 
Upsweep 32.0 10.4 31.9 16.4 22.7 18.8 18.6  13.7 1.93 0.18 
Jump 35.3 13.2 25.8 8.2 16.5 12.8 24.9 17.1 0.22 0.65 
Jump Down 20.5 11.2 17.1 11.1 11.7 12.0 19.2 14.4 2.12 0.17 
Jump Up 14.8 15.8 8.6 6.8 4.7 5.3 5.7 5.8 0.37 0.55 
Cycle 8.3 7.7 11.4 6.7 12.8 9.2 7.8 7.0 1.45 0.25 
Half Cycle 6.1 7.4 7.6 3.9 8.3 9.4 5.3 5.5 0.16 0.70 
Full Cycle 1.8 2.2 3.2 2.7 4.2 4.2 2.3 2.2 0.42 0.53 
Two Cycles 0.4 0.6 0.5 0.6 0.3 0.6 0.3 0.6 0.20 0.66 
Complex 18.1 13.2 21.6 7.5 34.0 28.6 12.4 12.8 0.10 0.76 
Multiple 
Jumps 
14.1 11.7 14.2 6.5 29.3 28.7 12.0 12.6 3.74 0.077 
Harmonic 3.9 3.4 7.3 4.7 4.6 7.4 0.4 0.7 17.79 0.0007* 
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Bandwidth (kHz) 
Call Type 
Sham (n=10) Transection (n=9) 
F 
Value 
P Value 
Baseline 1 WPS Baseline 1 WPS 
𝒙 SD 𝒙 SD 𝒙 SD 𝒙 SD 
Simple 17.9 3.7 16.3 4.2 17.9 5.6 10.9 3.2 10.94 0.0048* 
Constant 6.9 3.8 5.2 1.2 6.2 1.8 4.2 0.9 3.90 0.08 
Downsweep 18.1 10.5 13.9 8.3 11.5 5.5 10.3 3.1 1.46 0.28 
Upsweep 18.0 3.9 17.7 4.2 20.0 5.2 13.0 2.8 11.48 0.0041* 
Jump 25.1 8.0 27.9 5.3 27.7 3.8 24.8 3.7 0.45 0.51 
Jump Down 26.3 2.9 28.2 4.7 26.7 3.2 22.1 3.7 6.40 0.026* 
Jump Up 25.0 13.5 28.2 8.2 29.0 5.8 29.9 8.7 0.62 0.45 
Cycle 23.4 8.1 21.2 5.9 19.6 7.1 14.0 4.8 4.94 0.046* 
Half Cycle 20.7 5.5 21.7 6.0 19.0 6.1 12.7 5.4 6.41 0.030* 
Full Cycle 23.9 8.3 19.7 7.5 18.6 7.3 14.1 3.8 3.39 0.10 
Two Cycles 26.6 12.6 22.7 6.9 19.0 7.6 19.5 3.4 n/a n/a 
Complex 45.0 3.0 44.0 4.9 44.8 5.9 36.7 7.0 2.47 0.14 
Multiple 
Jumps 
42.8 5.2 43.7 4.1 44.0 6.7 36.8 6.9 2.83 0.12 
Harmonic 47.6 6.8 42.5 13.3 45.6 7.5 39.8 13.8 0.07 0.80 
Duration of Call (ms) 
Call Type 
Sham (n=10) Transection (n=9) 
F 
Value 
P Value 
Baseline 1 WPS Baseline 1 WPS 
𝒙 SD 𝒙 SD 𝒙 SD 𝒙 SD 
Simple 19.0 5.2 18.2 3.4 17.7 3.3 16.0 2.6 2.02 0.18 
Constant 17.0 8.3 17.0 4.2 19.3 9.6 18.0 3.9 0.02 0.89 
Downsweep 32.7 28.3 19.5 11.2 15.2 5.6 20.9 9.4 0.32 0.60 
Upsweep 18.3 3.2 18.2 3.1 17.3 1.8 14.5 3.2 7.33 0.016* 
Jump 26.5 11.1 29.0 7.1 34.5 10.1 27.7 8.0 0.16 0.70 
Jump Down 27.5 4.7 28.2 7.8 35.0 7.3 27.0 7.7 0.08 0.79 
Jump Up 20.5 8.5 29.4 7.4 30.3 14.3 27.0 7.7 0.33 0.58 
Cycle 45.9 13.1 35.7 9.9 31.0 9.1 41.9 15.8 0.73 0.41 
Half Cycle 38.5 10.0 29.9 7.5 27.8 7.5 35.1 15.6 0.75 0.41 
Full Cycle 57.2 21.5 46.9 14.5 38.2 13.4 54.5 12.0 0.00 0.97 
Two Cycles 70.4 35.8 72.3 31.9 60.8 45.9 127.3 25.7 n/a n/a 
Complex 47.5 9.3 50.5 15.6 50.3 15.8 59.7 14.7 1.15 0.31 
Multiple 
Jumps 
44.1 11.0 48.0 11.8 45.2 9.9 59.5 14.6 1.88 0.20 
Harmonic 54.6 14.8 54.7 22.9 72.8 36.4 45.0 15.1 1.93 0.21 
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Peak Frequency of Call (kHz) 
Call Type 
Sham (n=10) Transection (n=9) 
F 
Value 
P Value 
Baseline 1 WPS Baseline 1 WPS 
𝒙 SD 𝒙 SD 𝒙 SD 𝒙 SD 
Simple 84.9 5.3 84.1 4.9 83.7 13.1 81.5 4.7 1.28 0.28 
Constant 78.0 8.3 75.0 5.4 80.1 3.8 77.9 6.3 0.47 0.51 
Downsweep 83.0 9.4 83.2 11.9 89.5 6.4 89.6 10.5 0.89 0.39 
Upsweep 85.0 5.5 85.3 5.0 85.1 14.6 83.1 5.3 0.60 0.45 
Jump 93.5 8.0 93.4 3.7 94.2 2.0 91.1 3.3 1.14 0.30 
Jump Down 95.0 5.1 94.1 5.9 94.7 4.2 88.5 5.1 4.95 0.046* 
Jump Up 93.0 11.0 93.7 7.6 95.9 7.4 94.5 8.4 0.40 0.54 
Cycle 90.4 9.5 89.2 4.6 89.1 10.6 83.5 6.2 3.83 0.074 
Half Cycle 88.7 6.4 91.0 6.1 91.2 15.1 83.0 8.2 3.72 0.08 
Full Cycle 89.2 11.6 85.0 55.5 87.1 8.4 84.8 10.7 0.02 0.90 
Two Cycles 89.3 9.4 82.7 7.8 87.2 9.6 84.7 4.2 n/a n/a 
Complex 107.3 3.1 106.7 2.2 105.8 7.5 99.9 7.4 3.82 0.074 
Multiple 
Jumps 
106.5 3.9 107.4 4.2 106.1 7.8 100.1 7.1 3.74 0.077 
Harmonic 106.4 5.6 101.5 13.6 104.2 8.8 98.8 20.8 0.02 0.90 
Duration of Peak Frequency (ms) 
Call Type 
Sham (n=10) Transection (n=9) 
F 
Value 
P Value 
Baseline 1 WPS Baseline 1 WPS 
𝒙 SD 𝒙 SD 𝒙 SD 𝒙 SD 
Simple 14.6 4.0 14.4 4.6 14.4 2.4 11.3 2.0 10.11 0.0062* 
Constant 12.5 7.5 10.8 4.6 13.4 6.9 9.2 2.1 1.35 0.28 
Downsweep 3.6 2.8 2.8 1.7 1.9 1.3 4.5 2.2 1.44 0.28 
Upsweep 16.0 3.2 16.3 3.2 15.2 1.6 12.0 2.7 10.81 0.005* 
Jump 13.9 2.5 14.5 4.4 17.8 11.0 11.6 3.0 1.72 0.21 
Jump Down 11.8 4.1 11.3 4.7 12.7 2.7 8.7 3.1 0.80 0.39 
Jump Up 16.5 5.4 20.5 5.4 21.5 11.1 18.5 4.1 0.10 0.76 
Cycle 23.3 11.0 19.0 5.8 15.5 5.1 17.5 7.1 0.01 0.92 
Half Cycle 23.6 10.8 16.8 4.7 14.8 2.8 13.6 5.5 0.33 0.58 
Full Cycle 20.9 10.8 25.4 11.9 20.1 7.1 21.1 13.0 0.17 0.69 
Two Cycles 18.0 14.5 35.3 30.1 16.2 5.4 46.6 33.8 n/a n/a 
Complex 21.1 5.1 21.4 4.0 21.6 4.1 23.8 8.0 0.71 0.42 
Multiple 
Jumps 
19.3 3.9 20.4 4.2 20.7 3.4 23.6 7.7 0.84 0.38 
Harmonic 24.0 8.8 22.4 8.8 26.2 5.3 27.9 19.9 0.01 0.91 
Note: 𝑥 = mean; SD = standard deviation; WPS = weeks post-surgery; kHz = kilohertz; ms = 
milliseconds; bold values with an asterisk (*) = statistical significance (p < 0.05) between Sham and 
Transection groups at 1 WPS. Two mice from the transection group were excluded due to lack of 
calls. Outcomes could not be assessed for two cycle calls due to a very low percentage of mice 
with these types of calls.  
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Figure 4.11. Ultrasonic vocalization call bandwidth at 1 WPS. Box and whisker plots showing call 
bandwidth at 1 WPS for a) call categories, b) simple calls, c) jump calls, and d) cycle calls. Solid 
horizontal line = median, dashed horizontal line = mean, WPS = Weeks Post-Surgery; S = Sham, 
T = Transection, Asterisk (*) indicates significant difference between the two groups = p <0.05 
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Table 4.3. Ultrasonic Vocalization Call Series Outcomes 
 
USV Outcome 
Measure 
Sham (n=10) Transection (n=9) 
F 
Valu
e 
P 
Value 
Baseline 1 WPS Baseline 1 WPS 
𝒙 SD 𝒙 SD 𝒙 SD 𝒙 SD 
Number of Total 
Call Series in 90 s 
19.0 12.5 24.3 11.2 19.3 15.1 15.9 11.2 1.16 0.30 
Number of Calls 
in a Series 
10.5 4.3 11.4 3.7 9.7 2.3 9.3 2.5 0.84 0.38 
Length of Series 
 (s) 
0.98 0.44 1.11 0.43 0.93 0.24 0.94 0.34 0.19 0.67 
Longest Call 
Series (s) 
3.58 4.71 5.55 4.73 3.14 1.96 3.52 3.20 0.75 0.40 
Duration of IVI 
within a Series 
(ms) 
74.5 8.7 71.1 6.5 71.4 5.3 82.0 10.1 7.20 0.02* 
Pause Length  
(s) 
4.33 4.26 2.83 2.59 3.65 3.06 4.52 3.67 0.43 0.52 
Number of Calls 
in a Pause 
2.69 1.69 3.11 1.38 3.32 1.55 6.21 3.73 3.37 0.091 
Note: 𝑥 = mean; SD = standard deviation; WPS = weeks post-surgery; IVI = intervocalization 
interval; s = seconds; ms = milliseconds; bold values with an asterisk (*) = statistical significance 
(p < 0.05) between Sham and Transection groups at 1 WPS. Two mice from the transection group 
were excluded due to lack of calls.  
 
 
4.4.4 Effects of Denervation on Respiration 
Respiratory parameters under normoxic conditions and hypercapnic/ 
hypoxic conditions were analyzed separately. In normoxia, there were no 
significant differences in frequency, tidal volume, inspiratory time, expiratory time, 
peak inspiratory flow, or minute ventilation between groups at any time point 
(Table 4.4). However, during the hypercapnic/hypoxic challenge, transected mice 
displayed a significant decrease in tidal volume and minute ventilation at 11 WPS 
compared to sham mice (Tukey post hoc:  P = 0.029 and 0.047, respectively; 
Figure 4.12a and b). In addition, RLN transected mice displayed a trend for 
decreased peak inspiratory flows after injury. While there was not a statistically 
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significant interaction between group and time point (F3,57 = 2.473; P = 0.071) for 
peak inspiratory flow, a two-tailed t-test performed for each individual time point 
revealed a statistically significant difference between groups at 11 WPS (T19 =  
2.67, P = 0.015; Figure 4.12c). All other respiratory parameters were not 
significantly different between groups during the hypercapnic/hypoxic challenge 
(Table 4.5). 
 
Table 4.4. Normoxia Respiratory Outcomes 
 
WBP Metrics  
units 
Baseline 1 WPS 5 WPS 11 WPS 
S T S T S T S T 
Frequency 
breaths/minute 
304 
(44) 
290 
(44) 
285 
(67) 
292 
(68) 
340 
(44) 
346 
(42) 
371 
(23) 
366 
(28) 
Tidal Volume 
ml 
0.36 
(0.07) 
0.38 
(0.05) 
0.34 
(0.06) 
0.37 
(0.03) 
0.38 
(0.06) 
0.40 
(0.04) 
0.42 
(0.06) 
0.43 
(0.03) 
Inspiratory Time 
seconds 
0.06 
(0.01) 
0.06 
(0.01) 
0.07 
(0.02) 
0.07 
(0.01) 
0.05 
(0.01) 
0.05 
(0.01) 
0.05 
(0.00) 
0.05 
(0.01) 
Expiratory Time 
seconds 
0.16 
(0.03) 
0.18 
(0.03) 
0.18 
(0.05) 
0.18 
(0.05) 
0.15 
(0.03) 
0.15 
(0.02) 
0.13 
(0.01) 
0.13 
(0.01) 
Peak Inspiratory Flow 
ml/second 
9.9 
(1.7) 
10.1 
(1.8) 
8.9 
(2.6) 
9.4 
(2.1) 
11.7 
(2.3) 
12.3 
(1.9) 
13.8 
(2.6) 
13.7 
(1.5) 
Minute Ventilation 
ml/minute 
106 
(21) 
109 
(20) 
96 
(28) 
105 
(25) 
131 
(30) 
140 
(22) 
155 
(27) 
155 
(15) 
Note: WBP = Whole Body Plethysmography; S = Sham; T = Transection; ml = milliliters; WPS = 
Weeks Post-Surgery; WBP metric values represent the mean (standard deviation).  
 
 
Figure 4.12. Respiratory outcomes during hypercapnic/hypoxic conditions. After normoxic 
conditions, mice were exposed to a hypercapnic (7% CO2)/hypoxic (10.5% O2) challenge to induce 
increased respiratory effort. There was a significant difference between groups at 11 WPS for (a) 
tidal volume, (b) minute ventilation, and (c) peak inspiratory flow. WPS = weeks post-surgery; mL 
= milliliters; s = seconds; * = significant p value (p <0.05). Error bars = standard error. 
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Table 4.5. Hypercapnia + Hypoxia Challenge Respiratory Outcomes  
 
WBP Metrics  
units 
Baseline 1 WPS 5 WPS 11 WPS 
S T S T S T S T 
Frequency 
breaths/minute 
393 
(38) 
397 
(39) 
373 
(33) 
362 
(33) 
387 
(33) 
376 
(39) 
370 
(22) 
369 
(24) 
Tidal Volume 
ml 
0.65 
(0.07) 
0.65 
(0.04) 
0.66 
(0.07) 
0.67 
(0.03) 
0.68 
(0.07) 
0.67 
(0.05) 
0.76* 
(0.06) 
0.70* 
(0.04) 
Inspiratory Time 
seconds 
0.07 
(0.01) 
0.07 
(0.01) 
0.07 
(0.01) 
0.08 
(0.01) 
0.07 
(0.01) 
0.07 
(0.01) 
0.07 
(0.00) 
0.07 
(0.01) 
Expiratory Time 
seconds 
0.09 
(0.01) 
0.09 
(0.01) 
0.09 
(0.01) 
0.09 
(0.01) 
0.09 
(0.01) 
0.09 
(0.01) 
0.09 
(0.01) 
0.09 
(0.01) 
Peak Inspiratory Flow 
ml/second 
14.5 
(1.3) 
14.6 
(1.6) 
13.6 
(1.4) 
13.1 
(1.1) 
14.9 
(1.2) 
14.1 
(1.4) 
16.3* 
(0.09) 
15.0* 
(1.4) 
Minute Ventilation 
ml/minute 
251 
(21) 
257 
(24) 
245 
(27) 
242 
(17) 
258 
(19) 
251 
(24) 
278* 
(17) 
258* 
(24) 
Note: WBP = Whole Body Plethysmography; S = Sham; T = Transection; ml = milliliters; WPS = 
Weeks Post-Surgery; WBP metric values represent the mean (standard deviation). Bold values 
with an asterisk (*) denotes statistical significance (p < 0.05) between groups at the individual time 
point.  
 
During normoxia, results of the mixed effects model revealed a statistically 
significant difference in the mean number of apneas between the two groups (F1,57 
= 11.64, P = 0.0012). The group by interaction term was significant, indicating the 
change in the mean number of apneas over time was different between the two 
groups (F3,57 = 6.88, P = 0.0005). Post hoc Mann-Whitney U Tests showed 
significant differences between the two groups at all three post-surgical time points 
(P < 0.004 each), but not baseline (P = 0.769). Results of the estimated mean 
number of apneas by group over time is depicted in Figure 4.13a. The mixed 
effects model also detected a statistically significant mean difference between 
group (F1,57 = 9.30; P = 0.0035) and time point (F3,57 = 20.06; P < 0.0001) for the 
duration of apneas. There was no group by time interaction noted (F3,57 = 2.29; P 
= 0.0876), though Mann-Whitney U Tests at each time point revealed a significant 
decrease in the duration of apneas at 1 and 5 WPS for transected mice (P = 0.021 
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and 0.033, respectively; Figure 4.13b). The mean percentage of erratic breathing 
(Figure 4.13c) was also statistically significant between the two groups (F1,57 = 
19.53, P < 0.001). Mean percentage of erratic breathing was lower in RLN 
transected mice across the three post-surgical time points (Mann-Whitney U Tests: 
P = 0.0006, 0.0008, 0.0006, at 1 WPS, 5WPS, and 11 WPS, respectively). In all 
mice, the number of apneas detected moderately correlated with the percentage 
of erratic breathing when analyzed using a Pearson Correlation (R = 0.511, P < 
0.0001; Figure 4.13d). No differences in sighs were detected between groups.  
 
Figure 4.13. Apnea respiratory outcomes. (a and c) RLN transection resulted in significantly less 
apneas and less erratic breathing in all three post-surgical type points. (b) Apnea duration 
significantly decreased in transected mice at 1 and 5 WPS as shown. (d) The number of apneas 
moderately correlated with the percentage of erratic breathing in both groups across all time points. 
WPS = weeks post-surgery; asterisk (*) denotes statistical significance with p values ≤ 0.05. Error 
bars = standard error. 
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4.4.5 Effect of RLN Transection on Motor Neuron Counts in the Nucleus Ambiguus  
 Each mouse had 2-4 brainstem sections with an easily identifiable left and 
right nucleus ambiguus for analysis, all within the same brainstem region. On 
average, sham mice contained 65 (sd = 15) and 70 (sd = 20) neurons in the left 
and right nucleus ambiguus per section, respectively. RLN denervated mice 
contained 68 (sd = 14) and 67 (sd = 12) neurons in the left and right nucleus 
ambiguus per section, respectively. A two-way ANOVA did not detect a significant 
difference between groups or the left and right neuron counts for each section (F1 
= 0.50, P = 0.48). 
 
4.5 Discussion 
In this study, we built upon our previous work60,61 developing a mouse 
model of laryngeal nerve injury. We used a holistic approach to successfully create 
a translational model that mirrors many of the sequela associated with RLN injury 
in human patients, including VF immobility, as well as vocal and respiratory 
dysfunction. A combination of behavioral testing, including endoscopic33 and 
fluoroscopic36 imaging assays, along with ultrasonic vocalization and whole-body 
plethysmography assays allowed exploration of a wide range of potential functional 
complications (i.e., unilateral VF paralysis, dysphagia, dysphonia, and dyspnea) 
associated with RLN injury within the same animal. Furthermore, we continued to 
refine objective quantification of dynamic VF motion, including characterization of 
compensatory mechanisms of the uninjured VF. This study further validates our 
automated VF tracking software,33 and provides novel metrics to elucidate the 
146 
 
mechanics of altered VF motion following RLN damage and subsequent recovery 
patterns.  
As expected, mice experienced immediate unilateral VF paralysis after RLN 
transection, demonstrated by a decrease in range and frequency of right VF 
motion. In addition, a subset of denervated mice displayed paradoxical VF motion 
immediately after injury and at 13 WPS; however, the abnormal movement differed 
between time points. In both cases, physiological functional movement of the right 
VF was absent. Consequently, right VF motion appeared passive, such that the 
intact left VF “pulled” the right VF in an aberrant direction during abduction 
immediately post-transection. In contrast, at 13 WPS, over-adduction of the left VF 
resulted in contact with the right VF, thus displaying a pushing motion. Paradoxical 
VF movement has been reported in previous animal studies where RLN 
reinnervation was induced by repairing the transected nerve.12,62 It is presumable 
that the thyroarytenoid (adductor) muscle received aberrant reinnervation from 
former abductor axons, causing abnormal contraction of the intrinsic laryngeal 
muscles (i.e., synkinesis). Therefore, the paradoxical movement in these studies 
was likely due to active, but inappropriate muscle contraction, rather than the 
passive motion generated by the unaffected VF as observed in our current study. 
In addition, over-adduction of the unaffected VF has been noted in humans with 
unilateral VF paralysis,63,64 though its role in functional compensation in patients 
with unilateral VF paralysis needs further investigation. 
In addition to dynamic VF analysis, we continued to investigate dysphagia 
in this model. Unlike the infant pig model, RLN transection in adult B6 mice had 
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minimal impact on swallowing behavior, as noted in our previous work.60,61 This 
finding is likely due to the anatomical differences between the mouse and human 
larynx. Yet, while murine laryngeal anatomy limits the assessment of 
aspiration,36,37 other outcome metrics, especially those related to esophageal 
dysphagia, may be affected by RLN injury in this model. As the RLN also provides 
innervation to the esophagus in addition to the intrinsic laryngeal muscles, the 
trend for increased esophageal transit time following RLN transection observed in 
this study is consistent with pharyngoesophageal dysfunction documented in other 
RLN injury models15,65,66 and human unilateral VF paralysis patients.67,68 As such, 
future studies may benefit by utilizing a higher speed camera or alternative 
methods, such as manometry, to accurately determine if significant pharyngeal or 
esophageal dysphagia exists in this small, fast-drinking species.  
Next, the effect of RLN injury on murine vocal function was assessed with 
ultrasonic vocalization analysis. Previous laryngeal nerve transection studies have 
shown that unilateral RLN injury disrupts ultrasonic vocalizations in rodents.23,38,69 
However, these studies were limited in the acoustic parameters collected and 
lacked extensive analysis that is more easily performed with current technology. 
Our study offers the first robust analysis of vocalization acoustics following RLN 
injury in mice. Surprisingly, the number of calls generated did not differ between 
groups at any time point. However, high frequency modulated calls were 
significantly impaired by RLN injury at 1 WPS. Similarly, RLN transection impaired 
the frequency bandwidth of many call types at 1 WPS. These findings suggest that 
mice with unilateral VF paralysis lose the ability to modulate the frequency in their 
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calls, similar to human patients who experience impairment in their phonation 
frequency (i.e., pitch range) following injury.70-72 Unilateral VF paralysis patients 
also demonstrate impaired maximum phonation times,71 which was observed in 
the current study as decreased call durations and durations of peak frequency in 
a collection of call types in RLN transected mice. In addition to acoustic 
parameters, we examined murine ultrasonic vocalization call series, as patients 
with unilateral VF paralysis often suffer from vocal fatigue.73 Indeed, RLN 
transection resulted in an increased intervocalization interval, requiring more time 
from the end of one vocalization to the next. An increased intervocalization interval 
may indicate VF fatigue, requiring more time to rest the VFs in between calls. 
Moreover, the trend for an increased number of isolated calls within a pause after 
RLN transection may act as another indicator of fatigue. Thus, we have identified 
several translational outcome measures to further investigate vocal impairment 
and recovery in this model.  
Interestingly, the percentage of high frequency modulated calls in RLN 
transected mice recovered by 5 WPS, despite chronic ipsilateral VF paralysis at 
13 WPS. The recovery pattern is consistent with previous literature demonstrating 
the effects of rodent RLN denervation on ultrasonic vocalizations are short-
term.38,69 This recovery of vocalization may be due to a compensatory ability of the 
intact VF to cross the glottal midline and approximate the paralyzed VF as seen in 
a subset of mice during our endoscopy analysis. However, this is in contrast to 
humans, where over-adduction of the intact VF has been shown to result in worse 
vocal function.64 Thus, further work is necessary to establish the true 
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compensatory nature of the intact VF and the exact mechanism of spontaneous 
vocal recovery in unilateral VF paralysis.  
Lastly, this is the first animal study investigating the direct effect of RLN 
injury on respiratory function. Under normoxic conditions, respiratory parameters 
did not differ between groups. This was expected, as the majority of patients with 
unilateral VF paralysis do not develop significant abnormalities in their respiratory 
capacity.2 However, many patients do complain of breathing difficulty during 
increased respiratory effort, such as during conversation and physical activity.73 
As such, denervated mice exposed to a hypercapnic/hypoxic challenge to 
maximally increase their respiratory effort developed significantly impaired 
inspiratory flow, tidal volume, and minute ventilation at 11 WPS. Consistent with 
previous literature, inspiratory flow rate is often the most compromised spirometric 
parameter in human patients with unilateral VF paralysis.29 This outcome may be 
due to an increasingly atrophied VF that weakens over time and becomes flaccid 
and drawn into the inspiratory airstream, causing the VF to collapse and partially 
obstruct the airway. The obstruction of inspiratory flow would in turn limit tidal 
volume and minute ventilation. However, future studies utilizing EMG and/or 
histological assessments of the laryngeal muscles are necessary to confirm a lack 
of muscle tone and flaccid paralysis to support this hypothesis.  
Furthermore, patients with unilateral VF paralysis report the inability to hold 
their breath and have an impaired ability to perform a valsalva maneuver,73 
congruent with dysfunctional laryngeal closure. Thus, for this study, B6 mice were 
chosen as they have a propensity for dysrhythmic breathing contributing to 
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spontaneous apneas (i.e., pauses in breathing) during wakefulness.55,56 As 
apneas in this strain of mice have been associated with active laryngeal closure,56 
we hypothesized that ipsilateral VF paralysis induced by RLN injury would prevent 
laryngeal closure and inhibit the ability to generate and sustain apneic episodes. 
In this study, RLN transection significantly decreased the number and duration of 
apneas, which correlated with a decrease in erratic breathing. This “stabilized” 
breathing pattern may suggest a central compensatory mechanism to ensure 
adequate ventilation with a dysfunctional VF. However, this observation may 
simply be a mechanical consequence of the inability of the mice to actively close 
their larynx, leading to less spontaneous apneas and less variation in their 
breathing patterns. It is interesting to note that some of the mice in our study that 
were found to have left VF compensation (pushing motion seen with laryngoscopy) 
also generated the most apneas within the RLN transection group at 11 WPS. 
Though a small sample size precludes statistical analysis, future studies may 
investigate if the compensatory contact (i.e., laryngeal closure) from the left VF 
contributes to increased apneas. The correlation between VF compensation and 
apnea production may be a useful outcome metric to determine whether a 
stabilized breathing pattern following RLN injury is due to central neurologic 
processes versus an anatomical laryngeal closure mechanism.  
In addition to our behavioral analysis, we performed immunohistochemistry 
of the nucleus ambiguus to investigate neuronal cell counts at 13 WPS. Peripheral 
nerve injury often results in various percentages of retrograde cell death due to 
disruption in axon continuity.32 As the nucleus ambiguus is the motor nucleus 
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containing cell bodies for the RLN, cell death may have occurred in the right 
nucleus ambiguus of the transection group. However, cell counts did not 
significantly differ between left and right sides nor between treatment groups, likely 
because post-lesion cell death depends on numerous variables, such as age, 
severity of injury, and proximity of the injury to the soma.32 Though we utilized the 
severest injury type (i.e., transection), our adult mice with fully developed nervous 
systems are less susceptible to cell death than those with immature neurons.74,75 
Moreover, a distal injury, such as in our study, is often associated with no or limited 
cell death.76 Thus, the lack of cell death in the right nucleus ambiguus in RLN 
transected mice is congruent with current literature. 
In conclusion, we have identified several translational outcome measures 
in our mouse model of RLN injury, which we aim to utilize to objectively assess 
injury and subsequent recovery after RLN injury of various injury types and with 
different therapeutic interventions in future studies. In fact, we have begun work in 
a more prevalent RLN crush injury model to investigate electrical nerve stimulation 
as a potential treatment option. In this work,77 we have had preliminary success 
utilizing intraoperative vagal nerve stimulation as a clinically relevant treatment, 
though larger scale studies are necessary to establish optimal stimulation 
parameters. Furthermore, it is necessary to characterize the effects of 
intraoperative vagal nerve stimulation on all relative outcomes associated with 
swallowing, voice, and breathing as identified by this study, to understand its true 
translational potential.  
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5.1 Abstract 
Objectives: The gastrointestinal microbiota (GM) plays a fundamental role in 
health and disease and contributes to the bidirectional signaling between the 
gastrointestinal system and brain. The direct line of communication between these 
organ systems is through the vagus nerve. Therefore, vagal nerve stimulation 
(VNS), a commonly used technique for multiple disorders, has potential to 
modulate the enteric microbiota, enabling investigation and possibly treatment of 
numerous neurologic disorders in which the microbiota has been linked with 
disease. Here we investigate the effect of VNS in a mouse model of amyotrophic 
lateral sclerosis (ALS).  
Methods: B6SJL-Tg(SOD1*G93A)dl1Gur (SOD1dl) and wildtype mice underwent 
ventral neck surgery to access the vagus nerve. During surgery, the experimental 
group received 1 h of VNS, whereas the sham group underwent 1 h of sham 
treatment. The third (control) group did not undergo any surgical manipulation. 
Fecal samples were collected before surgery and at 8 d after the initial collection. 
Microbial DNA was sequenced to determine the GM profiles at both time points. 
Results: GM profiles did not differ between genotypes at either the initial or end 
point. In addition, VNS did not alter GM populations, according to the parameters 
chosen in this study. 
Conclusions: Results indicated that this short intraoperative treatment is safe and 
has no lasting effects on the GM. Future studies are warranted to determine 
whether different stimulation parameters or chronic use of VNS affect GM profiles.   
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5.2 Introduction 
The vagus nerve, the tenth and longest cranial nerve in the body, innervates 
numerous structures including the larynx, pharynx, heart, lungs, and 
gastrointestinal tract. The vagus nerve is composed of thousands of axons that 
work to provide a vast majority of the autonomic innervation in the body.39,70 This 
nerve plays a large role in interoceptive awareness and is often regarded as the 
body’s ‘sixth sense’.12,61,73 Although the function of the vagus nerve is largely 
parasympathetic, it also provides somatic innervation, mainly to the muscles 
responsible for swallowing and upper airway function.6 The vagus nerve comprises 
A, B, and C fiber types, all of which are characterized by different conduction 
velocities and stimulation thresholds.14,39,55,60 This nerve consists of both afferent 
(80%) and efferent (20%) fibers that provide sensory and motor information to 
maintain homeostasis in nearly every organ system in mammals.12,39,43,54,65,70  
Given the vagus nerve’s wide-ranging anatomic targets and 
neuromodulatory effects, targeted manipulation of this nerve has a broad range of 
potential experimental and therapeutic applications. In fact, vagal nerve stimulation 
(VNS) has been used experimentally to establish the contribution of the vagus 
nerve to numerous behaviors, including immune function, mood, pain, and 
memory.70 Furthermore, there is immense interest in using implantable and 
noninvasive VNS devices to modulate essential functions within the body.39 VNS 
has been shown as an effective therapeutic strategy for diverse disorders, and 
various forms of VNS are currently FDA-approved for treating refractory epilepsy, 
depression, migraines, cluster headaches, and obesity.12,30,51,55,60,70-72 In addition, 
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this technology is currently being explored in a multitude of other disorders, 
including arthritis, asthma, heart failure, gastroparesis, and inflammatory bowel 
disease, among many others.30,54,70 Despite the effectiveness of VNS as a 
treatment strategy, the richness and complexity of the information transmitted 
along the vagus nerve raises serious challenges that must be considered before 
widespread use of VNS.39 Because the vagus nerve innervates multiple organ 
systems, it is imperative to examine how using VNS to treat a disorder of one organ 
system might affect healthy function in another.  
 Numerous studies have been conducted on the safety of VNS in regard to 
cardiovascular and respiratory function.6,8,10,30 However, although studies have 
examined the effects of VNS on gastrointestinal function,45,46,50 no published study 
has investigated how VNS might influence gastrointestinal microbial populations.12 
This dearth is surprising, given that the vagus nerve is the direct link between the 
CNS and gastrointestinal tract, serving as a complex bidirectional line of 
communication between these 2 organ systems.9,12,16,38 This brain–gut axis is 
essential for maintaining homeostasis and is greatly influenced by the 
gastrointestinal microbiota in both health and disease states, thus yielding its label 
as the ‘brain–gut–microbiota axis’.9,15,16,38,67  
 As part of this 3-component axis, the gastrointestinal microbiome (GM) 
consists of more than 1013 microorganisms, predominantly bacterial species.28,33 
These commensal enteric bacteria are crucial for preventing invasion of pathogens 
and for maintaining gastrointestinal morphology, intestinal barrier function, normal 
digestion, mucosal immune function, and host metabolism.38 The bacteria in this 
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population have a substantial capacity for secretory and metabolic activity that 
influence the signals sent and received by the gastrointestinal tract to and from the 
brain. Through this complex system, the brain controls motor, antiinflammatory, 
and secretory functions of the gastrointestinal tract, and the gastrointestinal viscera 
can return sensory messages to modulate nervous system function.9,12,13,16,38 
Miscommunication between the 2 organ systems can elicit stress responses, 
influence mood and behavior, and has been linked to chronic diseases throughout 
the body, including obesity, inflammatory bowel disease, colorectal cancer, among 
many others.16,22,38,62,69 Therefore, alteration of the enteric microbiota has 
tremendous effects on both health and pathologic conditions.57  
 Moreover, the GM, through the vagus nerve, has been suggested as a 
contributor to the development of neurodevelopmental and neurodegenerative 
disorders, including Autism Spectrum Disorder, Alzheimer disease, and Parkinson 
disease.21,27,53,63 Amyotrophic lateral sclerosis (ALS) is another neurodegenerative 
disease with potential involvement of the GM. ALS is a fatal disease characterized 
by progressive loss of motor neurons. Typical clinical signs include limb paralysis, 
aspiration pneumonia due to swallowing impairment, and asphyxiation.32 Although 
the role of the gastrointestinal tract in ALS is largely unexplored, patients with ALS 
have exhibited delayed gastric emptying and extended colonic transit times,7,64 
signifying abnormal gastrointestinal function. Perhaps most promising, a previous 
study demonstrated alterations in the GM and gastrointestinal morphology in a 
mouse model of ALS.69,75 Because many human patients with ALS have mutations 
in the superoxide dismutase 1 (SOD1) gene, the most common mouse models 
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used to study ALS carry a mutated human SOD1 transgene.40 Recent studies 
using an SOD1 mouse model demonstrate that GM changes occur in young mice 
before the onset of disease and show that disease onset can be delayed by 
restoring the GM.69,75 These findings indicate that altered microbial populations 
and gastrointestinal pathology may contribute to the pathogenesis of ALS. 
Consequently, perhaps VNS could play a role in manipulating the gastrointestinal 
microbes that contribute to ALS and other neurologic diseases.  
Whether VNS will have beneficial or detrimental effects on the microbial 
populations in the gastrointestinal tract is unclear currently. It is concerning that 
patients undergoing VNS for treatment of disease conditions may experience 
changes in their GM profiles, potentially contributing to other chronic diseases or 
negatively modulating the treatment effect. Alternatively, VNS might produce a 
favorable effect, positively influencing the treatment efficacy and proving useful as 
an entirely separate therapeutic strategy for disorders with a known 
gastrointestinal dysbiosis. Therefore, as the use of VNS becomes more prevalent 
for a multitude of disorders, it is essential to understand the potential off-target 
effects of this treatment on GM composition. Therefore, the primary objective of 
this study was to examine the effects of intraoperative VNS on GM profiles in 
healthy and neurologically diseased mice.  
In this study, we used an SOD1dl mouse model of ALS,1,5 which has fewer 
copies of the mutated transgene, corresponding to a delayed onset of disease 
compared with the high transgene copy number SOD1 model used in the 
aforementioned studies.40,69,75 Primarily, we sought confirmation that commonly 
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used experimental stimulation parameters for promoting swallowing and upper 
airway function did not alter the GM profiles of the mouse models used in our 
studies. Our secondary objective was to classify the GM composition of mice from 
our transgenic SOD1dl colony compared with age-matched WT controls to explore 
whether altered GM populations were present prior to disease onset, analogous to 
recent findings in the similar high-copy-number SOD1 model.69,75 
 
5.3 Materials and Methods 
5.3.1 Animals 
  All experimental procedures performed in this study were reviewed and 
approved by the University of Missouri Animal Care and Use Committee (protocol 
no. 8980). The University of Missouri is USDA-licensed and AAALAC-accredited. 
The line of mice used in this study, B6SJL-Tg(SOD1*G93A)dl1Gur (SOD1dl), 
originally was purchased from Jackson Laboratories (Bar Harbor, ME), but a 
breeding colony has been maintained at the University of Missouri for 3 to 4 y. 
Mice undergo tail snips at weaning for genotyping purposes to discriminate 
transgenic from WT animals and confirm the copy number of the transgene. The 
animals for this study were moved from the barrier breeding room to a conventional 
room at least 1 mo (age, approximately 4 mo) prior to data collection and were 
housed in IVC (Tecniplast, West Chester, PA) with aspen chip bedding. Mice were 
group-housed by sex whenever possible. Mice had free access to food (Laboratory 
Rodent Diet 5001, Purina, St Louis, MO) and water. Room temperature was 
maintained between 20.0 °C and 26.0 °C, relative humidity was between 30% and 
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70%, and the photoperiod was a 12:12-h light:dark cycle. Standard enrichment 
(cotton squares) was provided to all cages.  
All mice were of the same health status and were housed in the same room 
during the experiment; surgery was performed in a separate room in the laboratory, 
outside of the vivarium. At the time of the study, colony sentinels were tested 
quarterly and were considered free of the following agents: mouse hepatitis virus, 
minute virus of mice, mouse parvovirus, Sendai virus, Theiler murine 
encephalomyelitis virus, mouse rotavirus, Mycoplasma pulmonis, Pasteurella 
pneumotropica, Salmonella spp., mouse pneumonia virus, reovirus 3, lymphocytic 
choriomeningitis virus, Ectromelia, mouse adenovirus types 1 and 2, K virus, and 
polyoma virus. Fecal PCR analysis was used to detect pinworms in sentinel mice, 
whereas cage PCR assays (pooled swabs by room) were used to detect fur mites. 
According to the standard procedures for the room, mice were not tested for 
Helicobacter spp.  
 
5.3.2 Experimental Design 
 A total of 30 B6SJL-Tg(SOD1*G93A)dl1Gur (SOD1dl) mice and 30 age-
matched WT controls were used for this study. Mice (age, 5 mo) were randomly 
selected from our SOD1dl colony. This time point is approximately 1 mo prior to 
disease onset, which typically is observed around 6 mo of age in our colony.17,56 
Experimental procedures were performed over the course of 3 mo by using 7 
cohorts of mice, depending on the availability of mice at the correct age. Mice were 
divided into 3 groups, each with 10 SOD1dl and 10 WT mice (equal sexes). The 
experimental group underwent surgery for 1 h of unilateral VNS. A second group 
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underwent surgery for 1 h of sham stimulation. The control group did not undergo 
surgery and remained in the animal housing room throughout the study. As such, 
control animals were not housed with mice from other groups, but animals from 
the experimental and sham treatment groups were housed together randomly. 
Fecal samples were collected from individual mice 1 d prior to surgery (day 0) and 
8 d later (that is, 1 wk after surgery). Fecal samples were stored at –80.0 °C until 
the end of the study, when microbial DNA was extracted and sequenced to 
characterize the GM at both time points. Figure 5.1 shows a timeline of 
experimental procedures.  
 
 
Figure 5.1. Timeline of fecal sample collections. All mice underwent baseline fecal collection at 5 
mo of age (day 0). Mice in the experimental and sham groups underwent either vagal nerve 
stimulation (VNS) or sham stimulation surgeries on day 1. Mice in the control group remained in 
the vivarium, with no surgical manipulation. Feces were collected again from all mice at 8 d after 
the initial collection. 
 
5.3.3 Surgical Procedure  
 Mice in the experimental and sham groups underwent surgery with a ventral 
neck approach to access the right cervical vagus nerve. Mice were anesthetized 
by using a ketamine (90 mg/kg SC; Henry Schein, Melville, NY)–xylazine (11.25 
mg/kg SC; Akorn, Lake Forest, IL) cocktail. Half doses of ketamine were given 
subcutaneously as needed to maintain the surgical plane of anesthesia throughout 
the procedure. We chose injectable anesthesia because our lab has anecdotally 
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experienced decreased efficacy of electrical stimulation in isoflurane-anesthetized 
mice. The eyes were lubricated to prevent drying, and the ventral neck was shaved 
and prepared aseptically for surgery. Mice were positioned in dorsal recumbency 
on a custom platform beneath a surgical microscope (model M125, Leica 
Microsystems, Buffalo Grove, IL). Core body temperature was maintained at 37 °C 
by using a homeothermic heating system (DC Temperature Controller; FHC, 
Bowdoin, ME), and reflexes were checked every 10 to 15 min. Supplemental 
oxygen (100%) was delivered through a nose cone at a flow rate of 1 L/min during 
stimulation or sham treatment.  
 A midline neck incision was made from the suprasternal notch to the 
mandible. The salivary glands were gently retracted laterally, and the right vagus 
nerve was identified in its cervical location. After careful isolation from the carotid 
artery and jugular vein, the vagus nerve was placed on bipolar electrodes (FHC, 
Bowdoin, ME). Mice in the experimental group received VNS for 1 h while 
maintained at surgical depth of anesthesia. For mice in the sham group, the vagus 
nerve was placed on the electrodes for 1 h while they remained under surgical 
anesthesia.  
 For both groups, the vagus nerve was removed from the electrodes after 1 
h of stimulation or sham treatment, and the neck incision was closed by using 
absorbable sutures (6-0 Monocryl, Ethicon, Somerville, NJ) and surgical glue 
(Tissumend II, Veterinary Products Laboratories, Phoenix, AZ). After suturing was 
complete, 0.3 mL of warm, sterile saline was administered subcutaneously; 
sustained-release buprenorphine (1 mg/kg SC; Zoopharm, Windsor, CO) and 
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flunixin meglumine (2.2 mg/kg SC; Merck, Kenilworth, NJ) were given as separate 
injections for pain control. Mice were transferred to a clean, heated cage for 
recovery; mice were monitored at least every 10 to 15 min and were returned to 
their home cage once fully ambulatory. The home cages were placed half on, half 
off of a heated water blanket overnight and returned to the vivarium the following 
morning. All mice were monitored daily after surgery for any signs of pain, distress, 
or surgical complications. Control mice had no experimental manipulation beyond 
fecal collection at days 0 and 8.  
 
5.3.4 Vagal Nerve Stimulation 
 Mice in the experimental group received VNS for 1 h during surgery. The 
right vagus nerve was placed on the electrodes, with the anode positioned distally 
(Figure 5.2). Once positioned, the nerve was stimulated by using a constant cur-
rent stimulator connected to a laptop equipped with LabChart software 
(ADInstruments, Colorado Springs, CO). Stimulation was verified by using a digital 
oscilloscope (Tektronix, Beaverton, OR) coupled to a current probe (Tektronix, 
Beaverton, OR) attached to the electrode leads. The nerve was stimulated 
according to the following parameters: biphasic 0.5-ms square-wave pulses 
(interstimulus interval, 0.1 ms) delivered at 20 Hz (stimulus intensity, 0.2 mA). We 
chose these parameters because of their effectiveness in peripheral nerve 
regeneration after injury2-4,34-37,68 and are commonly used parameters in our lab for 
various other projects to promote swallow and upper airway function in neurologic 
disorders.  
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Figure 5.2. Vagal nerve stimulation. The right vagus nerve (yellow arrow) was isolated in its cervical 
location and placed on bipolar electrodes (green arrow) for electrical stimulation delivered at 20 Hz 
with a 0.2-mA stimulus intensity. *, larynx. 
 
5.3.5 Fecal Collection  
 Fecal collection took place early in the morning (0700 to 0800) after the 
lights were turned on in the housing facility. Mice temporarily were placed 
individually into empty autoclaved cages and allowed to defecate. Approximately 
2 fecal pellets were collected aseptically from each mouse and placed into a sterile 
2-mL tube containing a stainless steel bead (diameter, 0.5 cm; Penn Ball Bearing, 
Delran, NJ).24 Fecal samples were collected the day prior to surgery (day 0) and 1 
wk after surgery (day 8). Fecal samples were stored at –80.0 °C prior to DNA 
extraction.  
 
5.3.6 DNA Extraction 
 DNA was extracted from all samples within 3 consecutive days, by using 
previously described methods.24,26 Briefly, lysis buffer was placed in all tubes 
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containing fecal samples. The samples were homogenized, followed by incubation 
at 70.0 °C for 20 min. After incubation, samples were centrifuged; the entire 
supernatant was transferred to a fresh tube, supplemented with 200 μL of 10 M 
ammonium acetate, and allowed to incubate on ice for 5 min. After centrifugation 
at 5000 × g for 5 min at room temperature, the supernatant was removed, mixed 
with an equivalent volume of isopropanol, and allowed to incubate on ice for 30 
min. Precipitated nucleic acids were pelleted by centrifuging at 16,000 × g for 15 
min at 4 °C, rinsed twice with 70% ethanol, resuspended in 10 mM Tris–1 mM 
EDTA, and then purified (DNeasy Blood and Tissue kit, Qiagen, Hilden, Germany) 
according to the manufacturer’s instructions. DNA yields were determined through 
fluorometry (Qubit, Life Technologies, Carlsbad, CA) by using a reagent kit (Quant-
iT BR dsDNA Kit, Invitrogen, Carlsbad, CA) according to the manufacturer’s 
instructions.  
 
5.3.7 Preparation of 16S rRNA Library and Sequencing  
 Extracted fecal DNA was sent to the University of Missouri DNA Core 
Facility for bacterial 16S rRNA amplification and sequencing according to a 
previously described protocol.24,26,42 Briefly, amplification of the V4 hypervariable 
region of the 16S rDNA gene with previously developed universal primers was 
used to create bacterial 16S rDNA amplicons. Amplicons were purified and 
evaluated by using an automated electrophoresis system (Fragment Analyzer, 
Advanced Analytical, Ankeny, IA). A fluorometer (Qubit, Life Technologies) was 
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used for quantification purposes, and samples were sequenced by using a desktop 
sequencer (MiSeq, Illumina, San Diego, CA).  
 
5.3.8 Informatics Analysis 
 Assembly, filtering, binning, and annotation of DNA sequences was 
performed at the University of Missouri Informatics Research Core Facility 
(Columbia, MO). Operational taxonomic units (OTU) were identified and given 
taxonomic assignments by using BLAST against the SILVA database of 16S rRNA 
sequences and taxonomy.24,26,42 Principal coordinate analysis of 1/4 root-
transformed sequence data and α-diversity indices were performed at the 
University of Missouri Metagenomics Center by using open-access Past 3.18 
software (https://folk.uio.no/ohammer/past/).  
 
5.3.9 Statistics 
 Differences in α-diversity and richness between genotypes on day 0 were 
evaluated by using t tests or Mann– Whitney rank–sum tests, depending on the 
results from Shapiro–Wilk normality tests. Differences in α-diversity and richness 
between treatment groups and genotypes on day 8 were tested by using 2-way 
ANOVA. Changes in α-diversity and richness among treatment groups and 
genotypes between days 0 and 8 were assessed by using 2-way ANOVA. All 
statistical analyses were performed by using SigmaPlot 12.5 (Systat Software, San 
Jose, CA). Differences between genotype GM compositions at day 0 were tested 
by using one-way permutational multivariate ANOVA (PERMANOVA) of ranked 
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Bray–Curtis and unranked Jaccard distances by using PAST 3.18 software. Two-
way PERMANOVA of ranked Bray–Curtis and unranked Jaccard distances were 
used to assess genotype and treatment effects on the GM profiles on day 8. 
Uncorrected P values less than 0.05 were considered significant. 
 
5.4 Results 
5.4.1 Surgical Procedures  
 Overall the SOD1dl and WT mice tolerated the surgical procedure well. 
Three mice (2 SOD1dl, 1 WT) in the experimental group received only 42 to 44 min 
of VNS treatment because they showed increased respiratory effort; in these mice, 
the treatment was stopped prematurely, and they recovered uneventfully. In 
addition, 2 WT mice in the experimental group stopped breathing during recovery. 
Although resuscitation with atipamezole (0.22 mg/kg; SQ) and chest compressions 
was attempted, the mice did not recover. Consequently, these mice were replaced 
with 2 additional age-matched WT mice to complete the study. Another 7 mice (4 
SOD1dl, 3 WT; 2 VNS, 5 sham) developed bradypnea and mild respiratory distress 
after surgery. During recovery, these mice were given atipamezole (0.22 mg/kg 
SC) to reverse anesthesia, which restored respiration and facilitated recovery.  
 
5.4.2 Fecal Collection and DNA Extraction  
 Fecal samples were collected from all mice in the study at day 0, except for 
one SOD1dl mouse that did not defecate in a timely manner and therefore was 
replaced in the study. Fecal samples were obtained from all surviving mice (n = 
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60) on day 8. DNA was extracted from all samples; all but one day 0 sample (WT 
mouse) and 2 day 8 samples (1 WT and 1 SOD1dl) generated sufficient high-quality 
reads to be interpreted.  
 
5.4.3 GM Richness, Diversity, and Composition Profiles  
 Prior to determining the GM composition, the number of OTUs (a measure 
of the richness of the sample) was quantified, and the relative abundance of those 
OTUs (that is, the diversity of the sample) was calculated for each fecal sample. 
Richness and diversity were compared between SOD1dl mice and age-matched 
WT controls at day 0 (before surgery) to determine whether differences between 
genotypes exist prior to disease onset in this model.69 According to Chao1 and 
Simpson indices, richness and diversity did not differ significantly between 
transgenic and WT mice at 5 mo of age (Figure 5.3A). Similarly, richness and 
diversity were compared between the 3 treatment groups (VNS treated, sham, and 
control) and 2 genotypes at day 8, and no significant differences were found 
(Figure 5.3B). Furthermore, changes in richness and diversity between days 0 and 
8 were not significantly influenced by genotype or treatment group (Figure 5.3C). 
Therefore, the overall number of OTUs and their relative abundance in each 
sample was not affected by genotype or treatment.  
 Next, we sought to determine whether the bacterial composition of the GM 
was unique to each genotype at day 0 and to each genotype and treatment group 
at day 8. In all mice, the most abundant bacteria included those in the 
Bacteroidales S24-7 group and the bacterial families of Rikenellaceae and 
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Lachnospiraceae. Taking into account all detected OTUs, samples at each time 
point were compared by using principal coordinate analysis. Unexpectedly, there 
was no separation between genotypes at day 0 (Figure 5.4A) or day 8 (Figure 
5.4B). Furthermore, there was no separation between treatment groups on day 8. 
At both time points, samples showed marked overlap, regardless of treatment 
group or genotype. Statistical analysis through PERMANOVA using Bray–Curtis 
and Jaccard indices confirmed no significant differences between the independent 
variables of this study. This finding suggests that GM profiles are not altered in 
presymptomatic SOD1dl mice compared with age-matched WT controls. In 
addition, the GM composition remained relatively stable over an 8-d time period, 
despite surgical procedures and electrical stimulation of the vagus nerve. We also 
confirmed that administration of antisedan after surgery to reverse anesthesia in 7 
mice did not significantly influence the GM composition (data not shown).  
 Interestingly but unsurprisingly, the GM composition varied depending on 
which breeding group from the SOD1dl colony produced the experimental animal, 
given that GM profiles are typically passed to offspring from the dam.38,41,52 The 
mice in the current study were born from 5 different breeder pairs within the SOD1dl 
colony. Breeder groups consisted of one affected SOD1dl male mated with a 
B6SJLF1/J female. Principal coordinate analysis showed distinct clustering of 
offspring produced from different breeding groups, regardless of genotype, treat-
ment group, or time point (day 0 or 8; Figure 5.5). Results from 2-way 
PERMANOVA comparing mice from the different breeder groups and each time 
point of the study showed the GM composition differed significantly (P = 0.0001) 
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between mice from the different breeding groups but not between time points. In 
addition, analyses were performed separately for the offspring from each breeder 
group to determine whether genotype or treatment effects differed significantly 
between mice from each breeding group; however, no significant results were 
found. These findings further support that neither genotype nor treatment affected 
the GM composition of the mice used in this study. 
 
Figure 5.3. Richness and α-diversity of fecal samples. Richness (left panels) was quantified 
according to the Chao1 index, whereas α-diversity (right panels) was characterized by using the 
Simpson index. (A) Neither richness nor α-diversity differed significantly between genotypes at day 
0. (B) Neither richness nor α-diversity differed significantly between genotypes or treatment groups 
at day 8. (C) Neither richness nor α-diversity differed between day 0 and day 8 samples across 
genotypes or treatment groups. OTU, operational taxonomic unit; VNS, vagal nerve stimulation.  
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Figure 5.4. Principal coordinate analyses of the samples at (A) day 0 and (B) day 8. Operational 
taxonomic unit-level data were normalized through 1/4 root transformation. No distinct clustering 
or separation of samples between genotypes or treatment groups was evident at either time point. 
VNS, vagal nerve stimulation. 
 
 
Figure 5.5. Principal coordinate analyses of samples from both time points (days 0 and 8). Different 
colors represent the offspring from different breeding groups at both time points (n = 7 to 18 per 
group of offspring); filled symbols represent day 0 data; open symbols indicate day 8 data. GM 
profiles cluster among offspring born from the same breeder pairs. Samples cluster significantly 
between breeder groups (P < 0.0001, PERMANOVA). No separation according to genotype oc-
curred when each breeder group was analyzed separately (data not shown). 
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5.5 Discussion  
 In summary, the results obtained from this study suggest that brief periods 
of intraoperative VNS, using the described stimulation parameters, do not have 
long-term effects on the GM composition in mice. In addition, GM profiles were 
similar between presymptomatic SOD1dl mice and their age-matched WT controls. 
Although GM profiles differed among offspring from different breeder pairs, the GM 
was consistent across both time points, regardless of genotype or treatment group. 
Given that this study is the first to investigate how VNS may modulate the GM, the 
lack of changes between treated and untreated mice does not automatically 
warrant dismissal of this experimental and potential therapeutic modality. Several 
explanations might account for the observed lack of GM modification due to 
treatment or genotype, and various study limitations must be discussed. 
 The first caveat of this study was that VNS was applied for a short duration 
(1 h) during a surgical procedure. Not only may surgery itself be a confounding 
variable, the short duration of VNS is minimally translatable to human patients, 
who receive implantable devices for VNS therapy.39,58,66 In the current study, the 
surgery variable was controlled by using a sham surgery group and a control group 
that did not receive either treatment or surgery. The surgical procedure and 
experimental protocol for this study were chosen to ensure that the VNS procedure 
does not alter the GM in the experimental mice undergoing the same procedures 
for different studies in our lab. It is reassuring to know that our experimental 
paradigm does not have lasting effects on the GM in our mouse models. However, 
for many human patients, VNS is often delivered through an implantable device 
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enabling long-term therapy,39,58,66 which operates when patients are awake and 
freely living their lives. Chronic application of VNS likely would have a greater effect 
on GM populations than a brief exposure to VNS during surgery.12 Therefore, 
additional studies using implantable VNS devices that can deliver chronic VNS 
therapy outside of a surgical procedure are warranted.  
 A second limitation of this study was that only one set of stimulation 
parameters was used. Again, we selected these stimulation parameters because 
they are commonly used in our laboratory to promote normal swallowing49 and 
upper airway function. We are currently examining laryngeal nerve stimulation in 
the SOD1dl mouse model and intraoperative VNS stimulation in a mouse model of 
recurrent laryngeal nerve injury. The parameters used in our studies are based on 
numerous other published works indicating these parameters are useful in pe-
ripheral nerve regeneration.2-4,34-37,68 Although it is reassuring to confirm that the 
stimulation parameters used in our studies do not significantly alter the GM in our 
mouse models, how other stimulation parameters might affect the GM is unknown. 
Stimulation parameters consist of variables including the frequency, pulse width, 
waveform, amplitude, and continuity of the pulses delivered to the nerve.11 
Furthermore, electrode design itself adds additional variables, which include the 
geometry, materials used, impedance, and the location of the electrode on the 
nerve.39 Finally, it is essential to consider the characteristics of the target neurons 
themselves. Given that the vagus nerve is composed of both afferent and efferent 
neurons, consisting of A, B, and C fiber types,14,39,55,60 different parameters and 
electrode designs might target some fiber types over others. Therefore, factors 
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such as axonal diameter, conduction velocity, and threshold potential60 of the 
target axons directly influence the stimulation parameters that should be used for 
the intended function.55 Consequently, all variables must be optimized for the 
effective use of VNS in its proposed function, whether that is inhibiting seizures, 
promoting vocal function, or manipulating the GM.  
 Identifying the optimal VNS parameters for a given function is challenging. 
Even when VNS is applied in an approved manner, such as for refractory epilepsy, 
the optimal VNS parameters for each individual patient are unknown.39,55,71 The 
stimulation parameters used in the current study were designed to target 
degenerating motor neurons by sending signals to the cell bodies in the brainstem 
to trigger upregulation of neurotrophic factors and regeneration-associated genes 
to promote nerve regeneration.2,4,31,36,59 Therefore, it remains likely that the GM 
could be modulated by using different stimulus parameters and electrode 
orientations that specifically target the gastrointestinal tract. For instance, in a 
swine model of obesity, bilateral thoracic VNS was delivered as bipolar pulse trains 
consisting of 30-Hz, 500-μs pulses for 30 s every 5 min at a maximum intensity of 
2 mA for 14 wk.66 In this swine model, there was a delay between the onset of 
simulation and the appearance of beneficial effects (that is, decreased weight gain, 
food consumption, and sweet cravings). Although VNS causes changes in the 
brain regions involved in the regulation of food intake, the underlying mechanisms 
of action for the observed beneficial effects of VNS in obesity are largely 
unknown.39,66 Given that the GM has been implicated in contributing to obesity,53 
perhaps part of the equation of VNS efficacy in this obesity model is its GM 
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modulation potential. In other words, VNS may be modulating the GM in 
experimental models where the gastrointestinal tract is targeted, thus contributing 
to the efficacy of treatment. However, this possibility has not been explored at this 
time.  
 Unexpectedly, we could not replicate the results of a recent study.69 This 
outcome likely was due to slight variations in experimental and statistical design, 
making comparisons between the 2 studies difficult. The previous study69 used the 
most common ALS mouse model, G93A-SOD1, which harbors high copy numbers 
of a transgene construct carrying a human SOD1 gene with a glycine-to-alanine 
transition at position 93.40,69 Fecal samples were collected from 2-mo-old mice to 
determine GM compositions prior to ALS symptom onset around 3 mo of age.69 
The authors used qPCR analysis to show that transgenic mice had reduced levels 
of Butyrivibrio fibrisolvens, Escherichia coli, and Peptostreptococcus, which may 
have contributed to an observed shift in the GM profiles between affected and WT 
mice.69 In our present study, we used mice with the same transgenic construct, 
although it is present at lower copy numbers, corresponding to a delayed 
phenotypic onset of disease.1,18 We, too, explored GM profiles in transgenic and 
age-matched WT controls approximately 1 mo prior to disease onset in our colony 
(6 mo of age). However, we found no significant differences in GM compositions 
between genotypes in our study.   
 One explanation for why we were unable to replicate the previous results69 
might be due to differences in the background strain. Our mice are maintained as 
a B6SJL hybrid strain. The background strain of mice in the aforementioned study 
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was not specifically stated.40 However, background strain significantly influences 
disease phenotype in SOD1 mouse models of ALS.1,44 Age at onset of disease 
symptoms, such as tremor, loss of limb tone, and decreased grip strength, as well 
as duration of survival differ significantly by genetic background. Different 
background strains of mice harbor distinct GM profiles, which vary by institutional 
vendor24 and various husbandry and environmental factors.25,29 Therefore, 
background strain likely influences the potential differences observed in GM 
profiles between transgenic and age-matched WT mice.   
 In addition, it is worth noting that our present study had large sample sizes 
(30 SOD1dl and 30 WT mice) and equal distribution according to sex between 
genotypes, because ALS phenotype can vary markedly depending on sex.44 Due 
to our large sample size, mice used in this study comprised offspring from 5 dif-
ferent breeder pairs in our colony. For feasibility purposes, the study was 
performed by using 7 cohorts of mice. The mice in the previous study40 likely were 
offspring from a single litter, with the entire study conducted as a single run. 
Therefore, the question arises regarding whether genotype-dependent differences 
in GM profiles might have emerged between offspring from the same breeder pair. 
Therefore, we confirmed our negative results by investigating the GM profiles 
between offspring from each breeder pair. Again we found no significant differ-
ences between genotypes in this second analysis.  
 Diet and caloric intake are 2 additional factors that might alter the GM 
composition in the high-copy-number SOD1 strain used in the previous study69 but 
not the low-copy-number SOD1dl strain used in our study. These factors have been 
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shown to greatly influence the GM.19,20,22,23,74 In our lab, we have demonstrated 
that the high-copy SOD1 strain develops dysphagia at weaning (approximately 3 
to 4 wk of age).17 High-copy SOD1 mice have decreased swallowing,47 licking, and 
mastication rates48 that can be identified prior to the onset of limb paralysis. 
Therefore, the high-copy strain develops dysphagia during the developmental and 
maturation life stages. The low-copy SOD1dl strain develops similar symptoms of 
dysphagia; however, they do not develop swallowing impairment until fully mature 
(that is, near 6 mo of age), consistent with the onset of other ALS symptoms in this 
model. Therefore, potential variations in diet and total caloric intake between 
transgenic and WT mice during developmental stages might affect the GM more 
strongly in the high-copy SOD1 strain than in the low-copy model, which already 
has established and maintained a GM profile prior to disease onset.  
 In conclusion, this study assessed the GM modulatory potential of VNS in 
healthy and neurologically diseased mice. Although the GM profiles did not differ 
significantly between transgenic and WT controls or with VNS treatment, 
numerous possibilities remain regarding future explorations in this continuously 
expanding neuromodulatory technology. Some of our mice undergoing surgery 
experienced respiratory difficulty, but this side effect likely was due to the 
prolonged anesthesia produced through an injectable anesthetic regimen rather 
than to genotype or treatment factors. Therefore, short-term intraoperative VNS is 
a relatively safe procedure to perform and, under specific stimulation parameters, 
does not alter GM populations. Additional studies examining VNS with stimulation 
parameters that better target the gastrointestinal tract and using chronic VNS are 
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warranted. Despite the neutral results from this study, VNS remains a promising 
experimental and therapeutic modality for manipulating gastrointestinal microbial 
communities. 
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Chapter Six 
 
SUMMARY AND FUTURE DIRECTIONS 
 
 
6.1 Summary 
 The goal of this work was to develop and refine a mouse model to 
investigate recurrent laryngeal nerve (RLN) injury and potential therapeutic 
interventions. As highlighted in the introduction of this dissertation, RLN injury and 
subsequent vocal fold (VF) paralysis often result in diminished health and poor 
quality of life for the patient due to airway complications associated with 
swallowing, respiration, and vocalization. Current studies that investigate these 
somatic manifestations of VF paralysis, especially in a single model, are lacking. 
Thus, this work sought to increase the translational potential in a mouse model of 
RLN injury. By developing a comprehensive behavioral regimen and refining 
methodology, we have added to the collective knowledge of RLN injury and have 
created a model that will aid researchers to better assess RLN injury and recovery 
in their studies.  
 In Chapter 2, we started our model development journey by differentiating 
the effects of superior laryngeal nerve (SLN) versus RLN injury on VF mobility and 
swallowing behavior. As both nerves branch from the vagus and supply sensory 
and motor information to intrinsic laryngeal muscles, it was essential to confirm the 
fidelity of the laryngeal innervation pattern and functional outcomes between mice 
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and humans. In this study, we confirmed chronic VF immobility after RLN 
transection with small changes in swallowing behavior. In contrast, the SLN had 
no visible effect on VF mobility and only affected swallow function if the nerve was 
injured bilaterally. In this study, we also performed preliminary work to investigate 
a more clinically prevalent injury, a crush injury, and a potential treatment strategy, 
intraoperative Vagal Nerve Stimulation (iVNS). Though the results of this pilot iVNS 
study are promising, additional work is necessary to refine the crush injury model 
and optimize iVNS treatment parameters in a larger sample size.  
 While it was relatively simple to determine if the VFs were mobile versus 
immobile after laryngeal nerve injury, quantification of mobility during functional 
recovery was quite challenging and inconsistent due to subjectivity between 
reviewers. Furthermore, objective methods were time consuming and did not 
capture the true motion of the VFs during dynamic movement. Thus, we sought to 
create a method for objective quantification of dynamic VF movement that could 
be automated for increased efficiency and high throughput analysis. By 
collaborating with students and faculty in the Department of Electrical Engineering 
and Computer Science at the University of Missouri, we have developed a novel 
software to track and quantify VF motion. As discussed in Chapters 3 and 4, with 
this software, we can now automatically and objectively quantify the range, 
frequency, and directionality of VF motion, as well as determine if paradoxical VF 
motion is present and characterize its activity. 
 In addition to enhancing the methods for VF motion quantification, in 
Chapter 4, we further refined available behavioral analyses to investigate the 
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sequela of RLN injury over time in a single animal model. With this study, we 
identified novel outcome metrics to identify voice and respiratory dysfunction in the 
mouse after RLN transection. Multiple ultrasonic acoustic parameters analogous 
to human vocal outcomes were affected by RLN injury. The mice also showed 
evidence of dyspnea during increased respiratory effort similar to humans with 
unilateral VF paralysis. Though dysphagia was not noted in this work, other 
methods such as manometry or automated video tracking with a higher speed 
camera may be useful in future studies to assess swallow dysfunction that cannot 
be captured with manual videofluoroscopic swallow study analysis.  
 Lastly, before moving forward with therapeutic investigations using iVNS in 
this model, it was necessary to ensure our chosen stimulation parameters did not 
have any off-target effects in the many other organ systems innervated by the 
vagus nerve. While numerous studies have been conducted on the safety of vagal 
nerve stimulation in regard to cardiorespiratory function,1-4 no published study has 
examined how iVNS may influence the gastrointestinal microbiome. As the brain-
gut-microbiome axis is critical for maintaining homeostasis,5-7 it is necessary to 
determine if iVNS alters the microbial population living within the mammalian 
gastrointestinal system. Thus, we performed iVNS in a mouse model of 
amyotrophic lateral sclerosis (ALS), a neurologic disorder affecting motor neurons. 
This model of neurologic disease (maintained on a hybrid B6-SJL background) 
was chosen over the standard B6 model used in our previous studies for several 
reasons. First, previous literature had noted altered gastrointestinal microbiota 
populations in a similar ALS model,8 and we sought to determine if the ALS model 
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in use in our lab had related changes. Second, nerve stimulation has therapeutic 
potential for multiple neurodegenerative diseases, and the lab plans to utilize 
implantable VNS devices in this model in future experiments. Therefore, this work 
laid the groundwork for multiple investigations in various models in the lab. 
Importantly, we have shown that our chosen stimulation parameters do not affect 
the gastrointestinal microbiome when applied for a short duration. However, it 
remains critical to examine long-term stimulation with different parameters to 
ensure chronic treatment will not influence gastrointestinal microbial populations.  
  
6.2 Future Directions 
6.2.1 Recurrent Laryngeal Nerve Crush Injury  
Work in our lab has already began to extrapolate the RLN transection model 
for use in more clinically relevant injury types, such as a crush (i.e., compression) 
injury, and for therapeutic investigations using iVNS. Multiple methods of inducing 
an RLN crush injury were attempted, yet many of these resulted in variable or 
inadequate severity of injury, making recovery analysis difficult. Thus, a custom 
designed “crush tool” (Figure 6.1) was developed to overcome the limitation of 
previously used compression methods. This tool is micromanipulator-controlled to 
relieve traction forces and utilizes positioning hooks on the compression surface 
to ensure each nerve is placed in the same location on the tool. The crush tool 
also features a remote activation of the crush to enhance ergonomics and avoid 
inadvertent movement of the crush tool. This tool provides adequate compression 
forces (~30 N) to fully disrupt all axons within the crush site, as seen on 
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transmission electron microscopy in Figure 6.2. The lab aims to utilize this tool in 
future RLN and facial nerve crush experiments. Plans to automate the crush action 
of the tool are in progress to further reduce human error in pressure on the remote 
activation lever and timing of the crush injury. 
  
Figure 6.1. Novel Nerve Crush Tool. A micromanipulator-controlled crush tool was developed to 
ensure reproducible compression forces across mice and studies. Features include positioning 
hooks (red arrow) and a remote activation device (yellow arrow). Automation of the crush tool is 
currently in progress.  
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Figure 6.2. Transmission Electron Microscopy of the RLN three days post-crush injury. The newly 
developed crush tool was utilized to crush the RLN in B6 mice, resulting in complete destruction of 
all axons (i.e., lack of myelin sheath and evidence of myelin debris (arrows)) within the nerve distal 
to the injury site. Functionally, the mice had complete ipsilateral vocal fold immobility at three days 
post-injury.  
 
6.2.2 Intraoperative Vagal Nerve Stimulation (iVNS) 
Because a crush injury is more prevalent in human patients with RLN injury, 
it is essential to perform therapeutic investigations using a crush technique to 
further increase the translational potential of this model. As such, we have started 
to perform additional studies using an RLN crush injury to investigate iVNS as a 
potential therapy. In these studies, we have begun to utilize the behavioral regimen 
outlined in this dissertation work to evaluate functional recovery in mice with and 
without iVNS treatment.  
Without iVNS treatment, our preliminary results have indicated that mice 
with an RLN crush injury exhibit similar functional outcomes as mice with RLN 
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transection injuries (i.e., ipsilateral, VF immobility and decreased apnea 
formation). However, as the nerve remains intact, spontaneous functional recovery 
is observed in the weeks following injury. The goal of iVNS treatment would be to 
hasten this recovery time, as human patients with RLN injury can take weeks to 
years to recover completely, if at all. This recovery period in mice is extremely 
quick due to their relatively short length of the RLN; thus, the most opportune time 
points for functional analysis to evaluate treatment outcomes remain to be 
elucidated in the crush injury model.  
Once identified, further work to investigate iVNS treatment can begin, 
including identifying the most optimal stimulation parameters specific for RLN 
regeneration and functional recovery. If effective, iVNS could be used during 
anterior neck and thoracic surgeries to prevent post-operative complications 
associated with RLN injury. This technology would be particularly advantageous in 
procedures in which intraoperative monitoring equipment is utilized. If an RLN 
injury is detected during surgery, therapy could be applied, perhaps through the 
monitoring equipment itself, with modifications incorporated to permit changes in 
current flow direction and stimulus parameters (e.g., frequency and duration). 
In conclusion, the RLN is a complex nerve that can dramatically impact 
quality of life if injured. This work has provided the foundations for an animal model 
to thoroughly investigate functional outcomes after RLN injury. With this model, we 
can better understand RLN injury and begin to explore treatments to regenerate 
RLN neurons in hopes to improve patient health outcomes. 
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Appendix 
 
TRANSMISSION ELECTRON MICROSCOPY PROTOCOL  
 
Recurrent Laryngeal Nerve Sample Collection 
1) Euthanize mouse with an overdose of pentobarbital (0.2 ml) 
2) Perfuse mouse 
a) Approximately 30 ml saline 
b) Followed by approximately 30 ml 4% paraformaldehyde (PFA) 
3) Incise ventral neck and reflect or transect skin from chin down to sternum 
4) Remove salivary glands and caudal portion of rib cage 
5) Prepare trachea, esophagus and RLNs for removal en block 
a) Use gentle blunt dissection to loosen connective tissue under trachea, 
esophagus, and RLNs 
b) Use microscissors to cut connective tissue and muscle at rib cage 
c) Transect en bloc section at level of the first rib, proximal to heart and 
lungs 
d) Make a midline cut through mandible  
e) Use microscissors to loosen larynx from oral cavity and transect at 
caudal portion of the tongue 
6) Remove en bloc section from mouse and transfer to a glass cutting dish 
7) Using a razor and scalpel blade transect entire section immediately 
proximal to carbon powder that is marking the crush site (if present).  
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8) Fix desired section (usually the rostral half) in 4% PFA + 2% Glutaraldehyde 
prior to resin embedding 
Follow standard TEM embedding and staining procedures 
Divide en bloc section into left and right sides prior to imaging 
1)  Stain a thin section with Toluidine blue and confirm visualization of the left 
and right RLN 
2) Using a diamond knife, cut the block into left and right sides to image 
separately 
  
203 
 
VITA 
 
 Megan M. Haney was born in Lincoln, Nebraska to Robert and Margie 
Haney.  She was raised in Lincoln, where she attended Saint Pius X High School 
and grew a passion for animals and science. After high school, she attended 
Kansas State University for her undergraduate education. As a freshman, she was 
admitted into the Kansas State University College of Veterinary Medicine Early 
Admission Program. This program allowed her to start her veterinary career a year 
early. Thus, she graduated Summa Cum Laude with a BS in Animal Sciences and 
Industry in 2010, followed by graduation Magna Cum Laude with her veterinary 
medicine degree (DVM) in 2014.  
 Immediately following veterinary school, she entered the University of 
Missouri Comparative Medicine Program. Through this program she completed a 
residency in laboratory animal medicine while working towards a doctoral degree 
(PhD) in Veterinary Pathobiology, partly supported by NIH T32 grant funding. She 
has conducted her dissertation work in the lab of Dr. Teresa E. Lever developing 
and characterizing a translational mouse model of recurrent laryngeal nerve injury 
for use in future therapeutic investigations.  
 
           
 
 
